Wiki · Index

Gene Index

Every gene the corpus names, re-scanned across the 851 published pages of this edition. Each entry carries its mention count and links straight to the papers and concept pages that discuss it — search a symbol or alias, or filter by cluster.

530
Genes
36,231
Mentions
851
Pages scanned
18
Clusters
APOE Amyloid & Tau core 3,814 499 docs
Matched on apoe[234]? apo[- ]?E[234]? apolipoprotein E
  1. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper291
  2. Convergent Synaptic Collapsepaper268
  3. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper153
  4. Which Genes Set the Threshold for Collapsepaper109
  5. The Narrow Gate Every Mitochondrial Protein Must Passpaper101
  6. Lipid Peroxidation and ApoER2–Dab1 Disruption in Sporadic Alzheimer's Diseasepaper87
  7. How the Genes Partition the Vascular Phenotypepaper80
  8. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper77
  9. Choline, Phosphatidylcholine and APOE4 in Alzheimer's Diseasepaper76
  10. Blood-Vessel Damage, Phase by Phasepaper65
  11. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper62
  12. The Genes That Protect — Phenocopy the Fortunatepaper58
  13. LRP1 and the Templated Spread of Misfolded Proteinpaper57
  14. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper57
  15. Seth Margolis Revisitedpaper51
  16. Vascular Pathology as a Substrate Across Phasespaper47
  17. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper45
  18. Tau Kindling in the Locus Coeruleuspaper44
  19. Cofilin Serine 3paper37
  20. Can a Drug Copy the Luckiest Mutation?paper36
  21. Estela Area-Gómez's MAM Theorypaper34
  22. The Brain's Architect and the Brake It Puts on Taupaper34
  23. Ceramide as a Structural and Signalling Node in Alzheimer's Diseasepaper32
  24. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper31
  25. The Losing Axonpaper30
  26. LL-37, Innate Immunity and Autophagic Collapse in Alzheimer's Diseasepaper29
  27. Reelin, N-Sulfated Heparan Sulfate and ApoER2paper29
  28. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper26
  29. Reelin-ApoE receptor axis disruptionconcept22
  30. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper21
  31. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper21
  32. Restoring Autophagy in Neurodegenerationpaper21
  33. The Drivers of Microglial Dysfunction in Alzheimer's Disease, Ranked by Causal Weightpaper21
  34. The Load-Bearing Neuronpaper21
  35. Gouraspaper20
  36. Margolispaper20
  37. ApoE4 structural vulnerabilityconcept18
  38. From Gut Ecology to the Failed Antidepressant Trialpaper18
  39. Peroxidized ApoE as proximate causeconcept18
  40. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper18
  41. Microglial Restraint as Resiliencepaper17
  42. Todd Golde's Amyloid Cascade, Read for What It Addspaper17
  43. Immune-pathogen interaction modelconcept16
  44. Lipid peroxidation cascade at synapseconcept16
  45. Multi-cellular pathologyconcept16
  46. Neurovascular dysfunction as initiating eventconcept16
  47. Post-translational modification dysregulationconcept16
  48. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper16
  49. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper15
  50. Lysosomal Membrane Damage as the Upstream Determinant of Microglial Statepaper15
  51. PARP Inhibitors and the Locus Coeruleuspaper14
  52. APOE4 Pathogen Interactionconcept12
  53. Moosmann & Sohrepaper12
  54. TOMM40 Import Gateconcept12
  55. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper11
  56. APOE4 Hubnode11
  57. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper11
  58. Gunnar Gouras's Intraneuronal Amyloid and the Synaptic Endosome, Twenty-Eight Years Onpaper10
  59. Iron Chelation and GPX4 Stabilizationpaper10
  60. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper10
  61. Lipid Transportconcept10
  62. Plaques Are Tombstones, Not Killerspaper10
  63. Rappoportpaper10
  64. Chronic Excitatory Insufficiencyconcept9
  65. The Bredesen Protocol Compared Against the Convergent Collapse Frameworkpaper9
  66. The Lipid That Kills Neurons and Spares Tumourspaper9
  67. The Locus Coeruleus and the Noradrenergic Prodrome of Alzheimer's Diseasepaper9
  68. The Mitochondria-Associated Membrane Hypothesis of Alzheimer's Disease, Evaluatedpaper9
  69. Anne Eckert's Neuroendocrine Theory and the Withdrawal of Protection in the Ageing Brainpaper8
  70. Cholesterol Homeostasisconcept8
  71. Dietary Fatty Acid APOE4 Rescueconcept8
  72. Endolysosomal Dysfunctionconcept8
  73. From Synapse Loss to Neuronal Death in Alzheimer's Diseasepaper8
  74. Gene Environment Interactionconcept8
  75. Homeostatic Collapsepaper8
  76. Lipid Metabolismconcept8
  77. ApoE-centric unified modelconcept7
  78. APOE4 Endolysosomal Dysfunctionconcept7
  79. Endosomal Traffickingconcept7
  80. Excitatory–Inhibitory Balance in Alzheimer'spaper7
  81. Layer II Immature Neurons, Disease-Associated Microglia and the Reelin–Ephexin5 Axispaper7
  82. Lipid Peroxidationconcept7
  83. LL-37, CLIC1 and Microglial Lysosomal Failurepaper7
  84. Templated Tau Misfolding Across the Three Phasespaper7
  85. The Microglion That Silences Tau's Phosphatasepaper7
  86. Alzheimer's Disease — A Process in Timepaper6
  87. Brain Lipid Homeostasis Restorationconcept6
  88. Cholesterol Transportconcept6
  89. Chronic intracellular infection modelconcept6
  90. Convergent Autophagic Collapsepaper6
  91. Cortical Immature Neurons of Layer IIpaper6
  92. Dual Pathogen AD Pathogenesisconcept6
  93. Epigenetic Repressionconcept6
  94. Fischer's Sixth Stage and the Leptomeningeal Compartment It Never Enteredpaper6
  95. Infectious etiology of late-onset ADconcept6
  96. Matrix Sulfation Nodeconcept6
  97. Membrane Biologyconcept6
  98. Norepinephrine as a Two-Armed Pincer on Taupaper6
  99. Olfactory Route Neuroinvasionconcept6
  100. Olfactory vector hypothesisconcept6
  101. One Sugar Lattice, Three Jobspaper6
  102. Ordered Attrition and Resilience as the Two Human-Evidence Anchors of Alzheimer'spaper6
  103. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper6
  104. Selective Tau Disruptionconcept6
  105. Smallpaper6
  106. Tau Scaffolding Interactionsconcept6
  107. Vesicular Traffickingconcept6
  108. Antibody Target Specificityconcept5
  109. ApoE isoform-heparin binding differencesconcept5
  110. Bioenergetic Collapsepaper5
  111. Cholesterol deficiency driving AD pathologyconcept5
  112. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper5
  113. Disciplinary Silos in Alzheimer's Disease Research, 1950–2020paper5
  114. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper5
  115. Mitochondrial Quality Control Across Five Diseasespaper5
  116. Plaque IgG Sequestrationconcept5
  117. Scott Small's Retromer and Endosomal Theorypaper5
  118. Systemic to Central Immune Signalingconcept5
  119. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper5
  120. The Cholinergic Nucleus Basalis in Alzheimer's Diseasepaper5
  121. The Enzyme That Cuts the Protective Latticepaper5
  122. The Indifferent Neuronpaper5
  123. The Inflammasome Versus the Reelin Brakepaper5
  124. Trauma Induced Viral Reactivationconcept5
  125. Vessel Associated Microglial Activationconcept5
  126. Viral Pathogenesisconcept5
  127. Abeta aggregation as necessary initiating eventconcept4
  128. Aleksandra Deczkowska's DAM Program and the Matrix-Degrading Armpaper4
  129. Autophagy Dysfunctionconcept4
  130. Compensatory Homeostasisconcept4
  131. Endosomal Nexusnode4
  132. Environmental Toxicologyconcept4
  133. Excitatory Neurotransmissionconcept4
  134. Fischer's Eighth Stage as a Measurement of Rate Against Host Capacitypaper4
  135. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper4
  136. Genetic evidence as gold standard for causalityconcept4
  137. Innate Immunityconcept4
  138. Long preclinical phase of AD pathologyconcept4
  139. Multifactorial modulation of disease trajectoryconcept4
  140. Pavel Kalvach's Case That Alzheimer's Is Not a Disease, Gradedpaper4
  141. PERK DLX1 Tau Axisconcept4
  142. Synaptic Physiologyconcept4
  143. Synaptic Plasticityconcept4
  144. Translational Regulation in Tauopathyconcept4
  145. Why Exercise Prevents but Does Not Curepaper4
  146. AD as accumulation of insults exceeding homeostasisconcept3
  147. Age-dependent feedback loops in neurodegenerationconcept3
  148. AI Neurotherapeutic Discoveryconcept3
  149. Amyloid Nucleationconcept3
  150. Antioxidant defense failureconcept3
  151. Autophagic Flux in Alzheimer's Diseasepaper3
  152. Autophagy-lysosomal failureconcept3
  153. Bess Frost's Chromatin Programme, the Elements It Releases, and the Restraint on cGASpaper3
  154. BIN1 Autophagic Regulationconcept3
  155. Blood-based biomarker discoveryconcept3
  156. cGAS–STING in Alzheimer's Diseasepaper3
  157. Chronobiologic neuroprotection via melatoninconcept3
  158. Cognitive resilience as dynamic protective conceptconcept3
  159. Dietary Sodium Neurodegenerationconcept3
  160. Entropy as organizing principleconcept3
  161. Environmental and socioeconomic risk factorsconcept3
  162. Environmental toxicology of neurodegenerationconcept3
  163. Epigenetic regulation of AD genesconcept3
  164. ESCRT III Membrane Scissionconcept3
  165. Evolutionary framework for AD causationconcept3
  166. Evolutionary mismatch between genes and modern lifestyleconcept3
  167. Evolutionary mismatch hypothesisconcept3
  168. Extracellular Matrix Pathologyconcept3
  169. Familial vs sporadic ADconcept3
  170. Fischer's Staged Deposit, 1907–1912paper3
  171. GAG-driven AD pathogenesisconcept3
  172. Glycobiologyconcept3
  173. Gut-brain axis in neuroinflammationconcept3
  174. Health disparities in ADconcept3
  175. Infectious etiology of LOADconcept3
  176. Innate immunity failure in sporadic ADconcept3
  177. Inside Out Plaqueconcept3
  178. Intracellular Amyloidconcept3
  179. Lipid-driven neurodegenerationconcept3
  180. Lipid-glycan crosstalk in ADconcept3
  181. Liver-brain metabolic axisconcept3
  182. Lysosomal Acidificationconcept3
  183. Lysosomal Storage Diseaseconcept3
  184. Membrane lipid pathology in ADconcept3
  185. Mercury as primary AD causeconcept3
  186. Metabolic dysfunction in neurodegenerationconcept3
  187. Metal-protein interaction in diseaseconcept3
  188. Microglial Protein Biomarkersconcept3
  189. Modifiability of AD riskconcept3
  190. Morphological analysis methodologyconcept3
  191. Mosaic model of aging brainconcept3
  192. Multi-pathway AD pathophysiology reviewconcept3
  193. Multifactorial causal networkconcept3
  194. Multifactorial prevention through modifiable risk factorsconcept3
  195. Neurotransmitter disruption cascadeconcept3
  196. Non-optimal aging rather than normal aging processconcept3
  197. Onset vs Progressionconcept3
  198. Oxidative stress as unifying mechanismconcept3
  199. Phase IIpaper3
  200. Population-specific AD genetic signaturesconcept3
  201. Precision medicine for ADconcept3
  202. Production-clearance equilibriumconcept3
  203. Proteasome Tau Feedbackconcept3
  204. Proteoglycan role in amyloid formationconcept3
  205. Quality Control Collapseconcept3
  206. Risk factor convergenceconcept3
  207. SorLA Lipid ER Regulationconcept3
  208. The Brain's Border Gatepaper3
  209. The Calcium Hypothesis and the Systems Failure Model of Alzheimer's Diseasepaper3
  210. The Immunometabolic Nexus of Neurodegenerationpaper3
  211. The Locus Coeruleus as Phase Bridgepaper3
  212. The Matrix as the Seventh Axis of Collapsepaper3
  213. The Phase II → III Transitionpaper3
  214. The Strongest Case FOR the Amyloid Cascadepaper3
  215. Transcriptional Pause Releaseconcept3
  216. UBE3A, PTPA and Ephexin5paper3
  217. Unified theory of AD etiologyconcept3
  218. Vascular Amyloid Interactionconcept3
  219. Vascular dysfunction as earliest detectable changeconcept3
  220. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper2
  221. Abeta as stress response markerconcept2
  222. Acyloxyacyl Hydrolase Neuroprotectionconcept2
  223. AD as accelerated aging of Abeta managementconcept2
  224. AD as clinical syndrome not diseaseconcept2
  225. AD caused by APP dysregulation not Abeta per seconcept2
  226. Adult Hippocampal Neurogenesis and the Substrate of Cognitive Reservepaper2
  227. Adult Neurogenesisconcept2
  228. Age-dependent threshold modelconcept2
  229. Age-related immune dysfunction enables neurotropic virusesconcept2
  230. Aging accelerators and deceleratorsconcept2
  231. Aging as Mechanismconcept2
  232. Aging as root cause of ADconcept2
  233. Aging-epigenetic-genetic interactionconcept2
  234. AI Disease Model Discoveryconcept2
  235. AI-based early diagnosisconcept2
  236. Aluminum as primary environmental causeconcept2
  237. Aluminum driving amyloid productionconcept2
  238. Amyloid and tau as secondary byproductsconcept2
  239. Amyloid as antimicrobial defenseconcept2
  240. Amyloid as downstream secondaryconcept2
  241. Amyloid clearance as important as depositionconcept2
  242. Amyloid Clinical Disconnectconcept2
  243. Amyloid plaques as fibrotic scar tissue from BBB repairconcept2
  244. Amyloid-beta as innate immune defenseconcept2
  245. Anti Ferroptotic Botanicalsconcept2
  246. Antimicrobial Defenseconcept2
  247. Antimicrobial hypothesis of amyloidconcept2
  248. APP and tau pathology linked through transport disruptionconcept2
  249. APP as dependence receptorconcept2
  250. Astrocyte network management hypothesisconcept2
  251. Astrocyte-driven amyloid buildupconcept2
  252. Asymptomatic AD Phenotypingconcept2
  253. ATN biomarker classification systemconcept2
  254. ATP-chaperone-protein folding axisconcept2
  255. Autoimmune contribution via BBB compromiseconcept2
  256. Autoimmune Neurodegenerationconcept2
  257. Autophagic Collapseconcept2
  258. Autophagyconcept2
  259. Autophagy-amyloid couplingconcept2
  260. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper2
  261. Axon initial segment as key disease locusconcept2
  262. Axonal atheroma hypothesisconcept2
  263. Axonal transport failure as unifying mechanismconcept2
  264. Bacterial exudate-driven neurodegenerationconcept2
  265. Barrier dysfunction pathologyconcept2
  266. BBB as gatekeeper failureconcept2
  267. BBB breakdown cascadeconcept2
  268. BBB degradation and pathogen invasionconcept2
  269. BBB-mediated vascular contributionconcept2
  270. BCG Immune Checkpoint Modulationconcept2
  271. Beta Alanine Neurotransmissionconcept2
  272. Beth Stevens's Complement-Pruning Programpaper2
  273. Bimodal brain (inference vs training)concept2
  274. Bioenergetic defects as early eventsconcept2
  275. Blood-based biomarker panels for preclinical detectionconcept2
  276. Blood-based lipid and protein module biomarkersconcept2
  277. Brain DNA blueprint is altered in AD neuronsconcept2
  278. Calcium-mediated tauopathyconcept2
  279. Cannabinoid Neuroprotectionconcept2
  280. Causation pyramid modelconcept2
  281. CDK3 Cell Cycle Toxicityconcept2
  282. Cellular Identityconcept2
  283. Cellular Vectorsconcept2
  284. Cholinergic network failure in ADconcept2
  285. Chronic intracellular pathogen-driven neurodegenerationconcept2
  286. Chronic neuroinflammation from infectionconcept2
  287. Chronic neuroinflammation from peripheryconcept2
  288. Circadian Immune Regulationconcept2
  289. Circadian regulation of glial functionconcept2
  290. Clearance failure vs. overproductionconcept2
  291. Collapse, Traced Cell Type by Cell Typepaper2
  292. Comparing Different Viral Triggerspaper2
  293. Computational AD Subtypingconcept2
  294. Convergent risk factor pathwaysconcept2
  295. Convergent signaling through Wnt-PCP-RhoA-ROCKconcept2
  296. Convergent Synaptic Collapseconcept2
  297. Cumulative axonal defect accumulationconcept2
  298. Cytoskeletal disorder as core pathologyconcept2
  299. Cytoskeletal Dynamicsconcept2
  300. Dark Genome Variationconcept2
  301. Double-hit mutation hypothesisconcept2
  302. Dynamic and region-independent disease mechanismsconcept2
  303. Eight factors of dementia frameworkconcept2
  304. Endosomal Lysosomal Networkconcept2
  305. Energy metabolism declineconcept2
  306. Environmental neurotoxicologyconcept2
  307. Environmental toxin contributionconcept2
  308. Epigenetic and genetic interplayconcept2
  309. Epigenetic Regulationconcept2
  310. Equilibrium at criticalityconcept2
  311. Existing HIV RT inhibitors as potential AD therapeuticsconcept2
  312. Exponential exposure-prevalence correlationconcept2
  313. Factor classification and connectivityconcept2
  314. Ferroptosisconcept2
  315. Ferroptosis in Neurodegenerationconcept2
  316. Functional model of neuron-glia interactionconcept2
  317. Gene dosage of APP directly causes pathogenesisconcept2
  318. Genetic shortcuts in FAD vs LOADconcept2
  319. GI-tract microbiome neurotoxicityconcept2
  320. Glial Biologyconcept2
  321. Glial contribution to neurodegenerationconcept2
  322. Glial inflammatory responseconcept2
  323. Glymphatic clearance failure amplifies pathologyconcept2
  324. Gut Brain Axisconcept2
  325. Gut Microbiome Lipid AD Axisconcept2
  326. Gut-brain axis in ADconcept2
  327. Human-germ interaction modelconcept2
  328. IDE-insulin-Abeta competitionconcept2
  329. Immunometabolismconcept2
  330. Immunosenescence as central aging mechanismconcept2
  331. Infection as co-factor in neurodegenerationconcept2
  332. Infectious etiology of ADconcept2
  333. Infectious origin of Alzheimer's diseaseconcept2
  334. Infectious-toxic-genetic synergyconcept2
  335. Inflamm-aging as disease driverconcept2
  336. Inflammaging integrates hallmarks of agingconcept2
  337. Information Theoretic Transcriptomicsconcept2
  338. Innate immune-mediated plaque formationconcept2
  339. Innate immunity network dysregulation in ADconcept2
  340. Integrated molecular-to-network perspectiveconcept2
  341. Integrative treatment across medical traditionsconcept2
  342. Interconnected homeostatic disruptionconcept2
  343. Intraneuronal amyloid accumulation as primary eventconcept2
  344. Iron Brain Paradoxconcept2
  345. Iron Dyshomeostasisconcept2
  346. Khachaturianpaper2
  347. Kinase Inhibitor Neuroprotectionconcept2
  348. Lifestyle and behavioral factorsconcept2
  349. Lifestyle as causal anchorconcept2
  350. Lifestyle intervention for cognitive reversalconcept2
  351. Lifestyle Microglial Modulationconcept2
  352. Limbic brain as circavital clock locusconcept2
  353. Lipid Dysregulationconcept2
  354. Lipid homeostasis as AD driverconcept2
  355. Load, Capacity and the Boundary of Convergent Clearance Failure in Neurodegenerationpaper2
  356. Locus coeruleus as ground zeroconcept2
  357. Membrane Biophysicsconcept2
  358. Membrane Lipid Dysregulationconcept2
  359. Memory building frameworkconcept2
  360. Memory construction disease modelconcept2
  361. Metabolic dysfunction as AD driverconcept2
  362. Metabolic-neurodegenerative disease connectionconcept2
  363. Microbial Pathogenesisconcept2
  364. Microbleeds as initiating vascular event in ADconcept2
  365. Microglial dysfunction as early eventconcept2
  366. Microglial Immunometabolismconcept2
  367. Microglial Lipid Regulationconcept2
  368. Microglial senescence as AD triggerconcept2
  369. Mitochondrial Dysfunctionconcept2
  370. Mitochondrial inheritance and ADconcept2
  371. Mitochondrial theory of agingconcept2
  372. Moving brain hypothesisconcept2
  373. MTHFR as catalytic pre-existing factorconcept2
  374. Multi-level heterogeneity of ADconcept2
  375. Multi-omics network approach to ADconcept2
  376. Multi-system medicine approach to ADconcept2
  377. Multidomain AD Interventionconcept2
  378. Multifactorial convergence modelconcept2
  379. Multifactorial etiologyconcept2
  380. Multifactorial risk accumulation modelconcept2
  381. Multipathology convergence theoryconcept2
  382. Multiple chronic stressorsconcept2
  383. Multiple converging factors in unified tauopathy frameworkconcept2
  384. NAD+ depletion drives neurodegenerationconcept2
  385. Navigable database of AD factorsconcept2
  386. Necrotic Cell Deathconcept2
  387. Need to understand normal APP functionconcept2
  388. Network-based combination therapyconcept2
  389. Neural Oscillationsconcept2
  390. Neuroendocrine shift at menopauseconcept2
  391. Neuroimmune Surveillanceconcept2
  392. Neuroinflammation as primary driver connecting all AD subsystemsconcept2
  393. Neuronal Excitabilityconcept2
  394. Neuronal lysis forming extracellular plaquesconcept2
  395. Neuronal network degradation as substrate of dementiaconcept2
  396. Neurovascular injury-repair cycle driving disease progressionconcept2
  397. Neurovascular unit as disease originconcept2
  398. NF-kB-miRNA inflammatory cascadeconcept2
  399. Nuclear pathology as early AD mechanismconcept2
  400. Omics Driven Profilingconcept2
  401. Omnigenic AD architectureconcept2
  402. Oral-brain infection axisconcept2
  403. Oxidative and nitrative stress as primary driverconcept2
  404. Oxidative Stressconcept2
  405. Oxygen deficiency as root causeconcept2
  406. P. gingivalis as keystone pathogenconcept2
  407. Peripheral Immunocyte Regulationconcept2
  408. Peripheral Lipid Biomarkersconcept2
  409. Peroxynitrite-mediated neurodegenerationconcept2
  410. Personalized multifactorial etiologyconcept2
  411. Phase IIIpaper2
  412. Polymicrobial brain infectionconcept2
  413. Polymicrobial causation of ADconcept2
  414. Precision genomics approachconcept2
  415. Precision Medicine ADconcept2
  416. Precision medicine protocolconcept2
  417. Preclinical Phase Activityconcept2
  418. Presymptomatic Lipidomic Signaturesconcept2
  419. Probabilistic multi-cause disease etiologyconcept2
  420. Programmed aging clock model of ADconcept2
  421. Proteostasis Collapseconcept2
  422. Proteostasis disruptionconcept2
  423. Psychosocial Risk Factorsconcept2
  424. Receptor-mediated amyloid internalizationconcept2
  425. Resilience as key to understanding AD clinical expressionconcept2
  426. Retrotransposon Activationconcept2
  427. Retroviral-like mechanisms drive disease propagationconcept2
  428. RNA-based diagnostics and therapeuticsconcept2
  429. Sex Dimorphic AD Mechanismsconcept2
  430. Sex Specific MiRNA Signaturesconcept2
  431. Sex-based hemoglobin differentialconcept2
  432. Sex-specific AD vulnerabilityconcept2
  433. Sex-specific disease mechanismsconcept2
  434. Signal Insufficiency Model (SIM)concept2
  435. Silica water as protective interventionconcept2
  436. Single Cell AD Signaturesconcept2
  437. Small ncRNA regulation of neurodegenerationconcept2
  438. Solomon Carter Fuller's 1911 Plaque Audit, Read Beside Oskar Fischer'spaper2
  439. Somatic Mosaicism in ADconcept2
  440. Somatic mutations as novel therapeutic targetsconcept2
  441. Somatic recombination creates pathogenic gene variantsconcept2
  442. SORL1 Lysosomal Functionconcept2
  443. Sphingolipid Signalingconcept2
  444. Stanley Prusiner's Prion Theory and Templated Neurodegeneration, Critically Evaluatedpaper2
  445. SuperAgers demonstrate pathology-cognition dissociationconcept2
  446. Synapse loss as primary eventconcept2
  447. Synaptic Competitionconcept2
  448. Synaptic Pathologyconcept2
  449. Synaptoblastic vs synaptoclastic balanceconcept2
  450. Syndromic Complexityconcept2
  451. Systemic circulating factors governing neurodegenerationconcept2
  452. Systemic disease beyond CNSconcept2
  453. Systemic disease interaction modelconcept2
  454. Systems approach to interconnected AD pathological hallmarksconcept2
  455. Tau as primary causative factor over amyloidconcept2
  456. Tau Biomarkersconcept2
  457. The Clearance Collapse — One Machinery, Three Failurespaper2
  458. The Failing Clock That Stops Defending the Brainstempaper2
  459. Theory integration across domainsconcept2
  460. Three-actor-group pathogenesisconcept2
  461. Toxic Abeta species and PTMsconcept2
  462. Trained Immunityconcept2
  463. Transcriptomic Isoform Complexityconcept2
  464. TXNIP as therapeutic targetconcept2
  465. Vascular and inflammatory contributionsconcept2
  466. Vascular-metabolic-infectious convergenceconcept2
  467. Viral infection triggers chronic brain inflammationconcept2
  468. Wnt-GSK3-beta pathway integrating amyloid and tau pathologyconcept2
  469. Adrenergic Signalingconcept1
  470. Amyloid-β Restrains Microglia Twicepaper1
  471. Asparaginyl Endopeptidase in the Locus Coeruleuspaper1
  472. Autophagy Failure Mechanisms in Neurodegeneration, and the Timeline of Plaque Formationpaper1
  473. BCG Vaccination in Alzheimer's Diseasepaper1
  474. Calcium Homeostasisconcept1
  475. Carlo Abbate's Adult Neurogenesis Theory of Alzheimer's Disease, Critically Evaluatedpaper1
  476. Depression as Reversible Collapsepaper1
  477. Down Syndrome as the Disease Run in Fast-Forwardpaper1
  478. Epigenetic Erosion as the Reversible Information Layer of Alzheimer's Diseasepaper1
  479. Fischer's Matrixpaper1
  480. Mitochondria-Associated ER Membranes and Ceramide in Alzheimer's Diseasepaper1
  481. Neuroimmune Interfacenode1
  482. Neuroinflammationconcept1
  483. Oskar Fischer's Eight Stages of Plaque Formationpaper1
  484. Perineuronal Netsconcept1
  485. Perineuronal Nets, Microglial Neuroinflammation, and Alzheimer'spaper1
  486. Re-evaluating Chini's CD38–NAD Programpaper1
  487. Re-evaluating Höglinger's Complex I → Tau Programpaper1
  488. Re-evaluating Tsai's 40 Hz Gamma Programpaper1
  489. The Cell Biology of the Word 'Ageing'paper1
  490. The Inflammasome–Complement–TREM2 Nexus in Alzheimer's Diseasepaper1
  491. The Pedunculopontine Nucleus in Alzheimer's Diseasepaper1
  492. The Plaque Was Staged Before It Was Countedpaper1
  493. The Somatostatin Interneuron in Alzheimer's Diseasepaper1
  494. Tryptophan Allocation Across the Kynurenine, NAD⁺ and Serotonergic Branchespaper1
  495. Wandering in Alzheimer's Diseasepaper1
  496. Where Autophagic Failure Causes Neurodegeneration, and Where It Is a Consequencepaper1
  497. Which Biomarkers Detect Which Phasepaper1
  498. Zhen Huang's Competitive Synaptic Plasticity and the Amyloid-β Monomer Depletion Modelpaper1
  499. α-Synuclein Templating and Synucleinopathy Propagationpaper1
RELN Reelin, synapse & ECM–PNN 2,549 59 docs
Matched on RELN reelin
  1. The Brain's Architect and the Brake It Puts on Taupaper287
  2. Can a Drug Copy the Luckiest Mutation?paper213
  3. The Enzyme That Cuts the Protective Latticepaper187
  4. The Load-Bearing Neuronpaper177
  5. Reelin, N-Sulfated Heparan Sulfate and ApoER2paper168
  6. The Inflammasome Versus the Reelin Brakepaper134
  7. One Sugar Lattice, Three Jobspaper122
  8. Tau Kindling in the Locus Coeruleuspaper107
  9. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper96
  10. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper93
  11. Cofilin Serine 3paper87
  12. Norepinephrine as a Two-Armed Pincer on Taupaper85
  13. Layer II Immature Neurons, Disease-Associated Microglia and the Reelin–Ephexin5 Axispaper80
  14. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper62
  15. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper56
  16. Reelin-ApoE receptor axis disruptionconcept53
  17. Cofilin Serine 3 in Alzheimer's Diseasepaper49
  18. Convergent Synaptic Collapsepaper42
  19. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper32
  20. Cortical Immature Neurons of Layer IIpaper30
  21. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper29
  22. The Timing of Locus Coeruleus Loss in Alzheimer's Diseasepaper29
  23. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper26
  24. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper25
  25. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper21
  26. The Genes That Protect — Phenocopy the Fortunatepaper21
  27. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper20
  28. Matrix Sulfation Nodeconcept17
  29. Lipid Peroxidation and ApoER2–Dab1 Disruption in Sporadic Alzheimer's Diseasepaper16
  30. Microglial Restraint as Resiliencepaper16
  31. Which Genes Set the Threshold for Collapsepaper16
  32. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper15
  33. Perineuronal Netsconcept14
  34. The Somatostatin Interneuron in Alzheimer's Diseasepaper13
  35. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper11
  36. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper11
  37. Alzheimer's Disease — A Process in Timepaper8
  38. Chronic Excitatory Insufficiencyconcept8
  39. From Gut Ecology to the Failed Antidepressant Trialpaper8
  40. APOE4 Hubnode7
  41. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper6
  42. The Indifferent Neuronpaper6
  43. Excitatory–Inhibitory Balance in Alzheimer'spaper5
  44. The Microglion That Silences Tau's Phosphatasepaper4
  45. ApoE4 structural vulnerabilityconcept3
  46. Immune-pathogen interaction modelconcept3
  47. Lipid peroxidation cascade at synapseconcept3
  48. Multi-cellular pathologyconcept3
  49. Neurovascular dysfunction as initiating eventconcept3
  50. Ordered Attrition and Resilience as the Two Human-Evidence Anchors of Alzheimer'spaper3
  51. Peroxidized ApoE as proximate causeconcept3
  52. Post-translational modification dysregulationconcept3
  53. Todd Golde's Amyloid Cascade, Read for What It Addspaper3
  54. Adrenergic Signalingconcept2
  55. Synaptic Plasticityconcept2
  56. Templated Tau Misfolding Across the Three Phasespaper2
  57. The Brakes on Microglial Activation in Alzheimer's Diseasepaper2
  58. Moosmann & Sohrepaper1
  59. The Losing Axonpaper1
APP Amyloid & Tau core 1,551 217 docs
Matched on amyloid precursor protein APP
  1. Convergent Synaptic Collapsepaper75
  2. Down Syndrome as the Disease Run in Fast-Forwardpaper60
  3. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper60
  4. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper52
  5. Convergent Autophagic Collapsepaper44
  6. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper33
  7. Autophagy Failure Mechanisms in Neurodegeneration, and the Timeline of Plaque Formationpaper32
  8. Amyloid-β Restrains Microglia Twicepaper28
  9. Mitochondrial Quality Control Across Five Diseasespaper26
  10. Scott Small's Retromer and Endosomal Theorypaper26
  11. Estela Area-Gómez's MAM Theorypaper23
  12. Gouraspaper23
  13. Restoring Autophagy in Neurodegenerationpaper22
  14. The Narrow Gate Every Mitochondrial Protein Must Passpaper22
  15. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper20
  16. Autophagic Flux in Alzheimer's Diseasepaper20
  17. Oxidative Stress and Autophagy Failure in Alzheimer's Diseasepaper20
  18. The Strongest Case FOR the Amyloid Cascadepaper20
  19. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper19
  20. Which Genes Set the Threshold for Collapsepaper19
  21. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper18
  22. Bioenergetic Collapsepaper17
  23. Ceramide as a Structural and Signalling Node in Alzheimer's Diseasepaper16
  24. CSF1R Inhibition Restores the Perineuronal Matrix and Destabilises the Rhythm It Supportspaper16
  25. LL-37, CLIC1 and Microglial Lysosomal Failurepaper16
  26. Smallpaper16
  27. The Bredesen Protocol Compared Against the Convergent Collapse Frameworkpaper16
  28. The Genes That Protect — Phenocopy the Fortunatepaper16
  29. The Losing Axonpaper16
  30. The Mitochondria-Associated Membrane Hypothesis of Alzheimer's Disease, Evaluatedpaper16
  31. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper15
  32. Gunnar Gouras's Intraneuronal Amyloid and the Synaptic Endosome, Twenty-Eight Years Onpaper15
  33. Load, Capacity and the Boundary of Convergent Clearance Failure in Neurodegenerationpaper15
  34. From Gut Ecology to the Failed Antidepressant Trialpaper14
  35. Lysosomal Acidification Failure as the Convergent Lesion of Neurodegenerationpaper14
  36. The Indifferent Neuronpaper14
  37. Todd Golde's Amyloid Cascade, Read for What It Addspaper14
  38. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper13
  39. Comparing Different Viral Triggerspaper13
  40. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper12
  41. Mitochondria-Associated ER Membranes and Ceramide in Alzheimer's Diseasepaper12
  42. The Raphe Nuclei in Alzheimer's Disease as a Subject in Their Own Rightpaper12
  43. Where Autophagic Failure Causes Neurodegeneration, and Where It Is a Consequencepaper12
  44. Carlo Abbate's Adult Neurogenesis Theory of Alzheimer's Disease, Critically Evaluatedpaper11
  45. Moosmann & Sohrepaper11
  46. The Morphological and Molecular Basis of Convergent Autophagic Collapsepaper11
  47. Can Vaccines Protect Against Dementia?paper10
  48. Proving That Misfolded Proteins Spread Like Prionspaper10
  49. Ralph Nixon's Inside-Out Thesispaper10
  50. The Timing of Locus Coeruleus Loss in Alzheimer's Diseasepaper10
  51. Fischer's Staged Deposit, 1907–1912paper9
  52. Iron Chelation and GPX4 Stabilizationpaper9
  53. Zhen Huang's Competitive Synaptic Plasticity and the Amyloid-β Monomer Depletion Modelpaper9
  54. Lithium in Alzheimer's Diseasepaper8
  55. Seth Margolis Revisitedpaper8
  56. The Cholinergic Nucleus Basalis in Alzheimer's Diseasepaper8
  57. The Lipid That Kills Neurons and Spares Tumourspaper8
  58. The Somatostatin Interneuron in Alzheimer's Diseasepaper8
  59. AD caused by APP dysregulation not Abeta per seconcept7
  60. Amyloid-β, the Oxidative Burst and Three Routes to a Disabled Phosphatasepaper7
  61. APP and tau pathology linked through transport disruptionconcept7
  62. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper7
  63. Gene dosage of APP directly causes pathogenesisconcept7
  64. How the Genes Partition the Vascular Phenotypepaper7
  65. Need to understand normal APP functionconcept7
  66. Structural Instructions at the Synapse Are Terminated by Destruction, Not Dephosphorylationpaper7
  67. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper6
  68. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper6
  69. Cofilin Serine 3paper6
  70. Endosomal Traffickingconcept6
  71. Khachaturianpaper6
  72. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper6
  73. Plaques Are Tombstones, Not Killerspaper6
  74. Rappoportpaper6
  75. APP as dependence receptorconcept5
  76. Axon initial segment as key disease locusconcept5
  77. Axonal transport failure as unifying mechanismconcept5
  78. CDK3 Cell Cycle Toxicityconcept5
  79. Cofilin Serine 3 in Alzheimer's Diseasepaper5
  80. Dynamic and region-independent disease mechanismsconcept5
  81. Kinase Inhibitor Neuroprotectionconcept5
  82. Lipid Peroxidation and ApoER2–Dab1 Disruption in Sporadic Alzheimer's Diseasepaper5
  83. Neuronal network degradation as substrate of dementiaconcept5
  84. Plaque Origin What is Establishedconcept5
  85. UBE3A, PTPA and Ephexin5paper5
  86. APP processing pathwayconcept4
  87. Asparaginyl Endopeptidase in the Locus Coeruleuspaper4
  88. Autophagic Failure as the Convergent Endpoint in Alzheimer's, Parkinson's, ALS and Huntington'spaper4
  89. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper4
  90. Chronic Excitatory Insufficiencyconcept4
  91. Excitatory–Inhibitory Balance in Alzheimer'spaper4
  92. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper4
  93. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper4
  94. Pavel Kalvach's Case That Alzheimer's Is Not a Disease, Gradedpaper4
  95. Phase IIIpaper4
  96. Prenatally Generated Immature Neurons and the Cellular Origin of Alzheimer's Diseasepaper4
  97. Stanley Prusiner's Prion Theory and Templated Neurodegeneration, Critically Evaluatedpaper4
  98. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper4
  99. The Brain's Architect and the Brake It Puts on Taupaper4
  100. The Calcium Hypothesis and the Systems Failure Model of Alzheimer's Diseasepaper4
  101. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper4
  102. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper4
  103. The Ventral Tegmental Area in Alzheimer's Diseasepaper4
  104. TOMM40 Import Gateconcept4
  105. Vaccines That May Prevent Dementiapaper4
  106. Alzheimer's Disease — A Process in Timepaper3
  107. Anne Eckert's Neuroendocrine Theory and the Withdrawal of Protection in the Ageing Brainpaper3
  108. Astrocytespaper3
  109. Brain DNA blueprint is altered in AD neuronsconcept3
  110. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper3
  111. Endosomal Nexusnode3
  112. Existing HIV RT inhibitors as potential AD therapeuticsconcept3
  113. Fischer's Sideliningpaper3
  114. Layer II Immature Neurons, Disease-Associated Microglia and the Reelin–Ephexin5 Axispaper3
  115. Multidomain AD Interventionconcept3
  116. Ordered Attrition and Resilience as the Two Human-Evidence Anchors of Alzheimer'spaper3
  117. Precision Medicine ADconcept3
  118. Precision medicine protocolconcept3
  119. Reelin, N-Sulfated Heparan Sulfate and ApoER2paper3
  120. Retroviral-like mechanisms drive disease propagationconcept3
  121. Signal Insufficiency Model (SIM)concept3
  122. Somatic Mosaicism in ADconcept3
  123. Somatic recombination creates pathogenic gene variantsconcept3
  124. Synaptoblastic vs synaptoclastic balanceconcept3
  125. The Inflammasome Versus the Reelin Brakepaper3
  126. The Innate-Immune Sensor That Converts the Diseasepaper3
  127. The Load-Bearing Neuronpaper3
  128. Transcriptomic Isoform Complexityconcept3
  129. Amyloid structural diversity and toxicityconcept2
  130. Autophagyconcept2
  131. Can a Drug Copy the Luckiest Mutation?paper2
  132. Collapse, Traced Cell Type by Cell Typepaper2
  133. Denervation supersensitivityconcept2
  134. Depression as Reversible Collapsepaper2
  135. Disciplinary Silos in Alzheimer's Disease Research, 1950–2020paper2
  136. Endolysosomal Dysfunctionconcept2
  137. Epigenetic Repressionconcept2
  138. Ferroptosisconcept2
  139. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper2
  140. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper2
  141. Lipid Metabolismconcept2
  142. LL-37, Innate Immunity and Autophagic Collapse in Alzheimer's Diseasepaper2
  143. LRP1 and the Templated Spread of Misfolded Proteinpaper2
  144. Lysosomal Acidificationconcept2
  145. Margolispaper2
  146. NMDA Receptor Blockade, Perineuronal Net Dynamics and Cell Death Modalities in Alzheimer'spaper2
  147. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper2
  148. Oligomer hypothesis of neurotoxicityconcept2
  149. One Sensor, Two Collapses — Which Arm Matters More?paper2
  150. Plaque-cognition dissociationconcept2
  151. Selective Tau Disruptionconcept2
  152. Standard Diagnostic Biomarkers Explainedpaper2
  153. Tau Scaffolding Interactionsconcept2
  154. Templated Tau Misfolding Across the Three Phasespaper2
  155. The Brakes on Microglial Activation in Alzheimer's Diseasepaper2
  156. The Clearance Collapse — One Machinery, Three Failurespaper2
  157. The Coerulean Interface — The Brainstem Origin of Alzheimer'spaper2
  158. The Drivers of Microglial Dysfunction in Alzheimer's Disease, Ranked by Causal Weightpaper2
  159. The Immune Cells That Keep the Peace — Until They Don'tpaper2
  160. Vesicular Traffickingconcept2
  161. A Counterfactual History of Alzheimer's Research Had Fischer's 1907 Findings Prevailedpaper1
  162. Abeta aggregation as necessary initiating eventconcept1
  163. Adult Hippocampal Neurogenesis and the Substrate of Cognitive Reservepaper1
  164. Aluminum as primary environmental causeconcept1
  165. Aluminum driving amyloid productionconcept1
  166. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper1
  167. Amyloid and tau as secondary phenomenaconcept1
  168. Autophagy-lysosomal failureconcept1
  169. Axonal Transportconcept1
  170. Biomarkers of Vascular Dementia and Their Overlap with Alzheimer's Diseasepaper1
  171. cGAS–STING in Alzheimer's Diseasepaper1
  172. Cholesterol Homeostasisconcept1
  173. Cholinergic primacy in ADconcept1
  174. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper1
  175. Cortical Immature Neurons of Layer IIpaper1
  176. Epigenetic regulation of AD genesconcept1
  177. ER Stressconcept1
  178. Exponential exposure-prevalence correlationconcept1
  179. Ferroptosis in Neurodegenerationconcept1
  180. From Synapse Loss to Neuronal Death in Alzheimer's Diseasepaper1
  181. Genetic evidence as gold standard for causalityconcept1
  182. Gut-brain axis in neuroinflammationconcept1
  183. Iron Brain Paradoxconcept1
  184. Iron Dyshomeostasisconcept1
  185. Long preclinical phase of AD pathologyconcept1
  186. Lysosomal Dysfunctionconcept1
  187. Microglial Lipid Regulationconcept1
  188. Mitochondrial Dysfunctionconcept1
  189. Multi-pathway AD pathophysiology reviewconcept1
  190. Multifactorial modulation of disease trajectoryconcept1
  191. NAD⁺ Restoration and CD38 Inhibitionpaper1
  192. Norepinephrine as a Two-Armed Pincer on Taupaper1
  193. One Sugar Lattice, Three Jobspaper1
  194. Oxidative Stressconcept1
  195. PANTHOSconcept1
  196. Perineuronal Nets, Microglial Neuroinflammation, and Alzheimer'spaper1
  197. Peripheral Lipid Biomarkersconcept1
  198. PERK DLX1 Tau Axisconcept1
  199. Presymptomatic Lipidomic Signaturesconcept1
  200. Receptor-based therapeutic approachconcept1
  201. Silica water as protective interventionconcept1
  202. Sleep as the Shared Off-Line State of Every Collapse Axispaper1
  203. Solomon Carter Fuller's 1911 Plaque Audit, Read Beside Oskar Fischer'spaper1
  204. Tau Kindling in the Locus Coeruleuspaper1
  205. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper1
  206. The Bredesen ReCODE Protocol Evaluatedpaper1
  207. The Enzyme That Cuts the Protective Latticepaper1
  208. The Immunometabolic Nexus of Neurodegenerationpaper1
  209. The Inflammasome–Complement–TREM2 Nexus in Alzheimer's Diseasepaper1
  210. The Locus Coeruleus and the Noradrenergic Prodrome of Alzheimer's Diseasepaper1
  211. The Locus Coeruleus as Phase Bridgepaper1
  212. The Microglion That Silences Tau's Phosphatasepaper1
  213. The Phase II → III Transitionpaper1
  214. Translational Regulation in Tauopathyconcept1
  215. Vascular Pathology as a Substrate Across Phasespaper1
  216. Wandering in Alzheimer's Diseasepaper1
  217. When the Gut Writes the First Depressionpaper1
TREM2 GWAS / LOAD risk 937 101 docs
Matched on s?TREM2
  1. Homeostatic Collapsepaper62
  2. Which Genes Set the Threshold for Collapsepaper59
  3. Which Biomarkers Detect Which Phasepaper56
  4. Lysosomal Membrane Damage as the Upstream Determinant of Microglial Statepaper49
  5. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper44
  6. Bioenergetic Collapsepaper36
  7. Convergent Synaptic Collapsepaper36
  8. Microglial Restraint as Resiliencepaper33
  9. The Genes That Protect — Phenocopy the Fortunatepaper33
  10. The Losing Axonpaper33
  11. The Inflammasome–Complement–TREM2 Nexus in Alzheimer's Diseasepaper31
  12. Amyloid-β Restrains Microglia Twicepaper28
  13. The Drivers of Microglial Dysfunction in Alzheimer's Disease, Ranked by Causal Weightpaper28
  14. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper27
  15. Michal Schwartz's Protective Autoimmunity as the Systemic Upstream of the Microglial Nichepaper26
  16. LL-37, CLIC1 and Microglial Lysosomal Failurepaper24
  17. The Immunometabolic Nexus of Neurodegenerationpaper22
  18. Layer II Immature Neurons, Disease-Associated Microglia and the Reelin–Ephexin5 Axispaper20
  19. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper17
  20. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper13
  21. The Plaque Was Staged Before It Was Countedpaper13
  22. Aleksandra Deczkowska's DAM Program and the Matrix-Degrading Armpaper11
  23. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper10
  24. How the Genes Partition the Vascular Phenotypepaper9
  25. Shatz & Brottpaper9
  26. The Microglion That Silences Tau's Phosphatasepaper9
  27. Disciplinary Silos in Alzheimer's Disease Research, 1950–2020paper8
  28. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper7
  29. Alzheimer's Disease — A Process in Timepaper7
  30. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper7
  31. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper7
  32. Oskar Fischer's Eight Stages of Plaque Formationpaper7
  33. The Clearance Collapse — One Machinery, Three Failurespaper7
  34. Cortical Immature Neurons of Layer IIpaper6
  35. Mitochondrial Quality Control Across Five Diseasespaper6
  36. Collapse, Traced Cell Type by Cell Typepaper5
  37. LL-37, Innate Immunity and Autophagic Collapse in Alzheimer's Diseasepaper5
  38. Metabolic-Homeostatic Axisnode5
  39. The Bredesen ReCODE Protocol Evaluatedpaper5
  40. The Cholinergic Nucleus Basalis in Alzheimer's Diseasepaper5
  41. The Innate-Immune Sensor That Converts the Diseasepaper5
  42. Autophagic Flux in Alzheimer's Diseasepaper4
  43. Ceramide as a Structural and Signalling Node in Alzheimer's Diseasepaper4
  44. Neuroinflammationconcept4
  45. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper4
  46. Phase IIpaper4
  47. Phase IIIpaper4
  48. The Mitochondria-Associated Membrane Hypothesis of Alzheimer's Disease, Evaluatedpaper4
  49. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper3
  50. Smallpaper3
  51. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper3
  52. Todd Golde's Amyloid Cascade, Read for What It Addspaper3
  53. Zhen Huang's Competitive Synaptic Plasticity and the Amyloid-β Monomer Depletion Modelpaper3
  54. Bioenergeticsconcept2
  55. Blood-Vessel Damage, Phase by Phasepaper2
  56. Chronobiologic neuroprotection via melatoninconcept2
  57. Cognitive resilience as dynamic protective conceptconcept2
  58. Fischer's Eighth Stage as a Measurement of Rate Against Host Capacitypaper2
  59. Fischer's Staged Deposit, 1907–1912paper2
  60. Homeostatic Microglial Collapseconcept2
  61. Multifactorial prevention through modifiable risk factorsconcept2
  62. Neuroimmune Interfacenode2
  63. Perineuronal Nets, Microglial Neuroinflammation, and Alzheimer'spaper2
  64. Plaques Are Tombstones, Not Killerspaper2
  65. Population-specific AD genetic signaturesconcept2
  66. Restoring Autophagy in Neurodegenerationpaper2
  67. The Brakes on Microglial Activation in Alzheimer's Diseasepaper2
  68. The Phase II → III Transitionpaper2
  69. Tryptophan Allocation Across the Kynurenine, NAD⁺ and Serotonergic Branchespaper2
  70. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper1
  71. Age-related immune dysfunction enables neurotropic virusesconcept1
  72. BCG Vaccination in Alzheimer's Diseasepaper1
  73. Beth Stevens's Complement-Pruning Programpaper1
  74. Can Vaccines Protect Against Dementia?paper1
  75. cognitive resilienceconcept1
  76. CSF1R Inhibition Restores the Perineuronal Matrix and Destabilises the Rhythm It Supportspaper1
  77. Depression as Reversible Collapsepaper1
  78. Eight factors of dementia frameworkconcept1
  79. Glymphatic clearance failure amplifies pathologyconcept1
  80. Innate Immunityconcept1
  81. Integrative treatment across medical traditionsconcept1
  82. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper1
  83. Lipid Peroxidation and ApoER2–Dab1 Disruption in Sporadic Alzheimer's Diseasepaper1
  84. Microglial dysfunction as early eventconcept1
  85. Moosmann & Sohrepaper1
  86. Multi-system medicine approach to ADconcept1
  87. Multiple converging factors in unified tauopathy frameworkconcept1
  88. Neuroimmunologyconcept1
  89. Neuroinflammation as primary driver connecting all AD subsystemsconcept1
  90. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper1
  91. Perineuronal Netsconcept1
  92. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper1
  93. Rappoportpaper1
  94. Scott Small's Retromer and Endosomal Theorypaper1
  95. Standard Diagnostic Biomarkers Explainedpaper1
  96. Systems approach to interconnected AD pathological hallmarksconcept1
  97. Tau as primary causative factor over amyloidconcept1
  98. The Somatostatin Interneuron in Alzheimer's Diseasepaper1
  99. Vaccines That May Prevent Dementiapaper1
  100. Vascular and inflammatory contributionsconcept1
  101. Viral infection triggers chronic brain inflammationconcept1
ARHGEF15 (Ephexin5) Reelin, synapse & ECM–PNN 867 21 docs
NLRP3 Microglia & innate immunity 779 76 docs
Matched on NLRP3
  1. The Innate-Immune Sensor That Converts the Diseasepaper94
  2. Bioenergetic Collapsepaper72
  3. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper69
  4. The Inflammasome–Complement–TREM2 Nexus in Alzheimer's Diseasepaper42
  5. Autophagic Flux in Alzheimer's Diseasepaper35
  6. Mitochondrial Quality Control Across Five Diseasespaper35
  7. One Sensor, Two Collapses — Which Arm Matters More?paper35
  8. The Inflammasome Versus the Reelin Brakepaper34
  9. The NLRP Inflammasome and the Perineuronal Net in Alzheimer's Diseasepaper33
  10. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper27
  11. NMDA Receptor Blockade, Perineuronal Net Dynamics and Cell Death Modalities in Alzheimer'spaper27
  12. LL-37, CLIC1 and Microglial Lysosomal Failurepaper22
  13. The Bredesen ReCODE Protocol Evaluatedpaper22
  14. The Microglion That Silences Tau's Phosphatasepaper22
  15. Depression as Reversible Collapsepaper21
  16. Amyloid-β, the Oxidative Burst and Three Routes to a Disabled Phosphatasepaper19
  17. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper14
  18. The Drivers of Microglial Dysfunction in Alzheimer's Disease, Ranked by Causal Weightpaper14
  19. The Phase II → III Transitionpaper12
  20. Restoring Autophagy in Neurodegenerationpaper9
  21. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper7
  22. The Clearance Collapse — One Machinery, Three Failurespaper7
  23. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper6
  24. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper6
  25. Autophagy as the Driver of System-Wide Agingpaper5
  26. Ralph Nixon's Inside-Out Thesispaper5
  27. The Ventral Tegmental Area in Alzheimer's Diseasepaper5
  28. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper4
  29. The Immunometabolic Nexus of Neurodegenerationpaper4
  30. When the Gut Writes the First Depressionpaper4
  31. Can Vaccines Protect Against Dementia?paper3
  32. LL-37, Innate Immunity and Autophagic Collapse in Alzheimer's Diseasepaper3
  33. The Losing Axonpaper3
  34. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper2
  35. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper2
  36. Age-related immune dysfunction enables neurotropic virusesconcept2
  37. Alzheimer's Disease — A Process in Timepaper2
  38. Amyloid-β Restrains Microglia Twicepaper2
  39. Beth Stevens's Complement-Pruning Programpaper2
  40. Ceramide as a Structural and Signalling Node in Alzheimer's Diseasepaper2
  41. Down Syndrome as the Disease Run in Fast-Forwardpaper2
  42. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper2
  43. Homeostatic Microglial Collapseconcept2
  44. Lysosomal Membrane Damage as the Upstream Determinant of Microglial Statepaper2
  45. Neuroinflammationconcept2
  46. Neuroinflammation as primary driver connecting all AD subsystemsconcept2
  47. Systems approach to interconnected AD pathological hallmarksconcept2
  48. Tau Pathologyconcept2
  49. Viral infection triggers chronic brain inflammationconcept2
  50. Aleksandra Deczkowska's DAM Program and the Matrix-Degrading Armpaper1
  51. Alzheimer's Disease as a Fifty-Year Process in Time and Spacepaper1
  52. Asparaginyl Endopeptidase in the Locus Coeruleuspaper1
  53. Astrocytespaper1
  54. Autophagyconcept1
  55. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper1
  56. BCG Vaccination in Alzheimer's Diseasepaper1
  57. Cellular Senescenceconcept1
  58. cGAS–STING in Alzheimer's Diseasepaper1
  59. Cholesterol Homeostasisconcept1
  60. Collapse, Traced Cell Type by Cell Typepaper1
  61. Energy metabolism declineconcept1
  62. Epigenetic and genetic interplayconcept1
  63. Homeostatic Collapsepaper1
  64. Innate Immunityconcept1
  65. Lifestyle and behavioral factorsconcept1
  66. Multifactorial etiologyconcept1
  67. Neuroimmunologyconcept1
  68. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper1
  69. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper1
  70. Ordered Attrition and Resilience as the Two Human-Evidence Anchors of Alzheimer'spaper1
  71. Phase IIpaper1
  72. Re-evaluating Tsai's 40 Hz Gamma Programpaper1
  73. Sleep as the Shared Off-Line State of Every Collapse Axispaper1
  74. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper1
  75. The Cell Biology of the Word 'Ageing'paper1
  76. The Somatostatin Interneuron in Alzheimer's Diseasepaper1
LILRB2 GWAS / LOAD risk 777 39 docs
Matched on LILRB2 PirB
  1. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper159
  2. Convergent Synaptic Collapsepaper75
  3. The Load-Bearing Neuronpaper74
  4. Shatz & Brottpaper71
  5. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper53
  6. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper52
  7. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper42
  8. Cofilin Serine 3 in Alzheimer's Diseasepaper36
  9. The Losing Axonpaper36
  10. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper35
  11. Cofilin Serine 3paper34
  12. From Synapse Loss to Neuronal Death in Alzheimer's Diseasepaper18
  13. Seth Margolis Revisitedpaper13
  14. The Timing of Locus Coeruleus Loss in Alzheimer's Diseasepaper13
  15. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper8
  16. The Matrix as the Seventh Axis of Collapsepaper8
  17. Homeostatic Collapsepaper7
  18. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper5
  19. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper4
  20. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper4
  21. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper3
  22. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper3
  23. Alzheimer's Disease — A Process in Timepaper2
  24. Bioenergetic Collapsepaper2
  25. Collapse, Traced Cell Type by Cell Typepaper2
  26. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper2
  27. Neuroimmune Interfacenode2
  28. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper2
  29. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper2
  30. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  31. Endolysosomal Dysfunctionconcept1
  32. Layer II Immature Neurons, Disease-Associated Microglia and the Reelin–Ephexin5 Axispaper1
  33. Michal Schwartz's Protective Autoimmunity as the Systemic Upstream of the Microglial Nichepaper1
  34. Microglial Immunometabolismconcept1
  35. Neuroimmunologyconcept1
  36. Perineuronal Netsconcept1
  37. Synaptic Competitionconcept1
  38. The Bredesen ReCODE Protocol Evaluatedpaper1
  39. Zhen Huang's Competitive Synaptic Plasticity and the Amyloid-β Monomer Depletion Modelpaper1
PVALB (parvalbumin) Reelin, synapse & ECM–PNN 680 83 docs
Matched on PVALB parvalbumin
  1. CSF1R Inhibition Restores the Perineuronal Matrix and Destabilises the Rhythm It Supportspaper44
  2. The Proteolytic Degradation of the Perineuronal Net and the Loss of PV Interneuronspaper44
  3. The Somatostatin Interneuron in Alzheimer's Diseasepaper42
  4. Collapse, Traced Cell Type by Cell Typepaper31
  5. The Matrix as the Seventh Axis of Collapsepaper30
  6. Fischer's Matrixpaper23
  7. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper23
  8. The Perineuronal Matrix and Cortical Layer Twopaper22
  9. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper20
  10. Adult Hippocampal Neurogenesis and the Substrate of Cognitive Reservepaper19
  11. The Load-Bearing Neuronpaper18
  12. The NLRP Inflammasome and the Perineuronal Net in Alzheimer's Diseasepaper17
  13. Blood-Vessel Damage, Phase by Phasepaper14
  14. One Sensor, Two Collapses — Which Arm Matters More?paper14
  15. The Ventral Tegmental Area in Alzheimer's Diseasepaper14
  16. Wandering in Alzheimer's Diseasepaper14
  17. Which Genes Set the Threshold for Collapsepaper14
  18. The Phase II → III Transitionpaper13
  19. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper12
  20. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper12
  21. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper11
  22. Bioenergetic Collapsepaper11
  23. Michal Schwartz's Protective Autoimmunity as the Systemic Upstream of the Microglial Nichepaper11
  24. The Cell Biology of the Word 'Ageing'paper11
  25. Excitatory–Inhibitory Balance in Alzheimer'spaper10
  26. The Bredesen ReCODE Protocol Evaluatedpaper10
  27. Cofilin Serine 3 in Alzheimer's Diseasepaper8
  28. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper8
  29. One Sugar Lattice, Three Jobspaper8
  30. Phase IIIpaper8
  31. The Brakes on Microglial Activation in Alzheimer's Diseasepaper8
  32. Convergent Synaptic Collapsepaper7
  33. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper7
  34. Down Syndrome as the Disease Run in Fast-Forwardpaper6
  35. NMDA Receptor Blockade, Perineuronal Net Dynamics and Cell Death Modalities in Alzheimer'spaper6
  36. When the Gut Writes the First Depressionpaper6
  37. Sleep as the Shared Off-Line State of Every Collapse Axispaper5
  38. The Cholinergic Nucleus Basalis in Alzheimer's Diseasepaper5
  39. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper5
  40. Vascular Pathology as a Substrate Across Phasespaper5
  41. Cofilin Serine 3paper4
  42. Homeostatic Collapsepaper4
  43. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper3
  44. Alzheimer's Disease as a Fifty-Year Process in Time and Spacepaper3
  45. Carlo Abbate's Adult Neurogenesis Theory of Alzheimer's Disease, Critically Evaluatedpaper3
  46. Disciplinary Silos in Alzheimer's Disease Research, 1950–2020paper3
  47. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper3
  48. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper3
  49. How the Genes Partition the Vascular Phenotypepaper3
  50. Oskar Fischer's Eight Stages of Plaque Formationpaper3
  51. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper3
  52. Perineuronal Nets, Microglial Neuroinflammation, and Alzheimer'spaper3
  53. Re-evaluating Tsai's 40 Hz Gamma Programpaper3
  54. Templated Tau Misfolding Across the Three Phasespaper3
  55. The Inflammasome Versus the Reelin Brakepaper3
  56. The Locus Coeruleus as Phase Bridgepaper3
  57. Aleksandra Deczkowska's DAM Program and the Matrix-Degrading Armpaper2
  58. Convergent Synaptic Collapseconcept2
  59. Homeostatic Microglial Collapseconcept2
  60. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper2
  61. Ordered Attrition and Resilience as the Two Human-Evidence Anchors of Alzheimer'spaper2
  62. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper2
  63. Which Biomarkers Detect Which Phasepaper2
  64. Adrenergic Signalingconcept1
  65. Alzheimer's Disease — A Process in Timepaper1
  66. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper1
  67. Bioenergetic Collapseconcept1
  68. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper1
  69. Ecce Homopaper1
  70. Energy Metabolismconcept1
  71. LC Morphology What is Establishedconcept1
  72. Mitochondrial Quality Control Across Five Diseasespaper1
  73. Moosmann & Sohrepaper1
  74. Neural Oscillationsconcept1
  75. PARP Inhibitors and the Locus Coeruleuspaper1
  76. Perineuronal Netsconcept1
  77. Phase Measurabilityconcept1
  78. Prenatally Generated Immature Neurons and the Cellular Origin of Alzheimer's Diseasepaper1
  79. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper1
  80. Reelin-ApoE receptor axis disruptionconcept1
  81. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper1
  82. The Plaque Was Staged Before It Was Countedpaper1
  83. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper1
PSEN1 Amyloid & Tau core 671 159 docs
Matched on PSEN1 PS1 presenilin[- ]?1
  1. Convergent Autophagic Collapsepaper44
  2. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper37
  3. Restoring Autophagy in Neurodegenerationpaper25
  4. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper23
  5. Estela Area-Gómez's MAM Theorypaper20
  6. Which Genes Set the Threshold for Collapsepaper19
  7. Iron Chelation and GPX4 Stabilizationpaper15
  8. Bioenergetic Collapsepaper14
  9. Lysosomal Acidification Failure as the Convergent Lesion of Neurodegenerationpaper14
  10. Convergent Synaptic Collapsepaper13
  11. Khachaturianpaper13
  12. Autophagy Failure Mechanisms in Neurodegeneration, and the Timeline of Plaque Formationpaper12
  13. CSF1R Inhibition Restores the Perineuronal Matrix and Destabilises the Rhythm It Supportspaper12
  14. The Bredesen Protocol Compared Against the Convergent Collapse Frameworkpaper12
  15. Comparing Different Viral Triggerspaper11
  16. LL-37, CLIC1 and Microglial Lysosomal Failurepaper11
  17. Load, Capacity and the Boundary of Convergent Clearance Failure in Neurodegenerationpaper11
  18. Mitochondrial Quality Control Across Five Diseasespaper11
  19. The Calcium Hypothesis and the Systems Failure Model of Alzheimer's Diseasepaper11
  20. Autophagic Flux in Alzheimer's Diseasepaper10
  21. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper10
  22. Moosmann & Sohrepaper10
  23. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper10
  24. The Morphological and Molecular Basis of Convergent Autophagic Collapsepaper10
  25. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper9
  26. Oxidative Stress and Autophagy Failure in Alzheimer's Diseasepaper8
  27. The Indifferent Neuronpaper8
  28. A Counterfactual History of Alzheimer's Research Had Fischer's 1907 Findings Prevailedpaper7
  29. Ceramide as a Structural and Signalling Node in Alzheimer's Diseasepaper7
  30. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper7
  31. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper7
  32. Autophagic Failure as the Convergent Endpoint in Alzheimer's, Parkinson's, ALS and Huntington'spaper6
  33. Cofilin Serine 3 in Alzheimer's Diseasepaper6
  34. Fischer's Staged Deposit, 1907–1912paper6
  35. From Gut Ecology to the Failed Antidepressant Trialpaper6
  36. The Raphe Nuclei in Alzheimer's Disease as a Subject in Their Own Rightpaper6
  37. Where Autophagic Failure Causes Neurodegeneration, and Where It Is a Consequencepaper6
  38. Can a Drug Copy the Luckiest Mutation?paper5
  39. Can Vaccines Protect Against Dementia?paper5
  40. Amyloid-β, the Oxidative Burst and Three Routes to a Disabled Phosphatasepaper4
  41. Cofilin Serine 3paper4
  42. How the Genes Partition the Vascular Phenotypepaper4
  43. Pavel Kalvach's Case That Alzheimer's Is Not a Disease, Gradedpaper4
  44. The Brain's Architect and the Brake It Puts on Taupaper4
  45. The Losing Axonpaper4
  46. Todd Golde's Amyloid Cascade, Read for What It Addspaper4
  47. Vaccines That May Prevent Dementiapaper4
  48. Astrocytespaper3
  49. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper3
  50. Ralph Nixon's Inside-Out Thesispaper3
  51. Templated Tau Misfolding Across the Three Phasespaper3
  52. The Clearance Collapse — One Machinery, Three Failurespaper3
  53. The Innate-Immune Sensor That Converts the Diseasepaper3
  54. The Load-Bearing Neuronpaper3
  55. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper3
  56. The Somatostatin Interneuron in Alzheimer's Diseasepaper3
  57. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper3
  58. UBE3A, PTPA and Ephexin5paper3
  59. Amyloid-β Restrains Microglia Twicepaper2
  60. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper2
  61. Calcium Homeostasisconcept2
  62. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper2
  63. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper2
  64. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper2
  65. Compensatory Homeostasisconcept2
  66. Depression as Reversible Collapsepaper2
  67. Excitatory Neurotransmissionconcept2
  68. Ferroptosisconcept2
  69. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper2
  70. Layer II Immature Neurons, Disease-Associated Microglia and the Reelin–Ephexin5 Axispaper2
  71. Lysosomal Acidificationconcept2
  72. Lysosomal Membrane Damage as the Upstream Determinant of Microglial Statepaper2
  73. Mitochondria-Associated ER Membranes and Ceramide in Alzheimer's Diseasepaper2
  74. NMDA Receptor Blockade, Perineuronal Net Dynamics and Cell Death Modalities in Alzheimer'spaper2
  75. One Sensor, Two Collapses — Which Arm Matters More?paper2
  76. Phase IIIpaper2
  77. Plaques Are Tombstones, Not Killerspaper2
  78. Scott Small's Retromer and Endosomal Theorypaper2
  79. Smallpaper2
  80. Standard Diagnostic Biomarkers Explainedpaper2
  81. Synaptic Physiologyconcept2
  82. The Drivers of Microglial Dysfunction in Alzheimer's Disease, Ranked by Causal Weightpaper2
  83. The Genes That Protect — Phenocopy the Fortunatepaper2
  84. The Immune Cells That Keep the Peace — Until They Don'tpaper2
  85. The Inflammasome Versus the Reelin Brakepaper2
  86. The Strongest Case FOR the Amyloid Cascadepaper2
  87. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper1
  88. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  89. Abeta aggregation as necessary initiating eventconcept1
  90. Adult Hippocampal Neurogenesis and the Substrate of Cognitive Reservepaper1
  91. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper1
  92. Anne Eckert's Neuroendocrine Theory and the Withdrawal of Protection in the Ageing Brainpaper1
  93. APOE4 Hubnode1
  94. APP and tau pathology linked through transport disruptionconcept1
  95. Asparaginyl Endopeptidase in the Locus Coeruleuspaper1
  96. Autophagic Collapseconcept1
  97. Autophagyconcept1
  98. Autophagy-lysosomal failureconcept1
  99. Axonal transport failure as unifying mechanismconcept1
  100. Chronic Excitatory Insufficiencyconcept1
  101. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper1
  102. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper1
  103. Cortical Immature Neurons of Layer IIpaper1
  104. Dynamic and region-independent disease mechanismsconcept1
  105. Endosomal Nexusnode1
  106. Environmental neurotoxicologyconcept1
  107. Epigenetic regulation of AD genesconcept1
  108. Ferroptosis in Neurodegenerationconcept1
  109. Fischer's Sideliningpaper1
  110. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper1
  111. Gene dosage of APP directly causes pathogenesisconcept1
  112. Genetic evidence as gold standard for causalityconcept1
  113. Gunnar Gouras's Intraneuronal Amyloid and the Synaptic Endosome, Twenty-Eight Years Onpaper1
  114. Gut-brain axis in ADconcept1
  115. Gut-brain axis in neuroinflammationconcept1
  116. Iron Brain Paradoxconcept1
  117. Iron Dyshomeostasisconcept1
  118. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper1
  119. Lipid Metabolismconcept1
  120. Lipid Peroxidationconcept1
  121. Lithium in Alzheimer's Diseasepaper1
  122. LL-37, Innate Immunity and Autophagic Collapse in Alzheimer's Diseasepaper1
  123. Long preclinical phase of AD pathologyconcept1
  124. LRP1 and the Templated Spread of Misfolded Proteinpaper1
  125. Lysosomal Dysfunctionconcept1
  126. Mapping Fischer's 1907 Histopathological Terms onto Modern Autophagy Sciencepaper1
  127. Metabolic-neurodegenerative disease connectionconcept1
  128. Microglial Restraint as Resiliencepaper1
  129. Multi-pathway AD pathophysiology reviewconcept1
  130. Multifactorial modulation of disease trajectoryconcept1
  131. NAD⁺ Restoration and CD38 Inhibitionpaper1
  132. Norepinephrine as a Two-Armed Pincer on Taupaper1
  133. One Sugar Lattice, Three Jobspaper1
  134. Perineuronal Nets, Microglial Neuroinflammation, and Alzheimer'spaper1
  135. PERK DLX1 Tau Axisconcept1
  136. Rappoportpaper1
  137. Re-evaluating Tsai's 40 Hz Gamma Programpaper1
  138. Reelin-ApoE receptor axis disruptionconcept1
  139. Reelin, N-Sulfated Heparan Sulfate and ApoER2paper1
  140. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper1
  141. Sleep as the Shared Off-Line State of Every Collapse Axispaper1
  142. Solomon Carter Fuller's 1911 Plaque Audit, Read Beside Oskar Fischer'spaper1
  143. Synaptic Pathologyconcept1
  144. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper1
  145. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper1
  146. The Brakes on Microglial Activation in Alzheimer's Diseasepaper1
  147. The Bredesen ReCODE Protocol Evaluatedpaper1
  148. The Coerulean Interface — The Brainstem Origin of Alzheimer'spaper1
  149. The Enzyme That Cuts the Protective Latticepaper1
  150. The Inflammasome–Complement–TREM2 Nexus in Alzheimer's Diseasepaper1
  151. The Lipid That Kills Neurons and Spares Tumourspaper1
  152. The Locus Coeruleus as Phase Bridgepaper1
  153. The Microglion That Silences Tau's Phosphatasepaper1
  154. The Mitochondria-Associated Membrane Hypothesis of Alzheimer's Disease, Evaluatedpaper1
  155. The Phase II → III Transitionpaper1
  156. The Ventral Tegmental Area in Alzheimer's Diseasepaper1
  157. Translational Regulation in Tauopathyconcept1
  158. TXNIP as therapeutic targetconcept1
  159. When the Gut Writes the First Depressionpaper1
LRP8 (ApoER2) Reelin, synapse & ECM–PNN 668 62 docs
Matched on LRP8 ApoER2 APOER2
  1. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper82
  2. Convergent Synaptic Collapsepaper57
  3. The Load-Bearing Neuronpaper51
  4. Can a Drug Copy the Luckiest Mutation?paper46
  5. Lipid Peroxidation and ApoER2–Dab1 Disruption in Sporadic Alzheimer's Diseasepaper46
  6. The Enzyme That Cuts the Protective Latticepaper35
  7. Reelin, N-Sulfated Heparan Sulfate and ApoER2paper33
  8. Cofilin Serine 3paper32
  9. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper32
  10. The Brain's Architect and the Brake It Puts on Taupaper20
  11. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper19
  12. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper18
  13. Layer II Immature Neurons, Disease-Associated Microglia and the Reelin–Ephexin5 Axispaper17
  14. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper15
  15. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper14
  16. Norepinephrine as a Two-Armed Pincer on Taupaper13
  17. The Inflammasome Versus the Reelin Brakepaper12
  18. Iron Chelation and GPX4 Stabilizationpaper11
  19. Cofilin Serine 3 in Alzheimer's Diseasepaper10
  20. Reelin-ApoE receptor axis disruptionconcept10
  21. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper9
  22. One Sugar Lattice, Three Jobspaper7
  23. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper6
  24. Alzheimer's Disease — A Process in Timepaper5
  25. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper5
  26. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper5
  27. Chronic Excitatory Insufficiencyconcept4
  28. Tau Kindling in the Locus Coeruleuspaper4
  29. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper3
  30. Excitatory–Inhibitory Balance in Alzheimer'spaper3
  31. Lipid Peroxidationconcept3
  32. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper3
  33. The Matrix as the Seventh Axis of Collapsepaper3
  34. Which Genes Set the Threshold for Collapsepaper3
  35. APOE4 Hubnode2
  36. Cortical Immature Neurons of Layer IIpaper2
  37. Endosomal Nexusnode2
  38. Ferroptosisconcept2
  39. Adrenergic Signalingconcept1
  40. ApoE4 structural vulnerabilityconcept1
  41. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper1
  42. Cholesterol Homeostasisconcept1
  43. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper1
  44. Convergent Synaptic Collapseconcept1
  45. Ferroptosis in Neurodegenerationconcept1
  46. From Gut Ecology to the Failed Antidepressant Trialpaper1
  47. Immune-pathogen interaction modelconcept1
  48. Iron Brain Paradoxconcept1
  49. Iron Dyshomeostasisconcept1
  50. Lipid peroxidation cascade at synapseconcept1
  51. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper1
  52. Matrix Sulfation Nodeconcept1
  53. Moosmann & Sohrepaper1
  54. Multi-cellular pathologyconcept1
  55. Neurovascular dysfunction as initiating eventconcept1
  56. Perineuronal Netsconcept1
  57. Peroxidized ApoE as proximate causeconcept1
  58. Post-translational modification dysregulationconcept1
  59. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper1
  60. The Genes That Protect — Phenocopy the Fortunatepaper1
  61. The Somatostatin Interneuron in Alzheimer's Diseasepaper1
  62. The Timing of Locus Coeruleus Loss in Alzheimer's Diseasepaper1
V-ATPase (ATP6V) Autophagy / lysosome / clearance 632 84 docs
Matched on V-ATPase ATP6V vacuolar[- ]?(?:type )?ATPase
  1. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper59
  2. Lysosomal Acidification Failure as the Convergent Lesion of Neurodegenerationpaper42
  3. The Bredesen Protocol Compared Against the Convergent Collapse Frameworkpaper37
  4. Oxidative Stress and Autophagy Failure in Alzheimer's Diseasepaper29
  5. Autophagic Failure as the Convergent Endpoint in Alzheimer's, Parkinson's, ALS and Huntington'spaper23
  6. Khachaturianpaper23
  7. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper22
  8. Convergent Autophagic Collapsepaper21
  9. Lysosomal Acidificationconcept21
  10. Autophagy Failure Mechanisms in Neurodegeneration, and the Timeline of Plaque Formationpaper20
  11. Biomarkers of Vascular Dementia and Their Overlap with Alzheimer's Diseasepaper20
  12. The Morphological and Molecular Basis of Convergent Autophagic Collapsepaper17
  13. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper15
  14. Re-evaluating Tsai's 40 Hz Gamma Programpaper15
  15. Comparing Different Viral Triggerspaper13
  16. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper12
  17. Mitochondrial Quality Control Across Five Diseasespaper12
  18. Restoring Autophagy in Neurodegenerationpaper12
  19. The Clearance Collapse — One Machinery, Three Failurespaper11
  20. Carlo Abbate's Adult Neurogenesis Theory of Alzheimer's Disease, Critically Evaluatedpaper8
  21. Convergent Synaptic Collapsepaper8
  22. Disciplinary Silos in Alzheimer's Disease Research, 1950–2020paper8
  23. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper8
  24. Load, Capacity and the Boundary of Convergent Clearance Failure in Neurodegenerationpaper8
  25. The Bredesen ReCODE Protocol Evaluatedpaper8
  26. Bioenergeticsconcept7
  27. LL-37, CLIC1 and Microglial Lysosomal Failurepaper7
  28. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper7
  29. Autophagyconcept6
  30. Bioenergetic Collapsepaper6
  31. Calcium Homeostasisconcept6
  32. Cholesterol Homeostasisconcept5
  33. Ferroptosisconcept5
  34. Fischer's Staged Deposit, 1907–1912paper5
  35. Lysosomal Dysfunctionconcept5
  36. Where Autophagic Failure Causes Neurodegeneration, and Where It Is a Consequencepaper5
  37. Which Genes Set the Threshold for Collapsepaper5
  38. Mitochondrial Dysfunctionconcept4
  39. Plaques Are Tombstones, Not Killerspaper4
  40. Autophagic Flux in Alzheimer's Diseasepaper3
  41. Endosomal Traffickingconcept3
  42. Gouraspaper3
  43. Lipid Metabolismconcept3
  44. Lipid Peroxidationconcept3
  45. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper3
  46. The Mitochondria-Associated Membrane Hypothesis of Alzheimer's Disease, Evaluatedpaper3
  47. Anti Ferroptotic Botanicalsconcept2
  48. Antimicrobial Defenseconcept2
  49. Autophagic Collapseconcept2
  50. BCG Immune Checkpoint Modulationconcept2
  51. Brain Lipid Homeostasis Restorationconcept2
  52. Cannabinoid Neuroprotectionconcept2
  53. Dietary Fatty Acid APOE4 Rescueconcept2
  54. Endolysosomal Dysfunctionconcept2
  55. Endosomal Nexusnode2
  56. Estela Area-Gómez's MAM Theorypaper2
  57. Gut Brain Axisconcept2
  58. Immunometabolismconcept2
  59. Lipid Transportconcept2
  60. Lysosomal Membrane Damage as the Upstream Determinant of Microglial Statepaper2
  61. Membrane Biologyconcept2
  62. Microglial Immunometabolismconcept2
  63. Neuroinflammationconcept2
  64. Oxidative Stressconcept2
  65. Peripheral Immunocyte Regulationconcept2
  66. Prenatally Generated Immature Neurons and the Cellular Origin of Alzheimer's Diseasepaper2
  67. Synaptic Competitionconcept2
  68. Trained Immunityconcept2
  69. Viral Pathogenesisconcept2
  70. Which Biomarkers Detect Which Phasepaper2
  71. Autophagic Fluxconcept1
  72. Energy Metabolismconcept1
  73. ER Stressconcept1
  74. Fischer's Sideliningpaper1
  75. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper1
  76. Glial Biologyconcept1
  77. Iron Chelation and GPX4 Stabilizationpaper1
  78. Metabolic-Homeostatic Axisnode1
  79. Microbial Pathogenesisconcept1
  80. Neural Oscillationsconcept1
  81. Proteostasis Collapseconcept1
  82. The Immunometabolic Nexus of Neurodegenerationpaper1
  83. TOMM40 Import Gateconcept1
  84. Tryptophan Allocation Across the Kynurenine, NAD⁺ and Serotonergic Branchespaper1
SST (somatostatin) Neuromodulator / circadian / kynurenine 598 30 docs
Matched on SST somatostatin
  1. The Somatostatin Interneuron in Alzheimer's Diseasepaper264
  2. The Brakes on Microglial Activation in Alzheimer's Diseasepaper118
  3. Wandering in Alzheimer's Diseasepaper79
  4. The Load-Bearing Neuronpaper41
  5. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper17
  6. Collapse, Traced Cell Type by Cell Typepaper12
  7. The Proteolytic Degradation of the Perineuronal Net and the Loss of PV Interneuronspaper12
  8. The Matrix as the Seventh Axis of Collapsepaper8
  9. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper7
  10. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper7
  11. Alzheimer's Disease as a Fifty-Year Process in Time and Spacepaper4
  12. Ordered Attrition and Resilience as the Two Human-Evidence Anchors of Alzheimer'spaper4
  13. Gunnar Gouras's Intraneuronal Amyloid and the Synaptic Endosome, Twenty-Eight Years Onpaper3
  14. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper3
  15. Cofilin Serine 3 in Alzheimer's Diseasepaper2
  16. CSF1R Inhibition Restores the Perineuronal Matrix and Destabilises the Rhythm It Supportspaper2
  17. Reelin-ApoE receptor axis disruptionconcept2
  18. Cofilin Serine 3paper1
  19. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper1
  20. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper1
  21. Matrix Sulfation Nodeconcept1
  22. Microglial Restraint as Resiliencepaper1
  23. One Sensor, Two Collapses — Which Arm Matters More?paper1
  24. One Sugar Lattice, Three Jobspaper1
  25. Perineuronal Netsconcept1
  26. Phase Measurabilityconcept1
  27. Templated Tau Misfolding Across the Three Phasespaper1
  28. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper1
  29. The NLRP Inflammasome and the Perineuronal Net in Alzheimer's Diseasepaper1
  30. Which Genes Set the Threshold for Collapsepaper1
DAB1 Reelin, synapse & ECM–PNN 582 43 docs
Matched on DAB1 Disabled-1
  1. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper56
  2. Can a Drug Copy the Luckiest Mutation?paper47
  3. Cofilin Serine 3paper47
  4. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper30
  5. Convergent Synaptic Collapsepaper26
  6. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper26
  7. The Enzyme That Cuts the Protective Latticepaper26
  8. The Load-Bearing Neuronpaper26
  9. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper25
  10. Lipid Peroxidation and ApoER2–Dab1 Disruption in Sporadic Alzheimer's Diseasepaper25
  11. Reelin, N-Sulfated Heparan Sulfate and ApoER2paper25
  12. The Brain's Architect and the Brake It Puts on Taupaper20
  13. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper19
  14. Norepinephrine as a Two-Armed Pincer on Taupaper18
  15. The Inflammasome Versus the Reelin Brakepaper18
  16. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper17
  17. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper15
  18. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper15
  19. One Sugar Lattice, Three Jobspaper12
  20. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper11
  21. Cofilin Serine 3 in Alzheimer's Diseasepaper11
  22. Layer II Immature Neurons, Disease-Associated Microglia and the Reelin–Ephexin5 Axispaper9
  23. Reelin-ApoE receptor axis disruptionconcept9
  24. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper8
  25. Tau Kindling in the Locus Coeruleuspaper7
  26. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper4
  27. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper3
  28. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper3
  29. Cortical Immature Neurons of Layer IIpaper3
  30. The Matrix as the Seventh Axis of Collapsepaper3
  31. Endosomal Nexusnode2
  32. Perineuronal Netsconcept2
  33. The Genes That Protect — Phenocopy the Fortunatepaper2
  34. The Somatostatin Interneuron in Alzheimer's Diseasepaper2
  35. Which Genes Set the Threshold for Collapsepaper2
  36. APOE4 Hubnode1
  37. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper1
  38. Convergent Synaptic Collapseconcept1
  39. From Gut Ecology to the Failed Antidepressant Trialpaper1
  40. Lipid Peroxidationconcept1
  41. Matrix Sulfation Nodeconcept1
  42. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper1
  43. The Timing of Locus Coeruleus Loss in Alzheimer's Diseasepaper1
CGAS Microglia & innate immunity 539 14 docs
CAMP (LL-37) Microglia & innate immunity 526 22 docs
MMP9 Reelin, synapse & ECM–PNN 502 58 docs
Matched on MMP-?9
  1. The Enzyme That Cuts the Protective Latticepaper92
  2. Phase IIIpaper91
  3. How the Genes Partition the Vascular Phenotypepaper30
  4. Telling Different Dementias Apartpaper30
  5. Amyloid-β Restrains Microglia Twicepaper23
  6. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper23
  7. Which Genes Set the Threshold for Collapsepaper20
  8. Aleksandra Deczkowska's DAM Program and the Matrix-Degrading Armpaper19
  9. The Losing Axonpaper19
  10. The Phase II → III Transitionpaper18
  11. Blood-Vessel Damage, Phase by Phasepaper15
  12. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper11
  13. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper6
  14. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper6
  15. Vascular Pathology as a Substrate Across Phasespaper6
  16. The Matrix as the Seventh Axis of Collapsepaper5
  17. The NLRP Inflammasome and the Perineuronal Net in Alzheimer's Diseasepaper5
  18. Zhen Huang's Competitive Synaptic Plasticity and the Amyloid-β Monomer Depletion Modelpaper5
  19. Disciplinary Silos in Alzheimer's Disease Research, 1950–2020paper4
  20. One Sugar Lattice, Three Jobspaper4
  21. The Cholinergic Nucleus Basalis in Alzheimer's Diseasepaper4
  22. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper4
  23. Adult Hippocampal Neurogenesis and the Substrate of Cognitive Reservepaper3
  24. Depression as Reversible Collapsepaper3
  25. Down Syndrome as the Disease Run in Fast-Forwardpaper3
  26. Fischer's Matrixpaper3
  27. Michal Schwartz's Protective Autoimmunity as the Systemic Upstream of the Microglial Nichepaper3
  28. Norepinephrine as a Two-Armed Pincer on Taupaper3
  29. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper3
  30. Adrenergic Signalingconcept2
  31. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper2
  32. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper2
  33. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper2
  34. Convergent Synaptic Collapsepaper2
  35. Homeostatic Collapsepaper2
  36. Perineuronal Netsconcept2
  37. Perineuronal Nets, Microglial Neuroinflammation, and Alzheimer'spaper2
  38. The Cell Biology of the Word 'Ageing'paper2
  39. The Load-Bearing Neuronpaper2
  40. The Locus Coeruleus as Phase Bridgepaper2
  41. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper2
  42. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper1
  43. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  44. AD as accelerated aging of Abeta managementconcept1
  45. Aging accelerators and deceleratorsconcept1
  46. Alzheimer's Disease — A Process in Timepaper1
  47. Alzheimer's Disease as a Fifty-Year Process in Time and Spacepaper1
  48. Beth Stevens's Complement-Pruning Programpaper1
  49. Clearance failure vs. overproductionconcept1
  50. Collapse, Traced Cell Type by Cell Typepaper1
  51. Convergent Synaptic Collapseconcept1
  52. Fischer's Sideliningpaper1
  53. Inflamm-aging as disease driverconcept1
  54. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper1
  55. Oskar Fischer's Eight Stages of Plaque Formationpaper1
  56. Re-evaluating Tsai's 40 Hz Gamma Programpaper1
  57. The Brakes on Microglial Activation in Alzheimer's Diseasepaper1
  58. The Inflammasome Versus the Reelin Brakepaper1
C4 (complement) Microglia & innate immunity 486 38 docs
Matched on C4d C4b
  1. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper80
  2. Convergent Synaptic Collapsepaper73
  3. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper62
  4. Shatz & Brottpaper57
  5. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper27
  6. The Timing of Locus Coeruleus Loss in Alzheimer's Diseasepaper25
  7. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper23
  8. The Load-Bearing Neuronpaper23
  9. From Synapse Loss to Neuronal Death in Alzheimer's Diseasepaper14
  10. The Matrix as the Seventh Axis of Collapsepaper10
  11. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper9
  12. Cofilin Serine 3 in Alzheimer's Diseasepaper9
  13. The Losing Axonpaper9
  14. Cofilin Serine 3paper8
  15. Homeostatic Collapsepaper7
  16. Collapse, Traced Cell Type by Cell Typepaper5
  17. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper4
  18. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper4
  19. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper4
  20. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper4
  21. The Phase II → III Transitionpaper4
  22. Bioenergetic Collapsepaper3
  23. Seth Margolis Revisitedpaper3
  24. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper2
  25. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper2
  26. Neuroimmune Interfacenode2
  27. Which Genes Set the Threshold for Collapsepaper2
  28. Alzheimer's Disease — A Process in Timepaper1
  29. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper1
  30. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper1
  31. Down Syndrome as the Disease Run in Fast-Forwardpaper1
  32. How the Genes Partition the Vascular Phenotypepaper1
  33. Michal Schwartz's Protective Autoimmunity as the Systemic Upstream of the Microglial Nichepaper1
  34. Neuroimmunologyconcept1
  35. Neuroinflammationconcept1
  36. Perineuronal Netsconcept1
  37. The Bredesen ReCODE Protocol Evaluatedpaper1
  38. The Cell Biology of the Word 'Ageing'paper1
SORL1 GWAS / LOAD risk 448 47 docs
Matched on SORL1 SORLA
  1. Scott Small's Retromer and Endosomal Theorypaper94
  2. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper55
  3. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper46
  4. Convergent Synaptic Collapsepaper43
  5. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper40
  6. Smallpaper30
  7. Beth Stevens's Complement-Pruning Programpaper24
  8. Cofilin Serine 3paper13
  9. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper9
  10. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper9
  11. Which Genes Set the Threshold for Collapsepaper9
  12. SORL1 Lysosomal Functionconcept5
  13. Where Autophagic Failure Causes Neurodegeneration, and Where It Is a Consequencepaper5
  14. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper4
  15. Endosomal Traffickingconcept4
  16. SorLA Lipid ER Regulationconcept4
  17. Antimicrobial hypothesis of amyloidconcept3
  18. BBB breakdown cascadeconcept3
  19. Circadian Immune Regulationconcept3
  20. Human-germ interaction modelconcept3
  21. Neuroimmune Surveillanceconcept3
  22. Neurovascular unit as disease originconcept3
  23. Autophagic Failure as the Convergent Endpoint in Alzheimer's, Parkinson's, ALS and Huntington'spaper2
  24. Disciplinary Silos in Alzheimer's Disease Research, 1950–2020paper2
  25. Endosomal Nexusnode2
  26. Entropy as organizing principleconcept2
  27. Evolutionary mismatch hypothesisconcept2
  28. Microglial Protein Biomarkersconcept2
  29. Mitochondrial Quality Control Across Five Diseasespaper2
  30. Modifiability of AD riskconcept2
  31. Mosaic model of aging brainconcept2
  32. Seth Margolis Revisitedpaper2
  33. Transcriptional Pause Releaseconcept2
  34. Autophagic Collapseconcept1
  35. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper1
  36. Ceramide as a Structural and Signalling Node in Alzheimer's Diseasepaper1
  37. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper1
  38. Convergent Autophagic Collapsepaper1
  39. Estela Area-Gómez's MAM Theorypaper1
  40. Gouraspaper1
  41. How the Genes Partition the Vascular Phenotypepaper1
  42. Khachaturianpaper1
  43. LL-37, CLIC1 and Microglial Lysosomal Failurepaper1
  44. Moosmann & Sohrepaper1
  45. Rappoportpaper1
  46. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper1
  47. The Clearance Collapse — One Machinery, Three Failurespaper1
CD38 Bioenergetic / mito / NAD 438 30 docs
Matched on CD38
  1. NAD⁺ Restoration and CD38 Inhibitionpaper118
  2. Re-evaluating Chini's CD38–NAD Programpaper62
  3. Michal Schwartz's Protective Autoimmunity as the Systemic Upstream of the Microglial Nichepaper41
  4. Mitochondrial Quality Control Across Five Diseasespaper36
  5. PARP Inhibitors and the Locus Coeruleuspaper21
  6. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper20
  7. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper19
  8. The Cell Biology of the Word 'Ageing'paper18
  9. The Locus Coeruleus and the Noradrenergic Prodrome of Alzheimer's Diseasepaper15
  10. Tryptophan Allocation Across the Kynurenine, NAD⁺ and Serotonergic Branchespaper12
  11. Iron Chelation and GPX4 Stabilizationpaper10
  12. Which Genes Set the Threshold for Collapsepaper10
  13. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper9
  14. Cellular Senescenceconcept9
  15. The Clearance Collapse — One Machinery, Three Failurespaper7
  16. Disciplinary Silos in Alzheimer's Disease Research, 1950–2020paper5
  17. Aging as root cause of ADconcept3
  18. Aleksandra Deczkowska's DAM Program and the Matrix-Degrading Armpaper3
  19. Amyloid-beta as innate immune defenseconcept3
  20. How the Genes Partition the Vascular Phenotypepaper3
  21. Inflammaging integrates hallmarks of agingconcept3
  22. NAD+ depletion drives neurodegenerationconcept3
  23. Brain Immune Interfaceconcept1
  24. Immune Checkpoint Therapyconcept1
  25. Immunometabolic Checkpointsconcept1
  26. LL-37, CLIC1 and Microglial Lysosomal Failurepaper1
  27. Meningeal T Cell Regulationconcept1
  28. Necrotic Cell Deathconcept1
  29. Phagocytic Clearanceconcept1
  30. Re-evaluating Tsai's 40 Hz Gamma Programpaper1
STING Microglia & innate immunity 430 15 docs
LRP1 Reelin, synapse & ECM–PNN 415 33 docs
Matched on LRP1
  1. LRP1 and the Templated Spread of Misfolded Proteinpaper168
  2. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper72
  3. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper43
  4. Different Tau Strains Cause Different Diseasespaper20
  5. How the Genes Partition the Vascular Phenotypepaper20
  6. Stanley Prusiner's Prion Theory and Templated Neurodegeneration, Critically Evaluatedpaper12
  7. Vascular Pathology as a Substrate Across Phasespaper9
  8. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper8
  9. α-Synuclein Templating and Synucleinopathy Propagationpaper7
  10. Proving That Misfolded Proteins Spread Like Prionspaper5
  11. The Locus Coeruleus as Phase Bridgepaper5
  12. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper5
  13. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper4
  14. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper4
  15. Blood-Vessel Damage, Phase by Phasepaper3
  16. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper3
  17. Templated Tau Misfolding Across the Three Phasespaper3
  18. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper2
  19. Alzheimer's Disease — A Process in Timepaper2
  20. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper2
  21. Endosomal Traffickingconcept2
  22. Restoring Autophagy in Neurodegenerationpaper2
  23. The Brain's Border Gatepaper2
  24. The Indifferent Neuronpaper2
  25. The Mitochondria-Associated Membrane Hypothesis of Alzheimer's Disease, Evaluatedpaper2
  26. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper1
  27. Can a Drug Copy the Luckiest Mutation?paper1
  28. Cholesterol Homeostasisconcept1
  29. Convergent Synaptic Collapsepaper1
  30. Glymphatic Clearance Failure in Alzheimer's Disease and the Noradrenergic Switchpaper1
  31. Gouraspaper1
  32. LL-37, Innate Immunity and Autophagic Collapse in Alzheimer's Diseasepaper1
  33. The Cell Biology of the Word 'Ageing'paper1
GSK3B Amyloid & Tau core 412 57 docs
Matched on GSK3B GSK-?3β GSK-?3beta GSK-?3
  1. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper145
  2. Lithium in Alzheimer's Diseasepaper93
  3. Convergent Synaptic Collapsepaper20
  4. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper18
  5. Carlo Abbate's Adult Neurogenesis Theory of Alzheimer's Disease, Critically Evaluatedpaper10
  6. Three Subtractive Alzheimer's Trials That Engaged Their Target and Left Patients Worsepaper10
  7. Norepinephrine as a Two-Armed Pincer on Taupaper9
  8. The Inflammasome Versus the Reelin Brakepaper9
  9. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper8
  10. Lipid Peroxidation and ApoER2–Dab1 Disruption in Sporadic Alzheimer's Diseasepaper8
  11. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper7
  12. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper6
  13. The Matrix as the Seventh Axis of Collapsepaper5
  14. Mitochondria-Associated ER Membranes and Ceramide in Alzheimer's Diseasepaper3
  15. Restoring Autophagy in Neurodegenerationpaper3
  16. UBE3A, PTPA and Ephexin5paper3
  17. Wnt-GSK3-beta pathway integrating amyloid and tau pathologyconcept3
  18. Can a Drug Copy the Luckiest Mutation?paper2
  19. Cofilin Serine 3paper2
  20. Cytoskeletal Collapse Nodenode2
  21. Cytoskeletal Perturbationstage2
  22. Down Syndrome as the Disease Run in Fast-Forwardpaper2
  23. Gunnar Gouras's Intraneuronal Amyloid and the Synaptic Endosome, Twenty-Eight Years Onpaper2
  24. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper2
  25. Plaques Are Tombstones, Not Killerspaper2
  26. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper2
  27. Tau Kindling in the Locus Coeruleuspaper2
  28. Tau Pathologyconcept2
  29. The Brain's Architect and the Brake It Puts on Taupaper2
  30. Adrenergic Signalingconcept1
  31. Alzheimer's Disease — A Process in Timepaper1
  32. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper1
  33. Amyloid plaques as fibrotic scar tissue from BBB repairconcept1
  34. Autophagic Flux in Alzheimer's Diseasepaper1
  35. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper1
  36. Gouraspaper1
  37. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper1
  38. Lipid Metabolismconcept1
  39. LL-37, CLIC1 and Microglial Lysosomal Failurepaper1
  40. Microbleeds as initiating vascular event in ADconcept1
  41. Mitochondrial Quality Control Across Five Diseasespaper1
  42. Multifactorial risk accumulation modelconcept1
  43. Neurovascular injury-repair cycle driving disease progressionconcept1
  44. One Sugar Lattice, Three Jobspaper1
  45. Perineuronal Netsconcept1
  46. Re-evaluating Höglinger's Complex I → Tau Programpaper1
  47. Reelin-ApoE receptor axis disruptionconcept1
  48. Reelin, N-Sulfated Heparan Sulfate and ApoER2paper1
  49. Resilience as key to understanding AD clinical expressionconcept1
  50. Scott Small's Retromer and Endosomal Theorypaper1
  51. Somatic mutations as novel therapeutic targetsconcept1
  52. SuperAgers demonstrate pathology-cognition dissociationconcept1
  53. The Calcium Hypothesis and the Systems Failure Model of Alzheimer's Diseasepaper1
  54. The Genes That Protect — Phenocopy the Fortunatepaper1
  55. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper1
  56. The Inflammasome–Complement–TREM2 Nexus in Alzheimer's Diseasepaper1
  57. The Locus Coeruleus and the Noradrenergic Prodrome of Alzheimer's Diseasepaper1
RHOA Reelin, synapse & ECM–PNN 389 29 docs
Matched on RhoA RHOA
  1. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper61
  2. Convergent Synaptic Collapsepaper45
  3. Cofilin Serine 3paper39
  4. Layer II Immature Neurons, Disease-Associated Microglia and the Reelin–Ephexin5 Axispaper36
  5. Seth Margolis Revisitedpaper31
  6. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper24
  7. UBE3A, PTPA and Ephexin5paper20
  8. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper17
  9. Margolispaper17
  10. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper13
  11. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper12
  12. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper10
  13. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper10
  14. From Synapse Loss to Neuronal Death in Alzheimer's Diseasepaper6
  15. The Load-Bearing Neuronpaper6
  16. The Locus Coeruleus and the Noradrenergic Prodrome of Alzheimer's Diseasepaper6
  17. Convergent signaling through Wnt-PCP-RhoA-ROCKconcept5
  18. Structural Instructions at the Synapse Are Terminated by Destruction, Not Dephosphorylationpaper5
  19. The Matrix as the Seventh Axis of Collapsepaper5
  20. The Timing of Locus Coeruleus Loss in Alzheimer's Diseasepaper4
  21. Cytoskeletal disorder as core pathologyconcept3
  22. Glial contribution to neurodegenerationconcept3
  23. Locus coeruleus as ground zeroconcept3
  24. Cytoskeletal Collapse Nodenode2
  25. The Bredesen Protocol Compared Against the Convergent Collapse Frameworkpaper2
  26. APOE4 Hubnode1
  27. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper1
  28. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper1
  29. Dynamics of Synaptic Competitionpaper1
MTOR Autophagy / lysosome / clearance 364 62 docs
Matched on mTOR MTOR mTORC1 mTORC2
  1. Restoring Autophagy in Neurodegenerationpaper29
  2. Bioenergetic Collapsepaper27
  3. NMDA Receptor Blockade, Perineuronal Net Dynamics and Cell Death Modalities in Alzheimer'spaper26
  4. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper22
  5. Autophagic Flux in Alzheimer's Diseasepaper20
  6. The Clearance Collapse — One Machinery, Three Failurespaper18
  7. Depression as Reversible Collapsepaper17
  8. Autophagy as the Driver of System-Wide Agingpaper13
  9. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper13
  10. The Bredesen Protocol Compared Against the Convergent Collapse Frameworkpaper12
  11. The Bredesen ReCODE Protocol Evaluatedpaper12
  12. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper11
  13. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper10
  14. HSV-1 Suppression of Neuronal Autophagy as a Viral Route into Alzheimer's Diseasepaper9
  15. Gunnar Gouras's Intraneuronal Amyloid and the Synaptic Endosome, Twenty-Eight Years Onpaper7
  16. Autophagic Failure as the Convergent Endpoint in Alzheimer's, Parkinson's, ALS and Huntington'spaper6
  17. Load, Capacity and the Boundary of Convergent Clearance Failure in Neurodegenerationpaper6
  18. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper6
  19. Where Autophagic Failure Causes Neurodegeneration, and Where It Is a Consequencepaper6
  20. BCG Vaccination in Alzheimer's Diseasepaper5
  21. Metabolic-Homeostatic Axisnode5
  22. The Immunometabolic Nexus of Neurodegenerationpaper5
  23. Biomarkers of Vascular Dementia and Their Overlap with Alzheimer's Diseasepaper4
  24. Comparing Different Viral Triggerspaper4
  25. Mitochondrial Quality Control Across Five Diseasespaper4
  26. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper4
  27. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper4
  28. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper3
  29. Can Vaccines Protect Against Dementia?paper3
  30. Lithium in Alzheimer's Diseasepaper3
  31. LL-37, CLIC1 and Microglial Lysosomal Failurepaper3
  32. Lysosomal Acidification Failure as the Convergent Lesion of Neurodegenerationpaper3
  33. UBE3A, PTPA and Ephexin5paper3
  34. When the Gut Writes the First Depressionpaper3
  35. Amyloid-β, the Oxidative Burst and Three Routes to a Disabled Phosphatasepaper2
  36. Bioenergeticsconcept2
  37. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper2
  38. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper2
  39. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper2
  40. LL-37, Innate Immunity and Autophagic Collapse in Alzheimer's Diseasepaper2
  41. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper2
  42. The Morphological and Molecular Basis of Convergent Autophagic Collapsepaper2
  43. Which Biomarkers Detect Which Phasepaper2
  44. Which Genes Set the Threshold for Collapsepaper2
  45. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  46. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper1
  47. Astrocytespaper1
  48. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper1
  49. Cellular Senescenceconcept1
  50. Convergent Autophagic Collapsepaper1
  51. Homeostatic Collapsepaper1
  52. How the Genes Partition the Vascular Phenotypepaper1
  53. Iron Chelation and GPX4 Stabilizationpaper1
  54. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper1
  55. Lysosomal Membrane Damage as the Upstream Determinant of Microglial Statepaper1
  56. NAD⁺ Restoration and CD38 Inhibitionpaper1
  57. Ralph Nixon's Inside-Out Thesispaper1
  58. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper1
  59. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper1
  60. The Losing Axonpaper1
  61. Tryptophan Allocation Across the Kynurenine, NAD⁺ and Serotonergic Branchespaper1
  62. Vaccines That May Prevent Dementiapaper1
ACAN (aggrecan) Reelin, synapse & ECM–PNN 357 64 docs
Matched on ACAN aggrecan
  1. The NLRP Inflammasome and the Perineuronal Net in Alzheimer's Diseasepaper26
  2. The Perineuronal Matrix and Cortical Layer Twopaper23
  3. CSF1R Inhibition Restores the Perineuronal Matrix and Destabilises the Rhythm It Supportspaper16
  4. The Proteolytic Degradation of the Perineuronal Net and the Loss of PV Interneuronspaper15
  5. The Matrix as the Seventh Axis of Collapsepaper13
  6. The Phase II → III Transitionpaper13
  7. The Plaque Was Staged Before It Was Countedpaper13
  8. One Sugar Lattice, Three Jobspaper12
  9. Perineuronal Nets, Microglial Neuroinflammation, and Alzheimer'spaper12
  10. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper10
  11. From Gut Ecology to the Failed Antidepressant Trialpaper10
  12. One Sensor, Two Collapses — Which Arm Matters More?paper9
  13. Phase IIIpaper9
  14. Templated Tau Misfolding Across the Three Phasespaper9
  15. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper9
  16. Which Genes Set the Threshold for Collapsepaper9
  17. Fischer's Matrixpaper8
  18. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper8
  19. The Raphe Nuclei in Alzheimer's Disease as a Subject in Their Own Rightpaper8
  20. Tau Kindling in the Locus Coeruleuspaper7
  21. The Enzyme That Cuts the Protective Latticepaper7
  22. The Load-Bearing Neuronpaper7
  23. Down Syndrome as the Disease Run in Fast-Forwardpaper6
  24. Oskar Fischer's Eight Stages of Plaque Formationpaper6
  25. Perineuronal Netsconcept6
  26. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper6
  27. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper5
  28. Homeostatic Collapsepaper5
  29. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper5
  30. Collapse, Traced Cell Type by Cell Typepaper4
  31. The Brakes on Microglial Activation in Alzheimer's Diseasepaper4
  32. Alzheimer's Disease — A Process in Timepaper3
  33. Bioenergetic Collapsepaper3
  34. Can a Drug Copy the Luckiest Mutation?paper3
  35. cognitive resilienceconcept3
  36. Fischer's Eighth Stage as a Measurement of Rate Against Host Capacitypaper3
  37. Michal Schwartz's Protective Autoimmunity as the Systemic Upstream of the Microglial Nichepaper3
  38. Norepinephrine as a Two-Armed Pincer on Taupaper3
  39. The Inflammasome Versus the Reelin Brakepaper3
  40. The Timing of Locus Coeruleus Loss in Alzheimer's Diseasepaper3
  41. Depression as Reversible Collapsepaper2
  42. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper2
  43. Microglial Restraint as Resiliencepaper2
  44. The Brain's Architect and the Brake It Puts on Taupaper2
  45. The Somatostatin Interneuron in Alzheimer's Diseasepaper2
  46. Which Biomarkers Detect Which Phasepaper2
  47. Adrenergic Signalingconcept1
  48. Adult Hippocampal Neurogenesis and the Substrate of Cognitive Reservepaper1
  49. Alzheimer's Disease as a Fifty-Year Process in Time and Spacepaper1
  50. Amyloid-β, the Oxidative Burst and Three Routes to a Disabled Phosphatasepaper1
  51. Cofilin Serine 3 in Alzheimer's Diseasepaper1
  52. Convergent Synaptic Collapseconcept1
  53. Cortical Immature Neurons of Layer IIpaper1
  54. Ecce Homopaper1
  55. Epigenetic Erosion as the Reversible Information Layer of Alzheimer's Diseasepaper1
  56. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper1
  57. Homeostatic Microglial Collapseconcept1
  58. How the Genes Partition the Vascular Phenotypepaper1
  59. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper1
  60. Mitochondrial Quality Control Across Five Diseasespaper1
  61. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper1
  62. Ordered Attrition and Resilience as the Two Human-Evidence Anchors of Alzheimer'spaper1
  63. The Cell Biology of the Word 'Ageing'paper1
  64. The Locus Coeruleus as Phase Bridgepaper1
BDNF Trophic / exercise / resilience 351 34 docs
Matched on BDNF
  1. BDNF and the Trophic Failure of the Synapse in Alzheimer's Diseasepaper186
  2. Depression as Reversible Collapsepaper29
  3. Tryptophan Allocation Across the Kynurenine, NAD⁺ and Serotonergic Branchespaper16
  4. Lithium in Alzheimer's Diseasepaper13
  5. From Synapse Loss to Neuronal Death in Alzheimer's Diseasepaper12
  6. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper11
  7. NMDA Receptor Blockade, Perineuronal Net Dynamics and Cell Death Modalities in Alzheimer'spaper11
  8. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper10
  9. Why Exercise Prevents but Does Not Curepaper8
  10. The Indifferent Neuronpaper7
  11. Adult Hippocampal Neurogenesis and the Substrate of Cognitive Reservepaper5
  12. Restoring Autophagy in Neurodegenerationpaper5
  13. When the Gut Writes the First Depressionpaper4
  14. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper3
  15. The Raphe Nuclei in Alzheimer's Disease as a Subject in Their Own Rightpaper3
  16. Autophagy-metabolism crosstalk in ADconcept2
  17. cognitive resilienceconcept2
  18. Energy failure as primary AD driverconcept2
  19. From Gut Ecology to the Failed Antidepressant Trialpaper2
  20. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper2
  21. Sigma-1 receptor-mediated neuroprotectionconcept2
  22. SSRI repurposing for neurodegenerationconcept2
  23. Synaptic Plasticityconcept2
  24. The Bredesen Protocol Compared Against the Convergent Collapse Frameworkpaper2
  25. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper1
  26. Adult Neurogenesisconcept1
  27. Can Vaccines Protect Against Dementia?paper1
  28. Carlo Abbate's Adult Neurogenesis Theory of Alzheimer's Disease, Critically Evaluatedpaper1
  29. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper1
  30. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper1
  31. Convergent Synaptic Collapsepaper1
  32. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper1
  33. Plaques Are Tombstones, Not Killerspaper1
  34. Prenatally Generated Immature Neurons and the Cellular Origin of Alzheimer's Diseasepaper1
TARDBP (TDP-43) Neurodegeneration overlap 277 57 docs
Matched on TARDBP TDP-?43
  1. The Indifferent Neuronpaper30
  2. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper25
  3. Mitochondrial Quality Control Across Five Diseasespaper19
  4. Proving That Misfolded Proteins Spread Like Prionspaper17
  5. Which Genes Set the Threshold for Collapsepaper17
  6. Restoring Autophagy in Neurodegenerationpaper16
  7. Telling Different Dementias Apartpaper15
  8. Estela Area-Gómez's MAM Theorypaper13
  9. Pavel Kalvach's Case That Alzheimer's Is Not a Disease, Gradedpaper9
  10. Stanley Prusiner's Prion Theory and Templated Neurodegeneration, Critically Evaluatedpaper9
  11. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper8
  12. Neurotropic Viral Invasion of the Central Nervous Systempaper7
  13. Autophagic Failure as the Convergent Endpoint in Alzheimer's, Parkinson's, ALS and Huntington'spaper6
  14. Where Autophagic Failure Causes Neurodegeneration, and Where It Is a Consequencepaper6
  15. Load, Capacity and the Boundary of Convergent Clearance Failure in Neurodegenerationpaper5
  16. Prenatally Generated Immature Neurons and the Cellular Origin of Alzheimer's Diseasepaper5
  17. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper4
  18. Bess Frost's Chromatin Programme, the Elements It Releases, and the Restraint on cGASpaper3
  19. Convergent Autophagic Collapsepaper3
  20. How the Genes Partition the Vascular Phenotypepaper3
  21. HSV-1 Suppression of Neuronal Autophagy as a Viral Route into Alzheimer's Diseasepaper3
  22. The Load-Bearing Neuronpaper3
  23. The Raphe Nuclei in Alzheimer's Disease as a Subject in Their Own Rightpaper3
  24. The Somatostatin Interneuron in Alzheimer's Diseasepaper3
  25. Todd Golde's Amyloid Cascade, Read for What It Addspaper3
  26. Carlo Abbate's Adult Neurogenesis Theory of Alzheimer's Disease, Critically Evaluatedpaper2
  27. cGAS–STING in Alzheimer's Diseasepaper2
  28. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper2
  29. From Gut Ecology to the Failed Antidepressant Trialpaper2
  30. LRP1 and the Templated Spread of Misfolded Proteinpaper2
  31. Mitochondria-Associated ER Membranes and Ceramide in Alzheimer's Diseasepaper2
  32. Phase Measurabilityconcept2
  33. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper2
  34. Scott Small's Retromer and Endosomal Theorypaper2
  35. Templated Tau Misfolding Across the Three Phasespaper2
  36. A Counterfactual History of Alzheimer's Research Had Fischer's 1907 Findings Prevailedpaper1
  37. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper1
  38. Astrocytespaper1
  39. Biomarkers of Vascular Dementia and Their Overlap with Alzheimer's Diseasepaper1
  40. Different Tau Strains Cause Different Diseasespaper1
  41. Disciplinary Silos in Alzheimer's Disease Research, 1950–2020paper1
  42. Fischer's Sideliningpaper1
  43. Khachaturianpaper1
  44. LL-37, CLIC1 and Microglial Lysosomal Failurepaper1
  45. Lysosomal Acidification Failure as the Convergent Lesion of Neurodegenerationpaper1
  46. Microglial Lipid Regulationconcept1
  47. Peripheral Lipid Biomarkersconcept1
  48. Phase IIIpaper1
  49. Presymptomatic Lipidomic Signaturesconcept1
  50. Standard Diagnostic Biomarkers Explainedpaper1
  51. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper1
  52. The Calcium Hypothesis and the Systems Failure Model of Alzheimer's Diseasepaper1
  53. The Glial Consortium and the Temporal Architecture of Neurodegenerationpaper1
  54. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper1
  55. The Losing Axonpaper1
  56. Three Subtractive Alzheimer's Trials That Engaged Their Target and Left Patients Worsepaper1
  57. Tryptophan Allocation Across the Kynurenine, NAD⁺ and Serotonergic Branchespaper1
PARP1 Bioenergetic / mito / NAD 271 34 docs
Matched on PARP-?1 PARP1
  1. PARP Inhibitors and the Locus Coeruleuspaper82
  2. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper39
  3. The Locus Coeruleus and the Noradrenergic Prodrome of Alzheimer's Diseasepaper22
  4. NAD⁺ Restoration and CD38 Inhibitionpaper13
  5. Tryptophan Allocation Across the Kynurenine, NAD⁺ and Serotonergic Branchespaper13
  6. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper12
  7. Re-evaluating Chini's CD38–NAD Programpaper8
  8. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper7
  9. Blood-Vessel Damage, Phase by Phasepaper7
  10. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper7
  11. cGAS–STING in Alzheimer's Diseasepaper6
  12. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper6
  13. The Cell Biology of the Word 'Ageing'paper6
  14. Which Genes Set the Threshold for Collapsepaper6
  15. Plaques Are Tombstones, Not Killerspaper5
  16. The Locus Coeruleus as Phase Bridgepaper4
  17. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper3
  18. Adult Hippocampal Neurogenesis and the Substrate of Cognitive Reservepaper2
  19. Alzheimer's Disease — A Process in Timepaper2
  20. Bioenergetic Collapseconcept2
  21. Collapse, Traced Cell Type by Cell Typepaper2
  22. Down Syndrome as the Disease Run in Fast-Forwardpaper2
  23. NMDA Receptor Blockade, Perineuronal Net Dynamics and Cell Death Modalities in Alzheimer'spaper2
  24. The Clearance Collapse — One Machinery, Three Failurespaper2
  25. Vascular Pathology as a Substrate Across Phasespaper2
  26. Alzheimer's Disease as a Fifty-Year Process in Time and Spacepaper1
  27. Anatomy of a Neurodegenerative Conduit — The Vagal Interfacepaper1
  28. Bess Frost's Chromatin Programme, the Elements It Releases, and the Restraint on cGASpaper1
  29. Energy Metabolismconcept1
  30. Epigenetic Erosion as the Reversible Information Layer of Alzheimer's Diseasepaper1
  31. How the Genes Partition the Vascular Phenotypepaper1
  32. Mitochondrial Quality Control Across Five Diseasespaper1
  33. Re-evaluating Höglinger's Complex I → Tau Programpaper1
  34. The Bredesen ReCODE Protocol Evaluatedpaper1
EPHB2 Reelin, synapse & ECM–PNN 236 18 docs
GPX4 Oxidative stress & ferroptosis 234 20 docs
PP2A Amyloid & Tau core 221 25 docs
CAV1 (caveolin-1) Vascular / BBB 216 12 docs
CDC42 Reelin, synapse & ECM–PNN 215 17 docs
TFEB Autophagy / lysosome / clearance 207 44 docs
Matched on TFEB
  1. Restoring Autophagy in Neurodegenerationpaper34
  2. Autophagic Flux in Alzheimer's Diseasepaper30
  3. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper16
  4. The Clearance Collapse — One Machinery, Three Failurespaper11
  5. The Bredesen Protocol Compared Against the Convergent Collapse Frameworkpaper10
  6. The Bredesen ReCODE Protocol Evaluatedpaper9
  7. Biomarkers of Vascular Dementia and Their Overlap with Alzheimer's Diseasepaper7
  8. Which Genes Set the Threshold for Collapsepaper7
  9. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper6
  10. Convergent Autophagic Collapsepaper5
  11. LL-37, CLIC1 and Microglial Lysosomal Failurepaper5
  12. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper5
  13. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper4
  14. Bioenergetic Collapsepaper4
  15. Cofilin Serine 3paper4
  16. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper4
  17. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper4
  18. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper3
  19. Lysosomal Acidification Failure as the Convergent Lesion of Neurodegenerationpaper3
  20. Mitochondrial Quality Control Across Five Diseasespaper3
  21. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper3
  22. NMDA Receptor Blockade, Perineuronal Net Dynamics and Cell Death Modalities in Alzheimer'spaper3
  23. A Counterfactual History of Alzheimer's Research Had Fischer's 1907 Findings Prevailedpaper2
  24. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper2
  25. Comparing Different Viral Triggerspaper2
  26. Gut Brain Axisconcept2
  27. Ralph Nixon's Inside-Out Thesispaper2
  28. Autophagic Fluxconcept1
  29. Autophagyconcept1
  30. Autophagy as the Driver of System-Wide Agingpaper1
  31. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper1
  32. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper1
  33. Convergent Synaptic Collapsepaper1
  34. Gouraspaper1
  35. How the Genes Partition the Vascular Phenotypepaper1
  36. LL-37, Innate Immunity and Autophagic Collapse in Alzheimer's Diseasepaper1
  37. Lysosomal Acidificationconcept1
  38. Lysosomal Dysfunctionconcept1
  39. Microbial Pathogenesisconcept1
  40. Proteostasis Collapseconcept1
  41. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper1
  42. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper1
  43. Templated Tau Misfolding Across the Three Phasespaper1
  44. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper1
BACE1 Amyloid & Tau core 202 65 docs
Matched on BACE1
  1. Convergent Synaptic Collapsepaper22
  2. Ceramide as a Structural and Signalling Node in Alzheimer's Diseasepaper19
  3. The Genes That Protect — Phenocopy the Fortunatepaper14
  4. The Lipid That Kills Neurons and Spares Tumourspaper13
  5. Lipid Peroxidation and ApoER2–Dab1 Disruption in Sporadic Alzheimer's Diseasepaper10
  6. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper9
  7. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper6
  8. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper5
  9. Fischer's Staged Deposit, 1907–1912paper4
  10. How the Genes Partition the Vascular Phenotypepaper4
  11. Restoring Autophagy in Neurodegenerationpaper4
  12. The Indifferent Neuronpaper4
  13. Vascular Pathology as a Substrate Across Phasespaper4
  14. Autophagy Failure Mechanisms in Neurodegeneration, and the Timeline of Plaque Formationpaper3
  15. Endosomal Traffickingconcept3
  16. Lithium in Alzheimer's Diseasepaper3
  17. Mitochondria-Associated ER Membranes and Ceramide in Alzheimer's Diseasepaper3
  18. Smallpaper3
  19. Amyloid clearance as important as depositionconcept2
  20. Blood-based biomarker panels for preclinical detectionconcept2
  21. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper2
  22. Endolysosomal Dysfunctionconcept2
  23. Epigenetic Repressionconcept2
  24. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper2
  25. Gouraspaper2
  26. Gunnar Gouras's Intraneuronal Amyloid and the Synaptic Endosome, Twenty-Eight Years Onpaper2
  27. LL-37, CLIC1 and Microglial Lysosomal Failurepaper2
  28. Nuclear pathology as early AD mechanismconcept2
  29. Oskar Fischer's Eight Stages of Plaque Formationpaper2
  30. Oxidative Stress and Autophagy Failure in Alzheimer's Diseasepaper2
  31. Plaques Are Tombstones, Not Killerspaper2
  32. Probabilistic multi-cause disease etiologyconcept2
  33. Scott Small's Retromer and Endosomal Theorypaper2
  34. Selective Tau Disruptionconcept2
  35. Tau Scaffolding Interactionsconcept2
  36. The Locus Coeruleus and the Noradrenergic Prodrome of Alzheimer's Diseasepaper2
  37. The Mitochondria-Associated Membrane Hypothesis of Alzheimer's Disease, Evaluatedpaper2
  38. The Plaque Was Staged Before It Was Countedpaper2
  39. Vesicular Traffickingconcept2
  40. Which Genes Set the Threshold for Collapsepaper2
  41. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper1
  42. Aluminum as primary environmental causeconcept1
  43. Aluminum driving amyloid productionconcept1
  44. Autophagy Dysfunctionconcept1
  45. Axonal Transportconcept1
  46. BDNF and the Trophic Failure of the Synapse in Alzheimer's Diseasepaper1
  47. Can a Drug Copy the Luckiest Mutation?paper1
  48. Can Vaccines Protect Against Dementia?paper1
  49. Cholesterol Homeostasisconcept1
  50. Endosomal Nexusnode1
  51. Environmental neurotoxicologyconcept1
  52. Exponential exposure-prevalence correlationconcept1
  53. Gut-brain axis in ADconcept1
  54. Innate Immunityconcept1
  55. Lipid Metabolismconcept1
  56. Metabolic-neurodegenerative disease connectionconcept1
  57. Mitochondrial Quality Control Across Five Diseasespaper1
  58. Ralph Nixon's Inside-Out Thesispaper1
  59. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper1
  60. Silica water as protective interventionconcept1
  61. Sphingolipid Signalingconcept1
  62. The Bredesen Protocol Compared Against the Convergent Collapse Frameworkpaper1
  63. The Calcium Hypothesis and the Systems Failure Model of Alzheimer's Diseasepaper1
  64. The Narrow Gate Every Mitochondrial Protein Must Passpaper1
  65. TXNIP as therapeutic targetconcept1
SPI1 GWAS / LOAD risk 199 11 docs
VCAM1 Vascular / BBB 197 8 docs
FYN Amyloid & Tau core 195 29 docs
Matched on Fyn FYN
  1. Cofilin Serine 3paper47
  2. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper42
  3. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper12
  4. Can a Drug Copy the Luckiest Mutation?paper12
  5. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper11
  6. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper9
  7. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper9
  8. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper8
  9. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper7
  10. From Synapse Loss to Neuronal Death in Alzheimer's Diseasepaper6
  11. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper5
  12. Amyloid-β, the Oxidative Burst and Three Routes to a Disabled Phosphatasepaper4
  13. Layer II Immature Neurons, Disease-Associated Microglia and the Reelin–Ephexin5 Axispaper3
  14. Autophagy Failure Mechanisms in Neurodegeneration, and the Timeline of Plaque Formationpaper2
  15. Seth Margolis Revisitedpaper2
  16. The Losing Axonpaper2
  17. UBE3A, PTPA and Ephexin5paper2
  18. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper1
  19. Comparing Different Viral Triggerspaper1
  20. Convergent Synaptic Collapsepaper1
  21. Lipid Peroxidation and ApoER2–Dab1 Disruption in Sporadic Alzheimer's Diseasepaper1
  22. Lysosomal Acidification Failure as the Convergent Lesion of Neurodegenerationpaper1
  23. Moosmann & Sohrepaper1
  24. Rappoportpaper1
  25. Reelin, N-Sulfated Heparan Sulfate and ApoER2paper1
  26. The Bredesen Protocol Compared Against the Convergent Collapse Frameworkpaper1
  27. The Inflammasome Versus the Reelin Brakepaper1
  28. The Morphological and Molecular Basis of Convergent Autophagic Collapsepaper1
  29. The Strongest Case FOR the Amyloid Cascadepaper1
TNF Microglia & innate immunity 195 58 docs
Matched on TNF
  1. The Losing Axonpaper33
  2. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper14
  3. The Immunometabolic Nexus of Neurodegenerationpaper10
  4. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper8
  5. Anti-TNF-alpha therapeutic strategyconcept7
  6. Convergent Synaptic Collapsepaper7
  7. TNF-alpha as central AD mediatorconcept7
  8. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper6
  9. LL-37, Innate Immunity and Autophagic Collapse in Alzheimer's Diseasepaper6
  10. The Brakes on Microglial Activation in Alzheimer's Diseasepaper6
  11. Activated microglia imaging for treatment guidanceconcept5
  12. Anatomy of a Neurodegenerative Conduit — The Vagal Interfacepaper5
  13. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper5
  14. Glial-driven neuroinflammatory disease modelconcept5
  15. LL-37, CLIC1 and Microglial Lysosomal Failurepaper5
  16. Restoring Autophagy in Neurodegenerationpaper5
  17. Amyloid-β Restrains Microglia Twicepaper3
  18. Neurotropic Viral Invasion of the Central Nervous Systempaper3
  19. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper3
  20. BCG Vaccination in Alzheimer's Diseasepaper2
  21. Can Vaccines Protect Against Dementia?paper2
  22. Cellular Senescenceconcept2
  23. Depression as Reversible Collapsepaper2
  24. Endolysosomal Dysfunctionconcept2
  25. Lithium in Alzheimer's Diseasepaper2
  26. Microglial Immunometabolismconcept2
  27. NAD⁺ Restoration and CD38 Inhibitionpaper2
  28. Neuroinflammationconcept2
  29. Phase IIpaper2
  30. Phase IIIpaper2
  31. Synaptic Competitionconcept2
  32. Vascular Pathology as a Substrate Across Phasespaper2
  33. Aleksandra Deczkowska's DAM Program and the Matrix-Degrading Armpaper1
  34. Astrocytespaper1
  35. Autophagic Collapseconcept1
  36. Autophagy as the Driver of System-Wide Agingpaper1
  37. Autophagy Failure Mechanisms in Neurodegeneration, and the Timeline of Plaque Formationpaper1
  38. Beth Stevens's Complement-Pruning Programpaper1
  39. Blood-Vessel Damage, Phase by Phasepaper1
  40. Ceramide as a Structural and Signalling Node in Alzheimer's Diseasepaper1
  41. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper1
  42. Convergent Autophagic Collapsepaper1
  43. Disciplinary Silos in Alzheimer's Disease Research, 1950–2020paper1
  44. How the Genes Partition the Vascular Phenotypepaper1
  45. Innate Immunityconcept1
  46. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper1
  47. Lysosomal Acidificationconcept1
  48. Mitochondrial Quality Control Across Five Diseasespaper1
  49. Moosmann & Sohrepaper1
  50. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper1
  51. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper1
  52. Plaques Are Tombstones, Not Killerspaper1
  53. The NLRP Inflammasome and the Perineuronal Net in Alzheimer's Diseasepaper1
  54. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper1
  55. Tryptophan Allocation Across the Kynurenine, NAD⁺ and Serotonergic Branchespaper1
  56. Vaccines That May Prevent Dementiapaper1
  57. Which Biomarkers Detect Which Phasepaper1
  58. Zhen Huang's Competitive Synaptic Plasticity and the Amyloid-β Monomer Depletion Modelpaper1
PINK1 Bioenergetic / mito / NAD 186 32 docs
Matched on PINK1
  1. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper23
  2. Bioenergetic Collapsepaper19
  3. LL-37, CLIC1 and Microglial Lysosomal Failurepaper17
  4. Mitochondrial Quality Control Across Five Diseasespaper17
  5. The Narrow Gate Every Mitochondrial Protein Must Passpaper17
  6. Which Genes Set the Threshold for Collapsepaper14
  7. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper11
  8. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper8
  9. Autophagic Failure as the Convergent Endpoint in Alzheimer's, Parkinson's, ALS and Huntington'spaper7
  10. TOMM40 Import Gateconcept6
  11. Autophagy as the Driver of System-Wide Agingpaper5
  12. Lysosomal Acidification Failure as the Convergent Lesion of Neurodegenerationpaper5
  13. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper4
  14. The Bredesen ReCODE Protocol Evaluatedpaper4
  15. Autophagic Flux in Alzheimer's Diseasepaper3
  16. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper3
  17. The Clearance Collapse — One Machinery, Three Failurespaper3
  18. Collapse, Traced Cell Type by Cell Typepaper2
  19. How the Genes Partition the Vascular Phenotypepaper2
  20. HSV-1 Suppression of Neuronal Autophagy as a Viral Route into Alzheimer's Diseasepaper2
  21. Ralph Nixon's Inside-Out Thesispaper2
  22. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper2
  23. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  24. Alzheimer's Disease — A Process in Timepaper1
  25. cGAS–STING in Alzheimer's Diseasepaper1
  26. Comparing Different Viral Triggerspaper1
  27. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper1
  28. Oxidative Stress and Autophagy Failure in Alzheimer's Diseasepaper1
  29. Phase IIpaper1
  30. Restoring Autophagy in Neurodegenerationpaper1
  31. The Cell Biology of the Word 'Ageing'paper1
  32. The Glial Consortium and the Temporal Architecture of Neurodegenerationpaper1
C1QA Microglia & innate immunity 185 55 docs
Matched on C1q C1QA C1QB
Often named withAPOEC3APPTREM2CR3PSEN1
  1. Beth Stevens's Complement-Pruning Programpaper19
  2. The Phase II → III Transitionpaper17
  3. Convergent Synaptic Collapsepaper10
  4. Which Genes Set the Threshold for Collapsepaper10
  5. From Synapse Loss to Neuronal Death in Alzheimer's Diseasepaper8
  6. The Losing Axonpaper8
  7. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper6
  8. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper6
  9. Phase IIIpaper6
  10. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper5
  11. Collapse, Traced Cell Type by Cell Typepaper4
  12. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper4
  13. The Load-Bearing Neuronpaper4
  14. The Somatostatin Interneuron in Alzheimer's Diseasepaper4
  15. The Timing of Locus Coeruleus Loss in Alzheimer's Diseasepaper4
  16. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper3
  17. Alzheimer's Disease — A Process in Timepaper3
  18. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper3
  19. CSF1R Inhibition Restores the Perineuronal Matrix and Destabilises the Rhythm It Supportspaper3
  20. Homeostatic Collapsepaper3
  21. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper3
  22. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper3
  23. Shatz & Brottpaper3
  24. Antimicrobial hypothesis of amyloidconcept2
  25. BBB breakdown cascadeconcept2
  26. Circadian Immune Regulationconcept2
  27. Down Syndrome as the Disease Run in Fast-Forwardpaper2
  28. Human-germ interaction modelconcept2
  29. Mitochondrial Quality Control Across Five Diseasespaper2
  30. Neuroimmune Surveillanceconcept2
  31. Neurovascular unit as disease originconcept2
  32. Phase IIpaper2
  33. Seth Margolis Revisitedpaper2
  34. SORL1 Lysosomal Functionconcept2
  35. The Cell Biology of the Word 'Ageing'paper2
  36. The Inflammasome–Complement–TREM2 Nexus in Alzheimer's Diseasepaper2
  37. UBE3A, PTPA and Ephexin5paper2
  38. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper1
  39. Bioenergetic Collapsepaper1
  40. Ceramide as a Structural and Signalling Node in Alzheimer's Diseasepaper1
  41. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper1
  42. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper1
  43. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper1
  44. How the Genes Partition the Vascular Phenotypepaper1
  45. LL-37, CLIC1 and Microglial Lysosomal Failurepaper1
  46. Microglial Restraint as Resiliencepaper1
  47. Neuroimmune Interfacenode1
  48. Neuroinflammationconcept1
  49. Plaques Are Tombstones, Not Killerspaper1
  50. Scott Small's Retromer and Endosomal Theorypaper1
  51. Synaptic Pathologyconcept1
  52. The Brakes on Microglial Activation in Alzheimer's Diseasepaper1
  53. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper1
  54. The Matrix as the Seventh Axis of Collapsepaper1
  55. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper1
PYCARD Microglia & innate immunity 178 20 docs
IDO1 Neuromodulator / circadian / kynurenine 175 10 docs
PRKN Bioenergetic / mito / NAD 172 30 docs
Matched on PRKN parkin PARK2
  1. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper27
  2. Bioenergetic Collapsepaper20
  3. Mitochondrial Quality Control Across Five Diseasespaper17
  4. Which Genes Set the Threshold for Collapsepaper14
  5. HSV-1 Suppression of Neuronal Autophagy as a Viral Route into Alzheimer's Diseasepaper10
  6. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper10
  7. Autophagic Failure as the Convergent Endpoint in Alzheimer's, Parkinson's, ALS and Huntington'spaper9
  8. LL-37, CLIC1 and Microglial Lysosomal Failurepaper8
  9. Autophagy as the Driver of System-Wide Agingpaper7
  10. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper7
  11. Lysosomal Acidification Failure as the Convergent Lesion of Neurodegenerationpaper5
  12. The Bredesen ReCODE Protocol Evaluatedpaper5
  13. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper4
  14. The Narrow Gate Every Mitochondrial Protein Must Passpaper4
  15. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper3
  16. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper3
  17. The Clearance Collapse — One Machinery, Three Failurespaper3
  18. Comparing Different Viral Triggerspaper2
  19. How the Genes Partition the Vascular Phenotypepaper2
  20. Ralph Nixon's Inside-Out Thesispaper2
  21. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  22. Alzheimer's Disease — A Process in Timepaper1
  23. Astrocytespaper1
  24. cGAS–STING in Alzheimer's Diseasepaper1
  25. Collapse, Traced Cell Type by Cell Typepaper1
  26. Oxidative Stress and Autophagy Failure in Alzheimer's Diseasepaper1
  27. Phase IIpaper1
  28. Restoring Autophagy in Neurodegenerationpaper1
  29. The Bredesen Protocol Compared Against the Convergent Collapse Frameworkpaper1
  30. The Cell Biology of the Word 'Ageing'paper1
MAP1LC3B (LC3) Autophagy / lysosome / clearance 171 33 docs
Matched on MAP1LC3B LC3
  1. Biomarkers of Vascular Dementia and Their Overlap with Alzheimer's Diseasepaper38
  2. Autophagic Flux in Alzheimer's Diseasepaper19
  3. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper13
  4. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper9
  5. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper8
  6. Restoring Autophagy in Neurodegenerationpaper8
  7. Fischer's Staged Deposit, 1907–1912paper7
  8. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper6
  9. Where Autophagic Failure Causes Neurodegeneration, and Where It Is a Consequencepaper6
  10. Convergent Autophagic Collapsepaper5
  11. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper5
  12. Astrocytespaper4
  13. Autophagic Failure as the Convergent Endpoint in Alzheimer's, Parkinson's, ALS and Huntington'spaper4
  14. Autophagy as the Driver of System-Wide Agingpaper4
  15. Load, Capacity and the Boundary of Convergent Clearance Failure in Neurodegenerationpaper4
  16. Which Genes Set the Threshold for Collapsepaper4
  17. Autophagy Failure Mechanisms in Neurodegeneration, and the Timeline of Plaque Formationpaper3
  18. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper3
  19. The Immunometabolic Nexus of Neurodegenerationpaper3
  20. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper2
  21. LL-37, CLIC1 and Microglial Lysosomal Failurepaper2
  22. Mitochondrial Quality Control Across Five Diseasespaper2
  23. The Bredesen ReCODE Protocol Evaluatedpaper2
  24. Bioenergetic Collapsepaper1
  25. Comparing Different Viral Triggerspaper1
  26. How the Genes Partition the Vascular Phenotypepaper1
  27. Khachaturianpaper1
  28. Lithium in Alzheimer's Diseasepaper1
  29. Oxidative Stress and Autophagy Failure in Alzheimer's Diseasepaper1
  30. Plaque Origin What is Establishedconcept1
  31. Plaques Are Tombstones, Not Killerspaper1
  32. Ralph Nixon's Inside-Out Thesispaper1
  33. The Clearance Collapse — One Machinery, Three Failurespaper1
SQSTM1 (p62) Autophagy / lysosome / clearance 170 31 docs
Matched on SQSTM1 p62
  1. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper34
  2. Restoring Autophagy in Neurodegenerationpaper23
  3. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper17
  4. Load, Capacity and the Boundary of Convergent Clearance Failure in Neurodegenerationpaper14
  5. Autophagic Failure as the Convergent Endpoint in Alzheimer's, Parkinson's, ALS and Huntington'spaper8
  6. Autophagic Flux in Alzheimer's Diseasepaper8
  7. Astrocytespaper6
  8. Autophagy as the Driver of System-Wide Agingpaper6
  9. The Immunometabolic Nexus of Neurodegenerationpaper5
  10. Which Genes Set the Threshold for Collapsepaper5
  11. HSV-1 Suppression of Neuronal Autophagy as a Viral Route into Alzheimer's Diseasepaper4
  12. Where Autophagic Failure Causes Neurodegeneration, and Where It Is a Consequencepaper4
  13. Anne Eckert's Neuroendocrine Theory and the Withdrawal of Protection in the Ageing Brainpaper3
  14. Convergent Autophagic Collapsepaper3
  15. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper3
  16. Mitochondrial Quality Control Across Five Diseasespaper3
  17. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper3
  18. The Clearance Collapse — One Machinery, Three Failurespaper3
  19. Bioenergetic Collapsepaper2
  20. Biomarkers of Vascular Dementia and Their Overlap with Alzheimer's Diseasepaper2
  21. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper2
  22. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper2
  23. The Bredesen ReCODE Protocol Evaluatedpaper2
  24. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper1
  25. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper1
  26. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper1
  27. How the Genes Partition the Vascular Phenotypepaper1
  28. Lithium in Alzheimer's Diseasepaper1
  29. NMDA Receptor Blockade, Perineuronal Net Dynamics and Cell Death Modalities in Alzheimer'spaper1
  30. Phase IIpaper1
  31. Plaques Are Tombstones, Not Killerspaper1
NFKB1 (NF-κB) Kinase & growth-factor signalling 164 47 docs
Matched on NFKB1 NF-?κB NF-?kB NF-?kappaB
  1. Mitochondrial Quality Control Across Five Diseasespaper27
  2. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper19
  3. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper9
  4. Blood-Vessel Damage, Phase by Phasepaper8
  5. The Brakes on Microglial Activation in Alzheimer's Diseasepaper8
  6. Anatomy of a Neurodegenerative Conduit — The Vagal Interfacepaper7
  7. How the Genes Partition the Vascular Phenotypepaper7
  8. Norepinephrine as a Two-Armed Pincer on Taupaper7
  9. Vascular Pathology as a Substrate Across Phasespaper7
  10. The NLRP Inflammasome and the Perineuronal Net in Alzheimer's Diseasepaper5
  11. The Enzyme That Cuts the Protective Latticepaper4
  12. NAD⁺ Restoration and CD38 Inhibitionpaper3
  13. Restoring Autophagy in Neurodegenerationpaper3
  14. The Coerulean Interface — The Brainstem Origin of Alzheimer'spaper3
  15. Acyloxyacyl Hydrolase Neuroprotectionconcept2
  16. Bacterial exudate-driven neurodegenerationconcept2
  17. Barrier dysfunction pathologyconcept2
  18. GI-tract microbiome neurotoxicityconcept2
  19. Gut Microbiome Lipid AD Axisconcept2
  20. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper2
  21. NF-kB-miRNA inflammatory cascadeconcept2
  22. One Sensor, Two Collapses — Which Arm Matters More?paper2
  23. Phase IIIpaper2
  24. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper2
  25. The Bredesen ReCODE Protocol Evaluatedpaper2
  26. The Immunometabolic Nexus of Neurodegenerationpaper2
  27. The Inflammasome Versus the Reelin Brakepaper2
  28. The Losing Axonpaper2
  29. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper1
  30. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  31. Autophagy as the Driver of System-Wide Agingpaper1
  32. Can Vaccines Protect Against Dementia?paper1
  33. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper1
  34. Energy metabolism declineconcept1
  35. Epigenetic and genetic interplayconcept1
  36. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper1
  37. Lifestyle and behavioral factorsconcept1
  38. LL-37, CLIC1 and Microglial Lysosomal Failurepaper1
  39. Multifactorial etiologyconcept1
  40. PARP Inhibitors and the Locus Coeruleuspaper1
  41. Phase IIpaper1
  42. The Cell Biology of the Word 'Ageing'paper1
  43. The Inflammasome–Complement–TREM2 Nexus in Alzheimer's Diseasepaper1
  44. The Innate-Immune Sensor That Converts the Diseasepaper1
  45. The Load-Bearing Neuronpaper1
  46. The Locus Coeruleus as Phase Bridgepaper1
  47. The Phase II → III Transitionpaper1
DCX (doublecortin) Reelin, synapse & ECM–PNN 162 8 docs
AKT1 (Akt) Kinase & growth-factor signalling 152 55 docs
Matched on AKT1 Akt
  1. Bioenergetic Collapsepaper17
  2. Lithium in Alzheimer's Diseasepaper16
  3. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper12
  4. Norepinephrine as a Two-Armed Pincer on Taupaper10
  5. Metabolic-Homeostatic Axisnode6
  6. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper5
  7. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper4
  8. Can a Drug Copy the Luckiest Mutation?paper4
  9. Mitochondrial Quality Control Across Five Diseasespaper4
  10. UBE3A, PTPA and Ephexin5paper4
  11. Lipid Peroxidation and ApoER2–Dab1 Disruption in Sporadic Alzheimer's Diseasepaper3
  12. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper3
  13. The Bredesen ReCODE Protocol Evaluatedpaper3
  14. The Enzyme That Cuts the Protective Latticepaper3
  15. The Immunometabolic Nexus of Neurodegenerationpaper3
  16. The Losing Axonpaper3
  17. Bioenergeticsconcept2
  18. Can Vaccines Protect Against Dementia?paper2
  19. Cofilin Serine 3paper2
  20. Comparing Different Viral Triggerspaper2
  21. Convergent Synaptic Collapsepaper2
  22. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper2
  23. HSV-1 Suppression of Neuronal Autophagy as a Viral Route into Alzheimer's Diseasepaper2
  24. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper2
  25. Reelin, N-Sulfated Heparan Sulfate and ApoER2paper2
  26. Tau Kindling in the Locus Coeruleuspaper2
  27. The Brain's Architect and the Brake It Puts on Taupaper2
  28. The Indifferent Neuronpaper2
  29. The Morphological and Molecular Basis of Convergent Autophagic Collapsepaper2
  30. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper1
  31. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  32. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper1
  33. Amyloid-β Restrains Microglia Twicepaper1
  34. BDNF and the Trophic Failure of the Synapse in Alzheimer's Diseasepaper1
  35. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper1
  36. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper1
  37. Depression as Reversible Collapsepaper1
  38. Endolysosomal Dysfunctionconcept1
  39. Homeostatic Collapsepaper1
  40. How the Genes Partition the Vascular Phenotypepaper1
  41. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper1
  42. Microglial Immunometabolismconcept1
  43. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper1
  44. NMDA Receptor Blockade, Perineuronal Net Dynamics and Cell Death Modalities in Alzheimer'spaper1
  45. One Sugar Lattice, Three Jobspaper1
  46. Synaptic Competitionconcept1
  47. Synaptic Pathologyconcept1
  48. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper1
  49. The Inflammasome Versus the Reelin Brakepaper1
  50. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper1
  51. The Timing of Locus Coeruleus Loss in Alzheimer's Diseasepaper1
  52. Tryptophan Allocation Across the Kynurenine, NAD⁺ and Serotonergic Branchespaper1
  53. Vaccines That May Prevent Dementiapaper1
  54. Which Biomarkers Detect Which Phasepaper1
  55. Zhen Huang's Competitive Synaptic Plasticity and the Amyloid-β Monomer Depletion Modelpaper1
PRNP Neurodegeneration overlap 150 28 docs
Matched on PRNP prion protein PrP
  1. Stanley Prusiner's Prion Theory and Templated Neurodegeneration, Critically Evaluatedpaper82
  2. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper7
  3. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper6
  4. Cofilin Serine 3paper5
  5. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper5
  6. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper5
  7. From Synapse Loss to Neuronal Death in Alzheimer's Diseasepaper4
  8. LRP1 and the Templated Spread of Misfolded Proteinpaper4
  9. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper3
  10. Proving That Misfolded Proteins Spread Like Prionspaper3
  11. The Indifferent Neuronpaper3
  12. Amyloid-β, the Oxidative Burst and Three Routes to a Disabled Phosphatasepaper2
  13. Can a Drug Copy the Luckiest Mutation?paper2
  14. Lysosomal Storage Diseaseconcept2
  15. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper2
  16. The Losing Axonpaper2
  17. α-Synuclein Templating and Synucleinopathy Propagationpaper2
  18. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper1
  19. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper1
  20. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper1
  21. Cofilin Serine 3 in Alzheimer's Diseasepaper1
  22. Convergent Autophagic Collapsepaper1
  23. Different Tau Strains Cause Different Diseasespaper1
  24. Fischer's Eighth Stage as a Measurement of Rate Against Host Capacitypaper1
  25. Iron Chelation and GPX4 Stabilizationpaper1
  26. Seth Margolis Revisitedpaper1
  27. Templated Tau Misfolding Across the Three Phasespaper1
  28. The Strongest Case FOR the Amyloid Cascadepaper1
GRN (progranulin) Autophagy / lysosome / clearance 146 15 docs
CLIC1 Microglia & innate immunity 145 1 doc
TOMM40 Bioenergetic / mito / NAD 145 18 docs
LRRK2 Neurodegeneration overlap 141 16 docs
MAOA/MAOB Neuromodulator / circadian / kynurenine 138 13 docs
C3 Microglia & innate immunity 132 49 docs
Matched on C3
Often named withC1QAAPOEAPPTREM2CR3PSEN1
  1. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper17
  2. Beth Stevens's Complement-Pruning Programpaper13
  3. Convergent Synaptic Collapsepaper8
  4. Which Genes Set the Threshold for Collapsepaper7
  5. From Synapse Loss to Neuronal Death in Alzheimer's Diseasepaper6
  6. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper5
  7. The Cholinergic Nucleus Basalis in Alzheimer's Diseasepaper5
  8. The Losing Axonpaper5
  9. The Phase II → III Transitionpaper4
  10. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper3
  11. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper3
  12. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper2
  13. Alzheimer's Disease — A Process in Timepaper2
  14. Antimicrobial hypothesis of amyloidconcept2
  15. BBB breakdown cascadeconcept2
  16. Circadian Immune Regulationconcept2
  17. Collapse, Traced Cell Type by Cell Typepaper2
  18. Homeostatic Collapsepaper2
  19. Human-germ interaction modelconcept2
  20. Neuroimmune Surveillanceconcept2
  21. Neurovascular unit as disease originconcept2
  22. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper2
  23. Phase IIpaper2
  24. Phase IIIpaper2
  25. Seth Margolis Revisitedpaper2
  26. Shatz & Brottpaper2
  27. SORL1 Lysosomal Functionconcept2
  28. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper2
  29. The Inflammasome–Complement–TREM2 Nexus in Alzheimer's Diseasepaper2
  30. Bioenergetic Collapsepaper1
  31. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper1
  32. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper1
  33. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper1
  34. CSF1R Inhibition Restores the Perineuronal Matrix and Destabilises the Rhythm It Supportspaper1
  35. Down Syndrome as the Disease Run in Fast-Forwardpaper1
  36. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper1
  37. How the Genes Partition the Vascular Phenotypepaper1
  38. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper1
  39. LL-37, CLIC1 and Microglial Lysosomal Failurepaper1
  40. Microglial Restraint as Resiliencepaper1
  41. Mitochondrial Quality Control Across Five Diseasespaper1
  42. Neuroimmune Interfacenode1
  43. Neuroinflammationconcept1
  44. Ordered Attrition and Resilience as the Two Human-Evidence Anchors of Alzheimer'spaper1
  45. Plaques Are Tombstones, Not Killerspaper1
  46. Sleep as the Shared Off-Line State of Every Collapse Axispaper1
  47. Synaptic Pathologyconcept1
  48. The Cell Biology of the Word 'Ageing'paper1
  49. Todd Golde's Amyloid Cascade, Read for What It Addspaper1
HTT (huntingtin) Neurodegeneration overlap 132 21 docs
Matched on HTT huntingtin
  1. Load, Capacity and the Boundary of Convergent Clearance Failure in Neurodegenerationpaper39
  2. Mitochondrial Quality Control Across Five Diseasespaper15
  3. Where Autophagic Failure Causes Neurodegeneration, and Where It Is a Consequencepaper14
  4. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper12
  5. Stanley Prusiner's Prion Theory and Templated Neurodegeneration, Critically Evaluatedpaper10
  6. Restoring Autophagy in Neurodegenerationpaper8
  7. Which Genes Set the Threshold for Collapsepaper7
  8. Autophagic Failure as the Convergent Endpoint in Alzheimer's, Parkinson's, ALS and Huntington'spaper4
  9. How the Genes Partition the Vascular Phenotypepaper4
  10. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper4
  11. Convergent Autophagic Collapsepaper3
  12. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper2
  13. Lithium in Alzheimer's Diseasepaper2
  14. Astrocytespaper1
  15. Bess Frost's Chromatin Programme, the Elements It Releases, and the Restraint on cGASpaper1
  16. CSF1R Inhibition Restores the Perineuronal Matrix and Destabilises the Rhythm It Supportspaper1
  17. LRP1 and the Templated Spread of Misfolded Proteinpaper1
  18. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper1
  19. Templated Tau Misfolding Across the Three Phasespaper1
  20. The Glial Consortium and the Temporal Architecture of Neurodegenerationpaper1
  21. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper1
NGF Trophic / exercise / resilience 126 19 docs
BIN1 GWAS / LOAD risk 122 27 docs
GFAP Astrocyte & glial markers 120 27 docs
Matched on GFAP
  1. Which Biomarkers Detect Which Phasepaper54
  2. Telling Different Dementias Apartpaper19
  3. How the Genes Partition the Vascular Phenotypepaper7
  4. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper6
  5. Collapse, Traced Cell Type by Cell Typepaper4
  6. Fischer's Staged Deposit, 1907–1912paper4
  7. Oskar Fischer's Eight Stages of Plaque Formationpaper3
  8. Adult Hippocampal Neurogenesis and the Substrate of Cognitive Reservepaper2
  9. Microglial Restraint as Resiliencepaper2
  10. Which Genes Set the Threshold for Collapsepaper2
  11. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper1
  12. Astrocytespaper1
  13. Autophagic Flux in Alzheimer's Diseasepaper1
  14. Bess Frost's Chromatin Programme, the Elements It Releases, and the Restraint on cGASpaper1
  15. Blood-Vessel Damage, Phase by Phasepaper1
  16. Cellular Senescenceconcept1
  17. Fischer's Eighth Stage as a Measurement of Rate Against Host Capacitypaper1
  18. Fischer's Sixth Stage and the Leptomeningeal Compartment It Never Enteredpaper1
  19. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper1
  20. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper1
  21. Phase IIpaper1
  22. Plaques Are Tombstones, Not Killerspaper1
  23. Standard Diagnostic Biomarkers Explainedpaper1
  24. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper1
  25. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper1
  26. The Plaque Was Staged Before It Was Countedpaper1
  27. The Raphe Nuclei in Alzheimer's Disease as a Subject in Their Own Rightpaper1
VLDLR Reelin, synapse & ECM–PNN 120 34 docs
Matched on VLDLR
  1. Can a Drug Copy the Luckiest Mutation?paper16
  2. The Enzyme That Cuts the Protective Latticepaper16
  3. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper9
  4. Norepinephrine as a Two-Armed Pincer on Taupaper8
  5. The Brain's Architect and the Brake It Puts on Taupaper8
  6. The Load-Bearing Neuronpaper6
  7. The Inflammasome Versus the Reelin Brakepaper5
  8. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper4
  9. Tau Kindling in the Locus Coeruleuspaper4
  10. LRP1 and the Templated Spread of Misfolded Proteinpaper3
  11. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper3
  12. Reelin-ApoE receptor axis disruptionconcept3
  13. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper3
  14. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper3
  15. Which Genes Set the Threshold for Collapsepaper3
  16. APOE4 Hubnode2
  17. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper2
  18. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper2
  19. Cofilin Serine 3paper2
  20. Layer II Immature Neurons, Disease-Associated Microglia and the Reelin–Ephexin5 Axispaper2
  21. One Sugar Lattice, Three Jobspaper2
  22. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper2
  23. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  24. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper1
  25. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper1
  26. From Gut Ecology to the Failed Antidepressant Trialpaper1
  27. Lipid Peroxidation and ApoER2–Dab1 Disruption in Sporadic Alzheimer's Diseasepaper1
  28. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper1
  29. Perineuronal Netsconcept1
  30. Reelin, N-Sulfated Heparan Sulfate and ApoER2paper1
  31. The Genes That Protect — Phenocopy the Fortunatepaper1
  32. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper1
  33. The Somatostatin Interneuron in Alzheimer's Diseasepaper1
  34. The Timing of Locus Coeruleus Loss in Alzheimer's Diseasepaper1
MME (neprilysin) Amyloid & Tau core 116 24 docs
UBE3A Autophagy / lysosome / clearance 109 14 docs
CASP1 Microglia & innate immunity 103 25 docs
Matched on CASP1 caspase[- ]?1
  1. The Innate-Immune Sensor That Converts the Diseasepaper30
  2. The Inflammasome Versus the Reelin Brakepaper18
  3. The NLRP Inflammasome and the Perineuronal Net in Alzheimer's Diseasepaper11
  4. One Sensor, Two Collapses — Which Arm Matters More?paper9
  5. The Microglion That Silences Tau's Phosphatasepaper4
  6. Bioenergetic Collapsepaper3
  7. cGAS–STING, DNA Surveillance and Synaptic Resilience in Alzheimer's Diseasepaper3
  8. LL-37, CLIC1 and Microglial Lysosomal Failurepaper3
  9. Amyloid-β, the Oxidative Burst and Three Routes to a Disabled Phosphatasepaper2
  10. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper2
  11. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper2
  12. NMDA Receptor Blockade, Perineuronal Net Dynamics and Cell Death Modalities in Alzheimer'spaper2
  13. The Drivers of Microglial Dysfunction in Alzheimer's Disease, Ranked by Causal Weightpaper2
  14. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  15. Alzheimer's Disease — A Process in Timepaper1
  16. Autophagy as the Driver of System-Wide Agingpaper1
  17. Depression as Reversible Collapsepaper1
  18. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper1
  19. Lysosomal Membrane Damage as the Upstream Determinant of Microglial Statepaper1
  20. Mitochondrial Quality Control Across Five Diseasespaper1
  21. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper1
  22. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper1
  23. The Bredesen ReCODE Protocol Evaluatedpaper1
  24. The Immunometabolic Nexus of Neurodegenerationpaper1
  25. The Phase II → III Transitionpaper1
C9ORF72 Neurodegeneration overlap 100 11 docs
GBA Neurodegeneration overlap 99 15 docs
NEFL (NfL) Reelin, synapse & ECM–PNN 99 22 docs
PPP2R2A (B55α) Kinase & growth-factor signalling 95 6 docs
CR3 Microglia & innate immunity 93 35 docs
Matched on CR3 CD11b ITGAM
  1. Beth Stevens's Complement-Pruning Programpaper12
  2. Convergent Synaptic Collapsepaper8
  3. The Phase II → III Transitionpaper8
  4. Which Genes Set the Threshold for Collapsepaper6
  5. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper5
  6. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper4
  7. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper3
  8. From Synapse Loss to Neuronal Death in Alzheimer's Diseasepaper3
  9. Shatz & Brottpaper3
  10. Antimicrobial hypothesis of amyloidconcept2
  11. BBB breakdown cascadeconcept2
  12. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper2
  13. Circadian Immune Regulationconcept2
  14. Collapse, Traced Cell Type by Cell Typepaper2
  15. Homeostatic Collapsepaper2
  16. Human-germ interaction modelconcept2
  17. Neuroimmune Surveillanceconcept2
  18. Neurovascular unit as disease originconcept2
  19. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper2
  20. Phase IIIpaper2
  21. Seth Margolis Revisitedpaper2
  22. SORL1 Lysosomal Functionconcept2
  23. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper2
  24. The Inflammasome–Complement–TREM2 Nexus in Alzheimer's Diseasepaper2
  25. Alzheimer's Disease — A Process in Timepaper1
  26. Amyloid-β Restrains Microglia Twicepaper1
  27. Carlo Abbate's Adult Neurogenesis Theory of Alzheimer's Disease, Critically Evaluatedpaper1
  28. CSF1R Inhibition Restores the Perineuronal Matrix and Destabilises the Rhythm It Supportspaper1
  29. Down Syndrome as the Disease Run in Fast-Forwardpaper1
  30. How the Genes Partition the Vascular Phenotypepaper1
  31. Neuroimmune Interfacenode1
  32. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper1
  33. Phase IIpaper1
  34. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper1
  35. UBE3A, PTPA and Ephexin5paper1
TOM40 Bioenergetic / mito / NAD 92 10 docs
BCAN (brevican) Reelin, synapse & ECM–PNN 91 32 docs
Matched on BCAN brevican
  1. The Phase II → III Transitionpaper12
  2. Which Genes Set the Threshold for Collapsepaper8
  3. Phase IIIpaper7
  4. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper6
  5. The Enzyme That Cuts the Protective Latticepaper5
  6. Norepinephrine as a Two-Armed Pincer on Taupaper4
  7. Collapse, Traced Cell Type by Cell Typepaper3
  8. CSF1R Inhibition Restores the Perineuronal Matrix and Destabilises the Rhythm It Supportspaper3
  9. Perineuronal Netsconcept3
  10. The Matrix as the Seventh Axis of Collapsepaper3
  11. The NLRP Inflammasome and the Perineuronal Net in Alzheimer's Diseasepaper3
  12. The Perineuronal Matrix and Cortical Layer Twopaper3
  13. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper3
  14. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper2
  15. Amyloid-β, the Oxidative Burst and Three Routes to a Disabled Phosphatasepaper2
  16. Depression as Reversible Collapsepaper2
  17. Down Syndrome as the Disease Run in Fast-Forwardpaper2
  18. Fischer's Matrixpaper2
  19. Perineuronal Nets, Microglial Neuroinflammation, and Alzheimer'spaper2
  20. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper2
  21. The Brakes on Microglial Activation in Alzheimer's Diseasepaper2
  22. The Proteolytic Degradation of the Perineuronal Net and the Loss of PV Interneuronspaper2
  23. Adult Hippocampal Neurogenesis and the Substrate of Cognitive Reservepaper1
  24. Alzheimer's Disease as a Fifty-Year Process in Time and Spacepaper1
  25. Epigenetic Erosion as the Reversible Information Layer of Alzheimer's Diseasepaper1
  26. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper1
  27. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper1
  28. How the Genes Partition the Vascular Phenotypepaper1
  29. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper1
  30. The Cell Biology of the Word 'Ageing'paper1
  31. The Load-Bearing Neuronpaper1
  32. The Locus Coeruleus as Phase Bridgepaper1
SNCA Neurodegeneration overlap 90 26 docs
Matched on SNCA α-synuclein alpha-synuclein α-syn
  1. Mitochondrial Quality Control Across Five Diseasespaper23
  2. Which Genes Set the Threshold for Collapsepaper14
  3. α-Synuclein Templating and Synucleinopathy Propagationpaper13
  4. Lysosomal Acidification Failure as the Convergent Lesion of Neurodegenerationpaper6
  5. The Glial Consortium and the Temporal Architecture of Neurodegenerationpaper4
  6. How the Genes Partition the Vascular Phenotypepaper3
  7. Proving That Misfolded Proteins Spread Like Prionspaper3
  8. Restoring Autophagy in Neurodegenerationpaper3
  9. cGAS–STING in Alzheimer's Diseasepaper2
  10. Disciplinary Silos in Alzheimer's Disease Research, 1950–2020paper2
  11. The Gut Ecosystem as the Upstream Originpaper2
  12. Astrocytespaper1
  13. Different Tau Strains Cause Different Diseasespaper1
  14. Estela Area-Gómez's MAM Theorypaper1
  15. From Gut Ecology to the Failed Antidepressant Trialpaper1
  16. Infectious etiology of ADconcept1
  17. Load, Capacity and the Boundary of Convergent Clearance Failure in Neurodegenerationpaper1
  18. P. gingivalis as keystone pathogenconcept1
  19. PARP Inhibitors and the Locus Coeruleuspaper1
  20. Phase IIIpaper1
  21. Polymicrobial brain infectionconcept1
  22. Standard Diagnostic Biomarkers Explainedpaper1
  23. Stanley Prusiner's Prion Theory and Templated Neurodegeneration, Critically Evaluatedpaper1
  24. The Immunometabolic Nexus of Neurodegenerationpaper1
  25. The Narrow Gate Every Mitochondrial Protein Must Passpaper1
  26. Where Autophagic Failure Causes Neurodegeneration, and Where It Is a Consequencepaper1
MMP2 Reelin, synapse & ECM–PNN 89 32 docs
Matched on MMP-?2
  1. Aleksandra Deczkowska's DAM Program and the Matrix-Degrading Armpaper25
  2. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper9
  3. Phase IIIpaper8
  4. Which Genes Set the Threshold for Collapsepaper4
  5. Amyloid-β Restrains Microglia Twicepaper3
  6. Cellular Senescenceconcept3
  7. The Enzyme That Cuts the Protective Latticepaper3
  8. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper2
  9. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper2
  10. Homeostatic Collapsepaper2
  11. Michal Schwartz's Protective Autoimmunity as the Systemic Upstream of the Microglial Nichepaper2
  12. One Sugar Lattice, Three Jobspaper2
  13. Perineuronal Netsconcept2
  14. Perineuronal Nets, Microglial Neuroinflammation, and Alzheimer'spaper2
  15. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper2
  16. The NLRP Inflammasome and the Perineuronal Net in Alzheimer's Diseasepaper2
  17. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper1
  18. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  19. AD as accelerated aging of Abeta managementconcept1
  20. Aging accelerators and deceleratorsconcept1
  21. Blood-Vessel Damage, Phase by Phasepaper1
  22. Clearance failure vs. overproductionconcept1
  23. Disciplinary Silos in Alzheimer's Disease Research, 1950–2020paper1
  24. Fischer's Matrixpaper1
  25. How the Genes Partition the Vascular Phenotypepaper1
  26. Inflamm-aging as disease driverconcept1
  27. Norepinephrine as a Two-Armed Pincer on Taupaper1
  28. Oskar Fischer's Eight Stages of Plaque Formationpaper1
  29. Re-evaluating Tsai's 40 Hz Gamma Programpaper1
  30. The Cell Biology of the Word 'Ageing'paper1
  31. The Losing Axonpaper1
  32. The Phase II → III Transitionpaper1
PIK3CA (PI3K) Kinase & growth-factor signalling 89 44 docs
Matched on PIK3CA PI3-?kinase PI3K
  1. Bioenergetic Collapsepaper17
  2. Metabolic-Homeostatic Axisnode6
  3. Lipid Peroxidation and ApoER2–Dab1 Disruption in Sporadic Alzheimer's Diseasepaper5
  4. Mitochondrial Quality Control Across Five Diseasespaper4
  5. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper3
  6. HSV-1 Suppression of Neuronal Autophagy as a Viral Route into Alzheimer's Diseasepaper3
  7. The Bredesen ReCODE Protocol Evaluatedpaper3
  8. The Load-Bearing Neuronpaper3
  9. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper2
  10. Bioenergeticsconcept2
  11. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper2
  12. Convergent Synaptic Collapsepaper2
  13. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper2
  14. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper2
  15. The Brain's Architect and the Brake It Puts on Taupaper2
  16. The Losing Axonpaper2
  17. Which Genes Set the Threshold for Collapsepaper2
  18. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper1
  19. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  20. Can Vaccines Protect Against Dementia?paper1
  21. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper1
  22. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper1
  23. Cofilin Serine 3 in Alzheimer's Diseasepaper1
  24. Cofilin Serine 3paper1
  25. Comparing Different Viral Triggerspaper1
  26. Depression as Reversible Collapsepaper1
  27. Endolysosomal Dysfunctionconcept1
  28. Homeostatic Collapsepaper1
  29. How the Genes Partition the Vascular Phenotypepaper1
  30. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper1
  31. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper1
  32. Microglial Immunometabolismconcept1
  33. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper1
  34. NMDA Receptor Blockade, Perineuronal Net Dynamics and Cell Death Modalities in Alzheimer'spaper1
  35. One Sugar Lattice, Three Jobspaper1
  36. Reelin, N-Sulfated Heparan Sulfate and ApoER2paper1
  37. Synaptic Competitionconcept1
  38. Synaptic Pathologyconcept1
  39. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper1
  40. The Bredesen Protocol Compared Against the Convergent Collapse Frameworkpaper1
  41. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper1
  42. Tryptophan Allocation Across the Kynurenine, NAD⁺ and Serotonergic Branchespaper1
  43. Which Biomarkers Detect Which Phasepaper1
  44. Zhen Huang's Competitive Synaptic Plasticity and the Amyloid-β Monomer Depletion Modelpaper1
RAB5A Autophagy / lysosome / clearance 85 16 docs
NTRK2 (TrkB) Trophic / exercise / resilience 83 20 docs
HIF1A Bioenergetic / mito / NAD 79 6 docs
PRKAA (AMPK) Bioenergetic / mito / NAD 79 23 docs
Matched on AMPK PRKAA1 PRKAA2
  1. Restoring Autophagy in Neurodegenerationpaper12
  2. Bioenergetic Collapsepaper9
  3. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper8
  4. Autophagy-Lysosomal Choke Points and Bistable Decline in Neurodegenerationpaper6
  5. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper5
  6. Autophagic Flux in Alzheimer's Diseasepaper5
  7. HSV-1 Suppression of Neuronal Autophagy as a Viral Route into Alzheimer's Diseasepaper5
  8. Autophagy as the Driver of System-Wide Agingpaper4
  9. Depression as Reversible Collapsepaper4
  10. The Clearance Collapse — One Machinery, Three Failurespaper4
  11. The Bredesen ReCODE Protocol Evaluatedpaper3
  12. Mitochondrial Quality Control Across Five Diseasespaper2
  13. NAD⁺ Restoration and CD38 Inhibitionpaper2
  14. Anne Eckert's Neuroendocrine Theory and the Withdrawal of Protection in the Ageing Brainpaper1
  15. Autophagic Failure as the Convergent Endpoint in Alzheimer's, Parkinson's, ALS and Huntington'spaper1
  16. Biomarkers of Vascular Dementia and Their Overlap with Alzheimer's Diseasepaper1
  17. Cell Death Modalities in Alzheimer's Disease and Their Convergence at the Perineuronal Netpaper1
  18. Iron Chelation and GPX4 Stabilizationpaper1
  19. LL-37, Innate Immunity and Autophagic Collapse in Alzheimer's Diseasepaper1
  20. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper1
  21. NMDA Receptor Blockade, Perineuronal Net Dynamics and Cell Death Modalities in Alzheimer'spaper1
  22. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper1
  23. The Locus Coeruleus and the Noradrenergic Prodrome of Alzheimer's Diseasepaper1
TNR (tenascin-R) Reelin, synapse & ECM–PNN 77 34 docs
Matched on tenascin-?R TNR
  1. Fischer's Matrixpaper8
  2. Perineuronal Nets, Microglial Neuroinflammation, and Alzheimer'spaper7
  3. Perineuronal Netsconcept5
  4. Phase IIIpaper5
  5. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper5
  6. The NLRP Inflammasome and the Perineuronal Net in Alzheimer's Diseasepaper4
  7. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper3
  8. Homeostatic Collapsepaper3
  9. Michal Schwartz's Protective Autoimmunity as the Systemic Upstream of the Microglial Nichepaper3
  10. The Matrix as the Seventh Axis of Collapsepaper3
  11. Which Genes Set the Threshold for Collapsepaper3
  12. cognitive resilienceconcept2
  13. Mitochondrial Quality Control Across Five Diseasespaper2
  14. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper2
  15. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper2
  16. The Proteolytic Degradation of the Perineuronal Net and the Loss of PV Interneuronspaper2
  17. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  18. Bioenergetic Collapsepaper1
  19. Can a Drug Copy the Luckiest Mutation?paper1
  20. Collapse, Traced Cell Type by Cell Typepaper1
  21. CSF1R Inhibition Restores the Perineuronal Matrix and Destabilises the Rhythm It Supportspaper1
  22. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper1
  23. How the Genes Partition the Vascular Phenotypepaper1
  24. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper1
  25. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper1
  26. One Sensor, Two Collapses — Which Arm Matters More?paper1
  27. One Sugar Lattice, Three Jobspaper1
  28. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper1
  29. Templated Tau Misfolding Across the Three Phasespaper1
  30. The Brakes on Microglial Activation in Alzheimer's Diseasepaper1
  31. The Enzyme That Cuts the Protective Latticepaper1
  32. The Load-Bearing Neuronpaper1
  33. The Plaque Was Staged Before It Was Countedpaper1
  34. The Raphe Nuclei in Alzheimer's Disease as a Subject in Their Own Rightpaper1
BECN1 Autophagy / lysosome / clearance 75 20 docs
PLCG2 GWAS / LOAD risk 75 15 docs
SOD1 Oxidative stress & ferroptosis 75 20 docs
SRC Kinase & growth-factor signalling 75 23 docs
Matched on Src[- ]family Src kinases?
  1. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper16
  2. Can a Drug Copy the Luckiest Mutation?paper6
  3. Cofilin Serine 3paper6
  4. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper5
  5. Reelin, N-Sulfated Heparan Sulfate and ApoER2paper5
  6. Layer II Immature Neurons, Disease-Associated Microglia and the Reelin–Ephexin5 Axispaper4
  7. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper4
  8. Convergent Synaptic Collapsepaper3
  9. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper3
  10. The Load-Bearing Neuronpaper3
  11. Alzheimer's Disease as a Failure of Proteolytic Timing, Read Out at Cofilin Serine 3paper2
  12. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper2
  13. Compensatory Architecture at the Alzheimer Synapse Is Turnover Rate, Not Reservepaper2
  14. The Brain's Architect and the Brake It Puts on Taupaper2
  15. The Inflammasome Versus the Reelin Brakepaper2
  16. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper2
  17. UBE3A, PTPA and Ephexin5paper2
  18. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper1
  19. Cofilin Serine 3 in Alzheimer's Diseasepaper1
  20. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper1
  21. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper1
  22. Seth Margolis Revisitedpaper1
  23. The Enzyme That Cuts the Protective Latticepaper1
TREX1 Vascular / BBB 75 7 docs
NFE2L2 (NRF2) Oxidative stress & ferroptosis 74 15 docs
P2RY12 Microglia & innate immunity 73 35 docs
Matched on P2RY12 P2Y12
  1. The Microglion That Silences Tau's Phosphatasepaper9
  2. Bioenergetic Collapsepaper7
  3. Homeostatic Collapsepaper7
  4. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper4
  5. Which Genes Set the Threshold for Collapsepaper4
  6. BCG Vaccination in Alzheimer's Diseasepaper3
  7. The Brakes on Microglial Activation in Alzheimer's Diseasepaper3
  8. The Losing Axonpaper3
  9. Collapse, Traced Cell Type by Cell Typepaper2
  10. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper2
  11. Down Syndrome as the Disease Run in Fast-Forwardpaper2
  12. Fischer's Staged Deposit, 1907–1912paper2
  13. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper2
  14. The Drivers of Microglial Dysfunction in Alzheimer's Disease, Ranked by Causal Weightpaper2
  15. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper1
  16. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  17. Aleksandra Deczkowska's DAM Program and the Matrix-Degrading Armpaper1
  18. Alzheimer's Disease — A Process in Timepaper1
  19. Blood-Vessel Damage, Phase by Phasepaper1
  20. Carlo Abbate's Adult Neurogenesis Theory of Alzheimer's Disease, Critically Evaluatedpaper1
  21. Depression as Reversible Collapsepaper1
  22. Epigenetic Erosion as the Reversible Information Layer of Alzheimer's Diseasepaper1
  23. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper1
  24. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper1
  25. Homeostatic Microglial Collapseconcept1
  26. How the Genes Partition the Vascular Phenotypepaper1
  27. Iron Chelation and GPX4 Stabilizationpaper1
  28. Microglial Restraint as Resiliencepaper1
  29. Mitochondrial Quality Control Across Five Diseasespaper1
  30. NAD⁺ Restoration and CD38 Inhibitionpaper1
  31. Oskar Fischer's Eight Stages of Plaque Formationpaper1
  32. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper1
  33. The Bredesen ReCODE Protocol Evaluatedpaper1
  34. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper1
  35. The Plaque Was Staged Before It Was Countedpaper1
CD33 GWAS / LOAD risk 71 19 docs
SIRT1 Bioenergetic / mito / NAD 69 23 docs
AQP4 Vascular / BBB 67 6 docs
IL6 Microglia & innate immunity 64 30 docs
Matched on IL-?6
  1. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper14
  2. The Losing Axonpaper7
  3. Cellular Senescenceconcept4
  4. Amyloid-β Restrains Microglia Twicepaper3
  5. Depression as Reversible Collapsepaper3
  6. The Brakes on Microglial Activation in Alzheimer's Diseasepaper3
  7. The Immunometabolic Nexus of Neurodegenerationpaper3
  8. BCG Vaccination in Alzheimer's Diseasepaper2
  9. Blood-Vessel Damage, Phase by Phasepaper2
  10. LL-37, Innate Immunity and Autophagic Collapse in Alzheimer's Diseasepaper2
  11. Vascular Pathology as a Substrate Across Phasespaper2
  12. Aleksandra Deczkowska's DAM Program and the Matrix-Degrading Armpaper1
  13. Autophagy as the Driver of System-Wide Agingpaper1
  14. Beth Stevens's Complement-Pruning Programpaper1
  15. Can Vaccines Protect Against Dementia?paper1
  16. Convergent Synaptic Collapsepaper1
  17. How the Genes Partition the Vascular Phenotypepaper1
  18. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper1
  19. Lithium in Alzheimer's Diseasepaper1
  20. Mitochondrial Quality Control Across Five Diseasespaper1
  21. NAD⁺ Restoration and CD38 Inhibitionpaper1
  22. Neurotropic Viral Invasion of the Central Nervous Systempaper1
  23. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper1
  24. Pathogen Reactivation Across the Three Temporal Phases of Alzheimer's Diseasepaper1
  25. Restoring Autophagy in Neurodegenerationpaper1
  26. Telling Different Dementias Apartpaper1
  27. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper1
  28. Tryptophan Allocation Across the Kynurenine, NAD⁺ and Serotonergic Branchespaper1
  29. Which Biomarkers Detect Which Phasepaper1
  30. Zhen Huang's Competitive Synaptic Plasticity and the Amyloid-β Monomer Depletion Modelpaper1
MAPK14 (p38) Kinase & growth-factor signalling 64 11 docs
FTH1/FTL (ferritin) Oxidative stress & ferroptosis 63 18 docs
PSEN2 Amyloid & Tau core 63 35 docs
Matched on PSEN2 PS2 presenilin[- ]?2
  1. Estela Area-Gómez's MAM Theorypaper9
  2. Which Genes Set the Threshold for Collapsepaper6
  3. Mitochondria-Associated ER Membranes and Ceramide in Alzheimer's Diseasepaper5
  4. Pavel Kalvach's Case That Alzheimer's Is Not a Disease, Gradedpaper3
  5. Todd Golde's Amyloid Cascade, Read for What It Addspaper3
  6. Anne Eckert's Neuroendocrine Theory and the Withdrawal of Protection in the Ageing Brainpaper2
  7. Convergent Autophagic Collapsepaper2
  8. Convergent Synaptic Collapsepaper2
  9. How the Genes Partition the Vascular Phenotypepaper2
  10. Standard Diagnostic Biomarkers Explainedpaper2
  11. The Strongest Case FOR the Amyloid Cascadepaper2
  12. The Timing of Locus Coeruleus Loss in Alzheimer's Diseasepaper2
  13. A Funnel Model from Upstream Etiologies to PANTHOS in Alzheimer's Diseasepaper1
  14. Amyloid-β Restrains Microglia Twicepaper1
  15. APP and tau pathology linked through transport disruptionconcept1
  16. Autophagic Flux in Alzheimer's Diseasepaper1
  17. Autophagy-lysosomal failureconcept1
  18. Axonal transport failure as unifying mechanismconcept1
  19. Cofilin Serine 3paper1
  20. Dynamic and region-independent disease mechanismsconcept1
  21. Epigenetic regulation of AD genesconcept1
  22. Fischer's Staged Deposit, 1907–1912paper1
  23. Gene dosage of APP directly causes pathogenesisconcept1
  24. Gut-brain axis in neuroinflammationconcept1
  25. Load, Capacity and the Boundary of Convergent Clearance Failure in Neurodegenerationpaper1
  26. Multi-pathway AD pathophysiology reviewconcept1
  27. Oligodendroglial Autophagy Failure and the Glial Network in Proteostatic Crisispaper1
  28. Ralph Nixon's Endosomal–Autophagic–Lysosomal Framework of Alzheimer's Disease, Gradedpaper1
  29. Re-evaluating Tsai's 40 Hz Gamma Programpaper1
  30. Scott Small's Retromer and Endosomal Theorypaper1
  31. Smallpaper1
  32. Solomon Carter Fuller's 1911 Plaque Audit, Read Beside Oskar Fischer'spaper1
  33. The Calcium Hypothesis and the Systems Failure Model of Alzheimer's Diseasepaper1
  34. The Genes That Protect — Phenocopy the Fortunatepaper1
  35. The Losing Axonpaper1
AIFM2 (FSP1) Oxidative stress & ferroptosis 62 4 docs
DLG4 (PSD-95) Reelin, synapse & ECM–PNN 62 28 docs
Matched on DLG4 PSD-?95
  1. Christopher Ramsden's ApoE-Peroxidation and ApoER2 Theory, Revisitedpaper7
  2. Nine Accounts of the Failing Synapse, and the One Lesion They Describepaper7
  3. Convergent Synaptic Collapsepaper5
  4. Cofilin Serine 3paper4
  5. Gunnar Gouras's Intraneuronal Amyloid and the Synaptic Endosome, Twenty-Eight Years Onpaper4
  6. Lipid Peroxidation and ApoER2–Dab1 Disruption in Sporadic Alzheimer's Diseasepaper4
  7. Carla Shatz's Synaptic Restraint System and the C4d–LilrB2 Resultpaper3
  8. The Indifferent Neuronpaper3
  9. UBE3A, PTPA and Ephexin5paper3
  10. Which Genes Set the Threshold for Collapsepaper3
  11. LilrB2, C4d, Ephexin5 and Reelin in Alzheimer's Diseasepaper2
  12. Ari Rappoport's Lipid-Raft Theory of Plasticity, Revisitedpaper1
  13. Astrocytespaper1
  14. Cofilin Serine 3 and the Two Endosomal Programmes That Describe Its Removalpaper1
  15. Cofilin Serine 3 in Alzheimer's Diseasepaper1
  16. Cytoskeletal Collapse Nodenode1
  17. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper1
  18. Four Ways to Switch Off Protein Phosphatase 2A in the Cortical Neuronpaper1
  19. From Synapse Loss to Neuronal Death in Alzheimer's Diseasepaper1
  20. Lithium as a Substrate of the Three-Phase Architecture of Alzheimer's Diseasepaper1
  21. Lithium in Alzheimer's Diseasepaper1
  22. Reelin, N-Sulfated Heparan Sulfate and ApoER2paper1
  23. Residence Time as the Common Variable in Endosomal Traffic, Amyloid and Proteolysispaper1
  24. Shatz & Brottpaper1
  25. Synaptic Pathologyconcept1
  26. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper1
  27. The Load-Bearing Neuronpaper1
  28. The Pruning Receptor, the Licensing Architecture Above Cofilin, and One Shared Compartmentpaper1
FNDC5 (irisin) Trophic / exercise / resilience 62 4 docs
SYK Microglia & innate immunity 62 12 docs
CX3CR1 Microglia & innate immunity 61 29 docs
Matched on CX3CR1
  1. The Brakes on Microglial Activation in Alzheimer's Diseasepaper8
  2. The Microglion That Silences Tau's Phosphatasepaper7
  3. Homeostatic Collapsepaper6
  4. Which Genes Set the Threshold for Collapsepaper4
  5. Amyloid-β Restrains Microglia Twicepaper3
  6. Alzheimer's Disease — A Process in Timepaper2
  7. BCG Vaccination in Alzheimer's Diseasepaper2
  8. Bioenergetic Collapsepaper2
  9. Collapse, Traced Cell Type by Cell Typepaper2
  10. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper2
  11. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper2
  12. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper2
  13. The Drivers of Microglial Dysfunction in Alzheimer's Disease, Ranked by Causal Weightpaper2
  14. The Locus Coeruleus as Phase Bridgepaper2
  15. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  16. Aleksandra Deczkowska's DAM Program and the Matrix-Degrading Armpaper1
  17. Blood-Vessel Damage, Phase by Phasepaper1
  18. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper1
  19. Down Syndrome as the Disease Run in Fast-Forwardpaper1
  20. Homeostatic Microglial Collapseconcept1
  21. How the Genes Partition the Vascular Phenotypepaper1
  22. Microglial Restraint as Resiliencepaper1
  23. Mitochondrial Quality Control Across Five Diseasespaper1
  24. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper1
  25. Templated Tau Misfolding Across the Three Phasespaper1
  26. The Bredesen ReCODE Protocol Evaluatedpaper1
  27. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper1
  28. The Immunometabolic Nexus of Neurodegenerationpaper1
  29. The Losing Axonpaper1
CLDN5 Vascular / BBB 60 6 docs
CTSD Autophagy / lysosome / clearance 60 20 docs
GSDMD Microglia & innate immunity 60 10 docs
KMO Neuromodulator / circadian / kynurenine 59 6 docs
CTSB Autophagy / lysosome / clearance 58 18 docs
PPP3CA (calcineurin) Kinase & growth-factor signalling 58 22 docs
CSF1R Microglia & innate immunity 56 20 docs
GRIN2B Reelin, synapse & ECM–PNN 56 20 docs
VPS35 Autophagy / lysosome / clearance 56 11 docs
HSD17B10 Bioenergetic / mito / NAD 55 3 docs
RAC1 Reelin, synapse & ECM–PNN 53 9 docs
TTR (transthyretin) Amyloid & Tau core 52 2 docs
ADAM10 Amyloid & Tau core 51 19 docs
ADAMTS4 Reelin, synapse & ECM–PNN 51 23 docs
CDKN1A (p21) Epigenetic & senescence 51 17 docs
NRGN (neurogranin) Reelin, synapse & ECM–PNN 51 4 docs
SARM1 Bioenergetic / mito / NAD 50 8 docs
NTRK1 (TrkA) Trophic / exercise / resilience 49 10 docs
ULK1 Autophagy / lysosome / clearance 48 14 docs
ACHE Neuromodulator / circadian / kynurenine 47 17 docs
MAPT Amyloid & Tau core 47 13 docs
SV2A Reelin, synapse & ECM–PNN 47 10 docs
TIMP3 Reelin, synapse & ECM–PNN 47 6 docs
OPTN Neurodegeneration overlap 46 12 docs
ACAT1 Lipid, sterol & membrane 45 11 docs
NAMPT Bioenergetic / mito / NAD 44 8 docs
ROCK2 Reelin, synapse & ECM–PNN 44 14 docs
TMEM119 Microglia & innate immunity 44 27 docs
Matched on TMEM119
  1. Homeostatic Collapsepaper7
  2. Bioenergetic Collapsepaper5
  3. BCG Vaccination in Alzheimer's Diseasepaper3
  4. Down Syndrome as the Disease Run in Fast-Forwardpaper2
  5. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper2
  6. The Brakes on Microglial Activation in Alzheimer's Diseasepaper2
  7. The Microglion That Silences Tau's Phosphatasepaper2
  8. Which Genes Set the Threshold for Collapsepaper2
  9. A Cell-Type-Resolved Map of Death Modalities Across the Progression of Alzheimer'spaper1
  10. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper1
  11. Aleksandra Deczkowska's DAM Program and the Matrix-Degrading Armpaper1
  12. Alzheimer's Disease — A Process in Timepaper1
  13. Blood-Vessel Damage, Phase by Phasepaper1
  14. Carlo Abbate's Adult Neurogenesis Theory of Alzheimer's Disease, Critically Evaluatedpaper1
  15. Collapse, Traced Cell Type by Cell Typepaper1
  16. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper1
  17. Depression as Reversible Collapsepaper1
  18. Epigenetic Erosion as the Reversible Information Layer of Alzheimer's Diseasepaper1
  19. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper1
  20. Homeostatic Microglial Collapseconcept1
  21. Iron Chelation and GPX4 Stabilizationpaper1
  22. Microglial Restraint as Resiliencepaper1
  23. Mitochondrial, Autophagy-Lysosomal and Metabolic Quality Control in Alzheimer's Diseasepaper1
  24. NAD⁺ Restoration and CD38 Inhibitionpaper1
  25. The 50-Year Front — The Temporal Architecture of Alzheimer'spaper1
  26. The Bredesen ReCODE Protocol Evaluatedpaper1
  27. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper1
ATP synthase (ATP5x) Bioenergetic / mito / NAD 42 5 docs
CHAT (ChAT) Neuromodulator / circadian / kynurenine 42 9 docs
GRIA1 (GluA1) Reelin, synapse & ECM–PNN 42 18 docs
MEF2C GWAS / LOAD risk 41 9 docs
LIMK1 Reelin, synapse & ECM–PNN 40 8 docs
HTRA1 Vascular / BBB 39 1 doc
ATF4 Cell death & ER stress 38 11 docs
NCAN (neurocan) Reelin, synapse & ECM–PNN 38 20 docs
NOTCH3 Vascular / BBB 38 1 doc
TBK1 Microglia & innate immunity 38 9 docs
APPL1 Autophagy / lysosome / clearance 37 8 docs
HDAC2 Epigenetic & senescence 37 4 docs
PICALM GWAS / LOAD risk 37 17 docs
SDC (syndecan) Reelin, synapse & ECM–PNN 37 6 docs
SNAP25 Reelin, synapse & ECM–PNN 37 7 docs
VCAN (versican) Reelin, synapse & ECM–PNN 37 25 docs
Matched on VCAN versican
  1. Phase IIIpaper3
  2. The NLRP Inflammasome and the Perineuronal Net in Alzheimer's Diseasepaper3
  3. The Sulfated Matrix That Gates Astrocytic Cholesterol Delivery to the Synapsepaper3
  4. Which Genes Set the Threshold for Collapsepaper3
  5. A Graded Synthesis of the Temporal, Cellular and Ecological Mechanisms of Alzheimer'spaper2
  6. Perineuronal Netsconcept2
  7. Perineuronal Nets, Microglial Neuroinflammation, and Alzheimer'spaper2
  8. Templated Misfolding as the Fourth Substrate of the Homeostatic–Matrix–Synaptic Modelpaper2
  9. cognitive resilienceconcept1
  10. Collapse, Traced Cell Type by Cell Typepaper1
  11. Containment, Not Clearance, as the Variable That Changes First in the Ageing Brainpaper1
  12. Existing and Candidate Interventions Mapped onto the Convergent Collapse Frameworkpaper1
  13. Forty-Hertz Sensory Entrainment as a Candidate Disease-Modifying Therapy in Alzheimer'spaper1
  14. Homeostatic Collapsepaper1
  15. Homeostatic Microglial Collapseconcept1
  16. How the Genes Partition the Vascular Phenotypepaper1
  17. Norepinephrine as a Two-Armed Pincer on Taupaper1
  18. The Enzyme That Cuts the Protective Latticepaper1
  19. The Homeostatic–Matrix–Synaptic (HMS) Collapse Modelpaper1
  20. The Load-Bearing Neuronpaper1
  21. The Matrix as the Seventh Axis of Collapsepaper1
  22. The Perineuronal Matrix and Cortical Layer Twopaper1
  23. The Phase II → III Transitionpaper1
  24. The Plaque Was Staged Before It Was Countedpaper1
  25. The Proteolytic Degradation of the Perineuronal Net and the Loss of PV Interneuronspaper1
CX3CL1 (fractalkine) Microglia & innate immunity 36 14 docs
ABCA1 GWAS / LOAD risk 35 17 docs
BACE2 Amyloid & Tau core 35 4 docs
EIF2S1 (eIF2α) Cell death & ER stress 35 10 docs
MFSD2A Vascular / BBB 35 6 docs
TRPML1 Autophagy / lysosome / clearance 35 17 docs
CTNNB1 (β-catenin) Kinase & growth-factor signalling 34 9 docs
SALL1 Microglia & innate immunity 34 23 docs
SIRT3 Bioenergetic / mito / NAD 34 11 docs
KL (klotho) Trophic / exercise / resilience 33 9 docs
TYROBP GWAS / LOAD risk 33 16 docs
NLRP1 Microglia & innate immunity 32 3 docs
SSH1 (slingshot-1) Reelin, synapse & ECM–PNN 32 5 docs
AGER (RAGE) Vascular / BBB 31 8 docs
DYRK1A Amyloid & Tau core 31 3 docs
MS4A GWAS / LOAD risk 31 8 docs
TLR4 Microglia & innate immunity 31 19 docs
ADAMTS5 Reelin, synapse & ECM–PNN 30 10 docs
SMPD1 (acid sphingomyelinase) Lipid, sterol & membrane 30 3 docs
SMPD3 Lipid, sterol & membrane 30 3 docs
TPH2 Neuromodulator / circadian / kynurenine 30 5 docs
ABCA7 GWAS / LOAD risk 29 9 docs
ARNTL (BMAL1) Neuromodulator / circadian / kynurenine 29 11 docs
CD68 Microglia & innate immunity 29 15 docs
ACSL4 Oxidative stress & ferroptosis 28 8 docs
BCL2 (Bcl-2) Cell death & ER stress 28 13 docs
MAPK1/3 (ERK1/2) Kinase & growth-factor signalling 28 14 docs
CLU GWAS / LOAD risk 27 12 docs
CYCS (cytochrome c) Bioenergetic / mito / NAD 27 10 docs
IL18 Microglia & innate immunity 27 14 docs
VDAC1 Bioenergetic / mito / NAD 27 7 docs
ABI3 GWAS / LOAD risk 26 14 docs
CDKN2A (p16) Epigenetic & senescence 26 4 docs
CHI3L1 (YKL-40) Astrocyte & glial markers 26 6 docs
KCNC (Kv3) Neuromodulator / circadian / kynurenine 26 6 docs
SLC2A1 (GLUT1) Vascular / BBB 26 5 docs
ABCB1 (P-gp) Vascular / BBB 25 8 docs
CHRNA7 Neuromodulator / circadian / kynurenine 25 9 docs
EIF2AK3 (PERK) Cell death & ER stress 25 13 docs
FUS Neurodegeneration overlap 25 9 docs
GGA3 Autophagy / lysosome / clearance 25 4 docs
LAMP1 Autophagy / lysosome / clearance 25 10 docs
SNAP29 Autophagy / lysosome / clearance 25 7 docs
CDK5 Amyloid & Tau core 24 13 docs
MBP (myelin basic protein) Myelin & axon inhibition 24 10 docs
NDST1 Reelin, synapse & ECM–PNN 24 11 docs
NMNAT2 Bioenergetic / mito / NAD 24 6 docs
QPRT Neuromodulator / circadian / kynurenine 24 2 docs
RORB Reelin, synapse & ECM–PNN 24 6 docs
CASP3 Cell death & ER stress 23 15 docs
IFNAR1/2 Down-syndrome chr21 23 4 docs
ATG5 Autophagy / lysosome / clearance 22 10 docs
ATP13A2 (PARK9) Autophagy / lysosome / clearance 22 7 docs
CR1 GWAS / LOAD risk 22 10 docs
DNM1L Bioenergetic / mito / NAD 22 14 docs
IAPP Neurodegeneration overlap 22 5 docs
MTHFR Trophic / exercise / resilience 22 6 docs
OTX2 Reelin, synapse & ECM–PNN 22 8 docs
SYN1 (synapsin) Reelin, synapse & ECM–PNN 22 7 docs
TH (tyrosine hydroxylase) Neuromodulator / circadian / kynurenine 22 10 docs
TOMM20 Bioenergetic / mito / NAD 22 9 docs
CD36 Microglia & innate immunity 21 10 docs
SYP (synaptophysin) Reelin, synapse & ECM–PNN 21 16 docs
TDO2 Neuromodulator / circadian / kynurenine 21 5 docs
CD200 Microglia & innate immunity 20 5 docs
HAPLN1 Reelin, synapse & ECM–PNN 20 10 docs
IRF (3/7/8) Microglia & innate immunity 20 7 docs
MMP3 Reelin, synapse & ECM–PNN 20 11 docs
RIPK1 Cell death & ER stress 20 5 docs
RTN4R (NgR) Myelin & axon inhibition 20 10 docs
CAMK2A (CaMKII) Reelin, synapse & ECM–PNN 19 10 docs
HS3ST2 Reelin, synapse & ECM–PNN 19 6 docs
IDE Amyloid & Tau core 19 8 docs
P2RX7 Microglia & innate immunity 19 6 docs
PRKACA (PKA) Kinase & growth-factor signalling 19 14 docs
TMEM175 Autophagy / lysosome / clearance 19 6 docs
ZBP1 Microglia & innate immunity 19 2 docs
AIF1 (Iba1) Microglia & innate immunity 18 9 docs
ATG7 Autophagy / lysosome / clearance 18 10 docs
CRP Microglia & innate immunity 18 9 docs
DNM2 Autophagy / lysosome / clearance 18 9 docs
GLP1R Neuromodulator / circadian / kynurenine 18 8 docs
GRIN2A Reelin, synapse & ECM–PNN 18 7 docs
NPY Neuromodulator / circadian / kynurenine 18 9 docs
SLC18A2 (VMAT2) Neuromodulator / circadian / kynurenine 18 6 docs
TMEM106B Autophagy / lysosome / clearance 18 3 docs
TP53 (p53) Epigenetic & senescence 18 10 docs
CAT (catalase) Oxidative stress & ferroptosis 17 11 docs
COL4A1 Vascular / BBB 17 1 doc
HTR1A Neuromodulator / circadian / kynurenine 17 5 docs
LDLR Lipid, sterol & membrane 17 11 docs
MFN2 Bioenergetic / mito / NAD 17 8 docs
SLC1A2 (EAAT2/GLT-1) Astrocyte & glial markers 17 6 docs
TXN Oxidative stress & ferroptosis 17 9 docs
DLX1 Reelin, synapse & ECM–PNN 16 7 docs
SLC40A1 (ferroportin) Oxidative stress & ferroptosis 16 5 docs
TFAM Bioenergetic / mito / NAD 16 9 docs
BNIP3L (NIX) Bioenergetic / mito / NAD 15 5 docs
EP300 (p300) Epigenetic & senescence 15 8 docs
PDGFRB Vascular / BBB 15 2 docs
PRKCA (PKC) Kinase & growth-factor signalling 15 11 docs
SLC17A8 (VGLUT3) Neuromodulator / circadian / kynurenine 15 2 docs
STIM1 Cell death & ER stress 15 4 docs
TXNIP Microglia & innate immunity 15 9 docs
VIP Neuromodulator / circadian / kynurenine 15 6 docs
BAX Cell death & ER stress 14 7 docs
CCL2 (MCP-1) Microglia & innate immunity 14 8 docs
CD2AP GWAS / LOAD risk 14 7 docs
CDK3 Epigenetic & senescence 14 6 docs
CLEC7A (dectin-1) Microglia & innate immunity 14 6 docs
IL10 Microglia & innate immunity 14 10 docs
INPP5D GWAS / LOAD risk 14 5 docs
MAVS Microglia & innate immunity 14 3 docs
OLIG2 Down-syndrome chr21 14 3 docs
PEMT Lipid, sterol & membrane 14 1 doc
PPP1CA (PP1) Kinase & growth-factor signalling 14 12 docs
SNAP47 Autophagy / lysosome / clearance 14 4 docs
VPS26 Autophagy / lysosome / clearance 14 7 docs
VPS4A Autophagy / lysosome / clearance 14 8 docs
AXL Microglia & innate immunity 13 4 docs
DDIT3 (CHOP) Cell death & ER stress 13 6 docs
FOXC1 Vascular / BBB 13 1 doc
HCAR2 (GPR109A) Bioenergetic / mito / NAD 13 2 docs
HEXB Autophagy / lysosome / clearance 13 11 docs
HSPA1A (Hsp70) Cell death & ER stress 13 7 docs
LCMT1 Kinase & growth-factor signalling 13 4 docs
MSR1 Microglia & innate immunity 13 9 docs
NEK7 Microglia & innate immunity 13 6 docs
NMRK1 Bioenergetic / mito / NAD 13 6 docs
PLG (plasminogen) Vascular / BBB 13 5 docs
S100B Reelin, synapse & ECM–PNN 13 2 docs
VAMP8 Autophagy / lysosome / clearance 13 7 docs
VMA21 Autophagy / lysosome / clearance 13 2 docs
GAD1 (GAD67) Reelin, synapse & ECM–PNN 12 4 docs
LEP (leptin) Neuromodulator / circadian / kynurenine 12 3 docs
LPL Microglia & innate immunity 12 8 docs
NLRP2 Microglia & innate immunity 12 2 docs
NOS2 (iNOS) Microglia & innate immunity 12 6 docs
PTGS2 (COX-2) Microglia & innate immunity 12 8 docs
RAB7A Autophagy / lysosome / clearance 12 6 docs
SPP1 Microglia & innate immunity 12 9 docs
STAT (1/3/6) Microglia & innate immunity 12 7 docs
TIMM23 Bioenergetic / mito / NAD 12 4 docs
TIMP1 Reelin, synapse & ECM–PNN 12 5 docs
VCP Neurodegeneration overlap 12 6 docs
VDR Neuromodulator / circadian / kynurenine 12 4 docs
ABCG2 (BCRP) Vascular / BBB 11 3 docs
C5AR1 Microglia & innate immunity 11 6 docs
DEGS1 Lipid, sterol & membrane 11 2 docs
FGA/FGB/FGG (fibrinogen) Vascular / BBB 11 5 docs
FOXP3 Microglia & innate immunity 11 2 docs
HAPLN4 (Bral2) Reelin, synapse & ECM–PNN 11 8 docs
HAS1/2/3 Reelin, synapse & ECM–PNN 11 5 docs
IGF1 Trophic / exercise / resilience 11 9 docs
MAP2 Reelin, synapse & ECM–PNN 11 7 docs
SMAD3 Kinase & growth-factor signalling 11 6 docs
SMAD7 Kinase & growth-factor signalling 11 6 docs
SOAT1 Lipid, sterol & membrane 11 6 docs
CD4 Microglia & innate immunity 10 3 docs
CST7 (cystatin F) Microglia & innate immunity 10 8 docs
IL1B Microglia & innate immunity 10 6 docs
LILRB5 GWAS / LOAD risk 10 4 docs
PDHA1 (PDH) Bioenergetic / mito / NAD 10 7 docs
RELCH Autophagy / lysosome / clearance 10 5 docs
VPS29 Autophagy / lysosome / clearance 10 5 docs
ADAMTS1 Reelin, synapse & ECM–PNN 9 4 docs
CD22 Microglia & innate immunity 9 1 doc
HTR2A Neuromodulator / circadian / kynurenine 9 4 docs
INSR Neuromodulator / circadian / kynurenine 9 7 docs
ITGAX Microglia & innate immunity 9 7 docs
NPC1 Autophagy / lysosome / clearance 9 3 docs
PPARGC1A Bioenergetic / mito / NAD 9 1 doc
PQBP1 Epigenetic & senescence 9 3 docs
RNASEH2A/B/C Microglia & innate immunity 9 2 docs
SIRT6 Bioenergetic / mito / NAD 9 6 docs
SLC7A11 (xCT) Oxidative stress & ferroptosis 9 5 docs
SOD2 Oxidative stress & ferroptosis 9 4 docs
ADAMTS2 Reelin, synapse & ECM–PNN 8 7 docs
ALOX15 Oxidative stress & ferroptosis 8 5 docs
ASAH1 (acid ceramidase) Lipid, sterol & membrane 8 1 doc
CD74 Microglia & innate immunity 8 3 docs
CHL1 Reelin, synapse & ECM–PNN 8 6 docs
HAMP (hepcidin) Oxidative stress & ferroptosis 8 1 doc
HMOX1 Oxidative stress & ferroptosis 8 3 docs
MAPK8 (JNK) Kinase & growth-factor signalling 8 5 docs
MLKL Cell death & ER stress 8 2 docs
MRC1 (CD206) Microglia & innate immunity 8 6 docs
OPA1 Bioenergetic / mito / NAD 8 4 docs
PLD3 GWAS / LOAD risk 8 4 docs
SATB1 Epigenetic & senescence 8 3 docs
SLC7A5 (LAT1) Vascular / BBB 8 4 docs
TET1/2/3 Epigenetic & senescence 8 2 docs
TFE3 Autophagy / lysosome / clearance 8 5 docs
TLR2 Microglia & innate immunity 8 5 docs
VEGF Trophic / exercise / resilience 8 6 docs
AIM2 Microglia & innate immunity 7 4 docs
CD28 Microglia & innate immunity 7 1 doc
CD47 Microglia & innate immunity 7 2 docs
DBH Neuromodulator / circadian / kynurenine 7 3 docs
FANCC Epigenetic & senescence 7 2 docs
FLVCR2 Vascular / BBB 7 1 doc
H2AX Epigenetic & senescence 7 4 docs
HDAC6 Epigenetic & senescence 7 3 docs
HEXIM1 Epigenetic & senescence 7 7 docs
HSF1 Cell death & ER stress 7 2 docs
ICAM1 Vascular / BBB 7 4 docs
IDO2 Neuromodulator / circadian / kynurenine 7 4 docs
LAMP2 Autophagy / lysosome / clearance 7 6 docs
NGFR (p75NTR) Trophic / exercise / resilience 7 4 docs
NRG1 (neuregulin-1) Reelin, synapse & ECM–PNN 7 5 docs
OGDH (KGDH) Bioenergetic / mito / NAD 7 2 docs
PARL Bioenergetic / mito / NAD 7 4 docs
PPP5C (PP5) Kinase & growth-factor signalling 7 6 docs
RIPK3 Cell death & ER stress 7 2 docs
ROCK1 Reelin, synapse & ECM–PNN 7 5 docs
SIRPA Microglia & innate immunity 7 2 docs
SIRT7 Bioenergetic / mito / NAD 7 4 docs
SMAD2 Kinase & growth-factor signalling 7 5 docs
TFRC Oxidative stress & ferroptosis 7 4 docs
TSPO Microglia & innate immunity 7 5 docs
VPS41 Autophagy / lysosome / clearance 7 2 docs
ACOX1 Lipid, sterol & membrane 6 3 docs
ACSL1 Lipid, sterol & membrane 6 4 docs
ADRB (β-AR) Neuromodulator / circadian / kynurenine 6 1 doc
Matched on ADRB1 ADRB2 β[12]?-AR β-adrenergic
  1. The Brakes on Microglial Activation in Alzheimer's Diseasepaper6
AOAH Microglia & innate immunity 6 6 docs
ATP2A2 (SERCA2) Cell death & ER stress 6 3 docs
CANX (calnexin) Cell death & ER stress 6 4 docs
CD14 Microglia & innate immunity 6 4 docs
CD163 Microglia & innate immunity 6 6 docs
CHST3 Reelin, synapse & ECM–PNN 6 3 docs
EPHA1 GWAS / LOAD risk 6 3 docs
ERBB4 Reelin, synapse & ECM–PNN 6 3 docs
GAP43 Reelin, synapse & ECM–PNN 6 2 docs
GPHN (gephyrin) Reelin, synapse & ECM–PNN 6 3 docs
GRAMD1B (Aster-B) Lipid, sterol & membrane 6 2 docs
HMGB1 Microglia & innate immunity 6 5 docs
LPCAT3 Lipid, sterol & membrane 6 3 docs
MAG Myelin & axon inhibition 6 4 docs
MCU Bioenergetic / mito / NAD 6 3 docs
MFN1 Bioenergetic / mito / NAD 6 4 docs
NOS3 (eNOS) Vascular / BBB 6 1 doc
NQO2 Oxidative stress & ferroptosis 6 2 docs
PLEKHM1 Autophagy / lysosome / clearance 6 3 docs
PLP1 Myelin & axon inhibition 6 3 docs
PPIF (cyclophilin D) Bioenergetic / mito / NAD 6 4 docs
RAB11A Autophagy / lysosome / clearance 6 4 docs
SLC5A7 (CHT1) Neuromodulator / circadian / kynurenine 6 1 doc
STX17 (syntaxin-17) Autophagy / lysosome / clearance 6 3 docs
TGFB1 Kinase & growth-factor signalling 6 6 docs
VAPB Neurodegeneration overlap 6 2 docs
AANAT Neuromodulator / circadian / kynurenine 5 3 docs
ADAR Microglia & innate immunity 5 2 docs
ALOX5 Oxidative stress & ferroptosis 5 4 docs
APAF1 Cell death & ER stress 5 5 docs
APLP1 Amyloid & Tau core 5 3 docs
APLP2 Amyloid & Tau core 5 2 docs
CHST11 Reelin, synapse & ECM–PNN 5 3 docs
CRH Neuromodulator / circadian / kynurenine 5 2 docs
EGFR Kinase & growth-factor signalling 5 3 docs
EPG5 Autophagy / lysosome / clearance 5 2 docs
GAD2 (GAD65) Reelin, synapse & ECM–PNN 5 2 docs
GCLC Oxidative stress & ferroptosis 5 3 docs
HSP90AA1 (Hsp90) Cell death & ER stress 5 3 docs
ITM2B (BRI2) Amyloid & Tau core 5 2 docs
ITPR1 (IP3R) Cell death & ER stress 5 2 docs
JAK1 Microglia & innate immunity 5 4 docs
JAK2 Microglia & innate immunity 5 1 doc
KEAP1 Oxidative stress & ferroptosis 5 2 docs
LMNB1 Epigenetic & senescence 5 4 docs
MOG Myelin & axon inhibition 5 2 docs
MRE11 Epigenetic & senescence 5 2 docs
NMRK2 Bioenergetic / mito / NAD 5 4 docs
NPTX2 Reelin, synapse & ECM–PNN 5 3 docs
POLG Bioenergetic / mito / NAD 5 2 docs
SMCR8 Autophagy / lysosome / clearance 5 3 docs
SYNJ1 Down-syndrome chr21 5 1 doc
TAX1BP1 Autophagy / lysosome / clearance 5 5 docs
WDR91 Autophagy / lysosome / clearance 5 2 docs
APBB1 Amyloid & Tau core 4 1 doc
Matched on APBB1 Fe65
  1. The Losing Axonpaper4
APOC1 GWAS / LOAD risk 4 2 docs
AVP (vasopressin) Neuromodulator / circadian / kynurenine 4 2 docs
CASP8 Cell death & ER stress 4 2 docs
CCR5 Microglia & innate immunity 4 2 docs
CSNK1D (CK1δ) Kinase & growth-factor signalling 4 2 docs
DGAT2 Lipid, sterol & membrane 4 3 docs
EXT1 Reelin, synapse & ECM–PNN 4 3 docs
FASN Lipid, sterol & membrane 4 2 docs
FKBP5 Neuromodulator / circadian / kynurenine 4 2 docs
GPX1 Oxidative stress & ferroptosis 4 3 docs
HK1 Bioenergetic / mito / NAD 4 4 docs
LHX6 Reelin, synapse & ECM–PNN 4 2 docs
LPCAT4 Lipid, sterol & membrane 4 2 docs
NAPRT Bioenergetic / mito / NAD 4 4 docs
NOD2 Microglia & innate immunity 4 4 docs
NR3C1 (GR) Epigenetic & senescence 4 4 docs
NRF1 (nuclear respiratory factor 1) Bioenergetic / mito / NAD 4 3 docs
PTEN Kinase & growth-factor signalling 4 4 docs
RECK Reelin, synapse & ECM–PNN 4 2 docs
RILPL1 Autophagy / lysosome / clearance 4 2 docs
SHH Kinase & growth-factor signalling 4 3 docs
SLC6A3 (DAT) Neuromodulator / circadian / kynurenine 4 1 doc
SREBF2 (SREBP-2) Lipid, sterol & membrane 4 3 docs
SUMF1 Autophagy / lysosome / clearance 4 2 docs
TBC1D24 Neurodegeneration overlap 4 2 docs
TGFBR1 Kinase & growth-factor signalling 4 3 docs
TIMP2 Reelin, synapse & ECM–PNN 4 3 docs
TLR6 Microglia & innate immunity 4 2 docs
TRIM44 Autophagy / lysosome / clearance 4 2 docs
ACE2 Vascular / BBB 3 2 docs
ATAD1 (Thorase) Bioenergetic / mito / NAD 3 2 docs
ATF3 Cell death & ER stress 3 3 docs
ATG16L1 Autophagy / lysosome / clearance 3 3 docs
ATP8B4 GWAS / LOAD risk 3 2 docs
B2M Microglia & innate immunity 3 2 docs
CAST (calpastatin) Reelin, synapse & ECM–PNN 3 2 docs
CD44 Microglia & innate immunity 3 2 docs
CDKN2D (p19INK4d) Epigenetic & senescence 3 2 docs
CHAC1 Oxidative stress & ferroptosis 3 3 docs
CTSS (cathepsin S) Autophagy / lysosome / clearance 3 1 doc
CXCL1 Microglia & innate immunity 3 3 docs
CXCR4 Microglia & innate immunity 3 2 docs
CYP46A1 Lipid, sterol & membrane 3 3 docs
FUNDC1 Bioenergetic / mito / NAD 3 3 docs
GAS6 Microglia & innate immunity 3 2 docs
GLUL (glutamine synthetase) Astrocyte & glial markers 3 3 docs
HLA-DRB1 GWAS / LOAD risk 3 2 docs
HSPA5 (BiP/GRP78) Cell death & ER stress 3 1 doc
ITGAM Microglia & innate immunity 3 2 docs
LDHA Bioenergetic / mito / NAD 3 3 docs
MIF Microglia & innate immunity 3 3 docs
Matched on MIF macrophage migration inhibitory factor
Often named withCD74
  1. Adult hippocampal neurogenesis restorationconcept1
  2. CD74 Microglial Signalingconcept1
  3. Sensory Loss Dementia Correlationconcept1
MTNR1A/B Neuromodulator / circadian / kynurenine 3 1 doc
Matched on MTNR1A MTNR1B melatonin receptor
  1. The Failing Clock That Stops Defending the Brainstempaper3
OMA1 Bioenergetic / mito / NAD 3 2 docs
OXR1 Oxidative stress & ferroptosis 3 2 docs
P2RY13 Microglia & innate immunity 3 2 docs
PLIN2 (perilipin-2) Lipid, sterol & membrane 3 3 docs
RCAN1 Down-syndrome chr21 3 1 doc
SAMHD1 Microglia & innate immunity 3 2 docs
SLC11A2 (DMT1) Oxidative stress & ferroptosis 3 2 docs
SLC19A1 Trophic / exercise / resilience 3 2 docs
SOX2 Epigenetic & senescence 3 2 docs
TLR9 Microglia & innate immunity 3 2 docs
TPH1 Neuromodulator / circadian / kynurenine 3 3 docs
WDR41 Autophagy / lysosome / clearance 3 3 docs
YAP1 Kinase & growth-factor signalling 3 2 docs
ADRA2A Neuromodulator / circadian / kynurenine 2 2 docs
ATF6 Cell death & ER stress 2 2 docs
ATG9A Autophagy / lysosome / clearance 2 2 docs
BCL2L1 (Bcl-xL) Cell death & ER stress 2 2 docs
BHMT Trophic / exercise / resilience 2 1 doc
CASP9 Cell death & ER stress 2 2 docs
CCR2 Microglia & innate immunity 2 2 docs
CLIC4 Microglia & innate immunity 2 1 doc
CST3 (cystatin C) Amyloid & Tau core 2 2 docs
CTSL (cathepsin L) Autophagy / lysosome / clearance 2 2 docs
FOXO3 Trophic / exercise / resilience 2 2 docs
GCLM Oxidative stress & ferroptosis 2 1 doc
Matched on GCLM
  1. Phase IIpaper2
GGA2 Autophagy / lysosome / clearance 2 1 doc
GHRL (ghrelin) Neuromodulator / circadian / kynurenine 2 1 doc
HMGCR Lipid, sterol & membrane 2 2 docs
IFITM3 Microglia & innate immunity 2 1 doc
KYNU Neuromodulator / circadian / kynurenine 2 1 doc
LRP2 (megalin) Vascular / BBB 2 1 doc
Matched on LRP2 megalin
  1. The Brain's Border Gatepaper2
NR1H3 (LXRα) Lipid, sterol & membrane 2 2 docs
OMG (OMgp) Myelin & axon inhibition 2 1 doc
PIN1 Amyloid & Tau core 2 2 docs
PROS1 Microglia & innate immunity 2 1 doc
RIN3 GWAS / LOAD risk 2 2 docs
RTN4 (Nogo-A) Myelin & axon inhibition 2 1 doc
SMAD4 Kinase & growth-factor signalling 2 2 docs
SSH2 Reelin, synapse & ECM–PNN 2 2 docs
WWTR1 (TAZ) Kinase & growth-factor signalling 2 1 doc
ATG13 Autophagy / lysosome / clearance 1 1 doc
C3AR1 Microglia & innate immunity 1 1 doc
CYBB (NOX2) Microglia & innate immunity 1 1 doc
ERN1 (IRE1) Cell death & ER stress 1 1 doc
MTR (methionine synthase) Trophic / exercise / resilience 1 1 doc
NMNAT1 Bioenergetic / mito / NAD 1 1 doc
NQO1 Oxidative stress & ferroptosis 1 1 doc
PAK1 Reelin, synapse & ECM–PNN 1 1 doc
PCSK9 Lipid, sterol & membrane 1 1 doc
PLA2G4A (cPLA2) Microglia & innate immunity 1 1 doc
RB1CC1 (FIP200) Autophagy / lysosome / clearance 1 1 doc
SERPINA3 Amyloid & Tau core 1 1 doc
Matched on SERPINA3 antichymotrypsin
Often named withABI3APOEAPPC3CLUDLX1
  1. Todd Golde's Amyloid Cascade, Read for What It Addspaper1
SERPINE1 (PAI-1) Vascular / BBB 1 1 doc
SHANK3 Reelin, synapse & ECM–PNN 1 1 doc
SIRT2 Bioenergetic / mito / NAD 1 1 doc
SLC6A2 (NET) Neuromodulator / circadian / kynurenine 1 1 doc
Matched on SLC6A2 norepinephrine transporter
  1. Norepinephrine as a Two-Armed Pincer on Taupaper1
SPOCK3 (testican-3) Reelin, synapse & ECM–PNN 1 1 doc
Matched on SPOCK3 testican-?3
Often named withABI3APOEAPPC3CLUDLX1
  1. Todd Golde's Amyloid Cascade, Read for What It Addspaper1

Method

Counts come from a case-insensitive, word-bounded text scan of each published page — the 153 papers rendered in full plus the concept, node and stage pages. The 51 PDF-only papers carry no text on the site and are not scanned. Each gene matches its symbol and its curated aliases (RELN also counts reelin; APOE counts ApoE4 and apolipoprotein E). A sentence naming two spellings counts twice. The entrant and external-scientist dossiers are withheld from this edition and are not scanned, so these tallies run lower than the full corpus.

Important noticeThis is a research platform, not a medical site. Nothing here is medical advice, a diagnosis, or a treatment recommendation, and none of it has been reviewed by a regulator. The drugs, doses and trials discussed are research literature, not prescriptions. If dementia affects you or someone you care about, speak to a doctor.

Compiled from the knowledge base and the research corpus under the Organic Network Synthesis methodology · the research corpus of Adult Cognitive Disease · the seven monographs are here. 2026.

857 interlinked articles · 153 papers in full · 51 as typeset PDFs · 635 concepts · 7 convergence nodes · 5 temporal stages.

Discussion

Corrections and disagreements are welcome here, and citation corrections most of all. Posting needs a GitHub account. Please read Taking Part first — in particular, nothing here is medical advice.